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CHAPTER 1 
INTRODUCTION 
Biomaterials have been used in the medical field for approximately one hundred 
years [Bhat 2002].  Although there is controversy over the term “biomaterial”, a widely 
accepted definition for biomaterials is: "A material intended to interface with biological 
systems to evaluate, treat, augment or replace any tissue, organ or function of the body." 
[Williams 1999].  It is important to note that living natural materials, such as tissues, 
should be called “biological materials” and should not be included in the definition of 
biomaterials [Shi 2005].    
In recent years, there has been an increased interest in biomaterial applications in 
the medical field. Some common examples are artificial joints, heart valves, and contact 
lenses. Table 1.1 shows the major applications of biomaterials, with a total U.S. market 
of $9 billion in 2000 [Ratner et al. 2004].  Despite some biomaterial successes during the 
past few years, one of the most constant problems is the “biocompatibility” of the 
biomaterial.  Biocompatibility is “the ability of a biomaterial to perform its desired 
function with respect to a medical therapy, without eliciting any undesirable local or 
systemic effects in the recipient or beneficiary of that therapy, but generating the most 
appropriate beneficial cellular or tissue response in that specific situation, and optimizing 
the clinically relevant performance of that therapy” [Williams 2008].  Thus, two key  
Table 1.1 Numbers of Medical Devices Used Each Year in U.S. (Global numbers are 
typically 2-3 times the U.S.  numbers) [Ratner et al. 2004] .   
2 
 
Medical Devices Numbers of Usage/yr 
Catheter 200,000,000 
Blood Bags 40,000,000 
Contact lens (2000) 30,000,000 
Intraocular lens (2003) 2,500,000 
Coronary stents 1,500,000 
Dental implant (2000) 910,000 
Hip and knee prostheses (2002) 500,000 
Pacemaker 400,000 
Renal dialyzer (2001) 320,000 
Vascular graft 300,000 
Heart-Lung (Oxygenators) 300,000 
Breast implant 250,000 
Heart valve 100,000 
 
  
3 
 
aspects of biomaterials need to be evaluated: performance of desired functions and 
assessment of interference with the biological system.  
Research of biocompatible materials has drawn more and more attention since 
first introduced in the literature in 1967.  Publication data shows that it has become an 
almost exponentially growing topic in research within the past twenty years as shown in 
Figure 1.1.  Due to the complexity and diversity of the circumstances in which 
biomaterials are being used, biocompatibility issues are very complicated.  Although, 
many creative works have been performed to improve the biocompatibility of materials, 
some key draw backs still remain unsolved, especially in long-term implantable medical 
devices [Williams 2008].  One major long-term problem of current blood-contacting 
biomaterials is haemocompatibility, which includes platelet adhesion, activation, and 
aggregation, followed by thrombus formation and detaching (shedding emboli) [Hayward 
and Chapman 1984; Courtney et al. 1994; Williams 2008].   These adverse host 
responses can further lead to the severe health problems, including severe bleeding 
resulting from platelet depletion, life-threatening stroke due to emboli transported to the 
brain and ischemia (lack of oxygen), and death of downstream tissue due to thrombosis 
formation. 
The prevalent strategy for enhancing the haemocompatibility of biomedical 
polymers is surface modification. Modifications include grafting anticoagulants such as 
heparin [Marconi et al. 1996; Thorslund et al. 2005] and hirudin [Lahann et al. 2001; Lin 
and Tseng 2001], increasing the surface hydrophilicity via poly(ethyleneoxide) [Amiji 
and Park 1993], and passivation by coupling albumin to the surface [Amiji and Park 
1993; De Queiroz et al. 1997].  However, some problems still exist with such methods.  
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Figure 1.1 Annual numbers of articles with the word "biocompatibility" in topic (data 
obtained from ISI Web of Knowledge) 
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The immobilized active proteins, such as albumin and hirudin, are susceptible to 
conformational changes and enzymatic deterioration in vivo and are often only suitable 
for short-term applications [Bamford and Al-Lamee 1992; Muntean 1999; Williams 
2008].  
Recently, nitric oxide (NO), a well-known anti-platelet factor which is 
endogenously generated by endothelia cells, has been used to improve the 
haemocompatibility of biomaterials [Bohl and West 2000; Frost et al. 2005]. However, 
these biomaterials still have their limitations, including limited lifetime release of NO or 
a non-constant NO release rate. Recently, a polymer which uses endogenous NO to 
minimize platelet adhesion  has been designed [Duan and Lewis 2002] and the minimum 
NO flux for complete platelet inhibition on the polymer surface has been determined to 
be 0.3-0.6 fmol/(cm2·s) [Ramamurthi and Lewis 2000].  The polymer exploited 
endogenous NO (S-nitrosothiols, RSNO) to generate an NO flux from the polymer 
surface.  Therefore, the polymer did not involve incorporating limited amount of NO 
donors into the polymer.  
The design concept was based on the following theory. First, there is abundant S-
nitrosothiols (mostly S-nitroso-albumin with concentrations around the M level 
[MacArthur et al. 2007]) in the blood providing an unlimited NO resource for the 
modified polymer [Stamler and Loscalzo 1992].  Second, NO can be transferred between 
different thiol compounds. The transfer rate is fast and preferentially transferred from S-
nitroso-albumin to cysteine [Meyer et al. 1994; Wang et al. 2001].  It also has been 
shown that NO can be transferred in vivo from S-nitroso bovine serum albumin 
(BSANO) to L-cysteine [Scharfstein 1994].  Third, S-nitrosocysteine (the compound 
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formed once NO is transferred to cysteine) is unstable with trace concentrations of some 
metal ions catalysis, such that NO is released to inhibit platelet adhesion [Askew et al. 
1995; Swift and Williams 1997; Stamler and Toone 2002].  Thus, the above properties of 
thiols gave rise to the design of attaching cysteine to the surface of a polymer so that NO 
can be transferred from S-nitroso-albumin to the cysteine on the polymer and then 
released to inhibit platelet adhesion and aggregation.  
Previous experimental results showed significant inhibition of platelet adhesion to 
the modified polymer surface. However, complete inhibition still has not been achieved 
despite several optimization attempts of this polymer  [Duan 2001; Fahlenkamp 2003].  
Thus, this work focused on the kinetics of the reactions between a cysteine-modified 
biomaterial and the S-nitrosothiols to predict the NO release rate of this modified 
biomaterial surface for comparison with the release rate required for complete inhibition 
of platelet adhesion in physiological conditions.   Specifically, this work explored and 
developed the kinetic model of the multiple reactions between a cysteine-modified 
polyethylene terephthalate polymer (Cys-PET) and nitroso bovine serum albumin 
(BSANO) in various in vitro conditions and predicted the NO release rate from the 
polymer surface. Meanwhile, various potential deactivating factors of the polymer were 
studied so that an optimized storage condition could be determined for the polymer and 
the effective life time of the polymer could be estimated in the physiological condition. 
Although transnitrosation kinetics in free solution have been studied earlier 
[Meyer et al. 1994; Hogg 1999; Wang et al. 2001; Hu and Chou 2006], this study is 
unique since there is no reported kinetic study for the transnitrosation and release of NO 
involving immobilized components applied to the minimization of platelet adhesion. In 
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addition, reported kinetic data for the transnitrosation between S-nitroso proteins and low 
molecular weight thiols are not consistent and complete [Meyer et al. 1994; Zhang and 
Means 1996; Hogg 1999; Wang et al. 2001], thus this study can help to fill this gap.  The 
kinetic model will also be helpful to reveal the possible reasons that cause the incomplete 
inhibition of platelet adhesion.  Thus, more pertinent optimizations of the polymer can be 
made.  The work was accomplished through five objectives.   
1.1 Objective #1: S-nitrosocysteine (CySNO) Decomposition in Polymer-free 
Solution. 
The hypothesis was that various factors can affect CySNO decomposition such as 
light, pH and metal ion.  The decomposition rate is one of the dominant parameters that 
can affect NO release rate from the polymer surface. Thus, by studying the CySNO 
decomposition in the polymer-free solution condition, behaviors of the CySNO in the 
immobilized form can be predicted.  Because NO is extremely reactive due to its free 
radical essence [Wang et al. 2002], it is hard to measure the NO release rate directly from 
the polymer. Thus an indirect method was used through monitoring the CySNO 
disappearance rate which can be quantified by spectrophotometric analysis.  In this study, 
CySNO decomposition in various buffers with different purity grades at different pH was 
studied and a chelate effect was also studied.  In addition, light effects from the 
spectrophotometer were also evaluated and results from two spectrophotometers were 
compared. Finally, a possible mechanism for CySNO decomposition, involving metal ion 
concentration and pH, was presented.  
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1.2 Objective #2: S-nitroso-bovine-serum-albumin (BSANO) Transnitrosation 
with Free Cysteine (CySH). 
In order to better understand the transnitrosation between BSANO and 
immobilized cysteine (CySH), transnitrosation with free CySH (not bound to polymer) 
was studied first.  As NO transfer is hard to monitor directly as mentioned earlier, the 
kinetics were studied through monitoring BSANO and CySNO concentration changes 
with time in batch conditions.  Molecular weight filtration was used to separate BSANO 
and CySNO and a chemiluminescence method was used to measuring their 
concentrations. A mathematic model was developed to fit the experiment data and key 
kinetic parameters were calculated using data analysis software.  Ascorbic acid effects on 
the transnitrosation were also studied due to its well known ability of promoting the NO 
release from nitrosothiols [Holmes and Williams 2000; Smith and Dasgupta 2000]. 
1.3 Objective #3: Immobilization of CySH on PET Surface. 
The hypothesis was that the imine bond which is formed during previous 
developed immobilization techniques might be unstable in neutral pH solution and the 
peptide bond can be a good candidate for immobilization, also CySH itself can be 
oxidized by various factors.  Previous studies showed that cysteine can be detached from 
PET in acidic condition completely within 1 hour [Duan and Lewis 2002; Gappa-
Fahlenkamp et al. 2004] probably due to imine bond hydrolysis [Vazquez et al. 1990; 
Migneault et al. 2004].  In order assess this hypothesis, Cys-PET made by the previous 
method was incubated in buffer solutions and the CySH concentration in the solution and 
on the polymer was monitored through Ellman’s method and chemiluminescence 
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method, respectively.  Afterwards, the kinetics of CySH detaching from the PET surface 
were studied.  To overcome the potential unstable bond, several alternative methods were 
developed to attach cysteine or its derivatives on the PET surface via a peptide bond. The 
stability of the new CySH modified polymer in aqueous solution was evaluated.  The 
immobilized CySH oxidation due to different environment conditions was studied by 
monitoring CySH surface concentration during various treatments, such as light, air and 
temperature.  The light and air effect was studied only for dry conditions, while for the 
aqueous condition, only temperature effect was studied as the modified polymer is 
intended to be used in an oxygenated environment without light (in vivo).  A detailed 
kinetic model was developed based on the experimental data and an optimized storage 
condition was determined.   
1.4 Objective #4: BSANO Transnitrosation Kinetics with Immobilized CySH 
and Prediction of NO Flux from Cys-PET in a Flow System. 
The hypothesis was that the partial platelet inhibition previously observed was 
due to insufficient NO release from the modified polymer surface.  In order to assess the 
hypothesis, Cys-PET and BSANO transnitrosation followed by CySNO decomposition in 
batch conditions were monitored by measuring BSANO and cysteine surface 
concentration changes using a chemiluminescence based assay which was previously 
established.  A mathematical model was developed similarly as in object #2 and key 
kinetic parameters were determined.   The kinetic model and parameters were then 
applied to a tubular flow reactor (with laminar flow) and the NO flux from the polymer 
surface at steady state was predicted using a mathematical model. Various factors, 
including flow rate, BSANO concentration, cysteine surface concentration and CySNO 
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decomposition rate constant and transnitrosation reaction equilibrium constant, were 
evaluated as to their effect on the NO release rate.  The predicted NO was compared with 
the minimum NO flux required to inhibit platelet adhesion as mentioned earlier. 
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CHAPTER 2 
REVIEW OF LITERATURE 
 
Platelets hold an important role in the haemostatic response.  Platelets prevent the 
loss of blood following a wound by adhering to the site of vascular damage and then 
forming a thrombus that can stop bleeding.  A more detailed illustration of the 
haemostasis sequence is shown in Figure 2.1.  Briefly, platelets adhere to the vascular 
damage site in a few seconds after injury.  Then platelet aggregation starts and it forms a 
loose and permeable haemostatic plug which can close up the rupture.  As more platelets 
are attracted to the site, the plug becomes impermeable and then the coagulation cascade 
starts, forming fibrin fibrils which can fortify the primary thrombus and finally forming a 
stronger thrombus to stop bleeding [Roderique and Wynands 1967; Blockmans et al. 
1995].  However, such positive mechanisms can cause significant adverse sequences 
when foreign materials are in contact with blood [Authi et al. 1993].  Platelet adhesion to 
materials, when applied to medical devices, can adversely affect the material 
performance.   
In order to develop a haemocompatible biomaterial, the mechanism of the 
interaction between the foreign material and blood must be fully understood.  This 
chapter will first focus on the mechanism of haemostatic response in the biological  
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Figure 2.1 Haemostasis sequence involving the platelets at different levels. Figure 
modified from [Roderique and Wynands 1967].  
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system, which includes platelet activation and inhibition.  Afterwards, the biochemistry 
of nitric oxide (NO) and its interaction with thiols in blood, to form S-nitrosothiols, will 
be explored, leading to the rationale of using cysteine-modified polymers to inhibit 
platelet adhesion.  Finally, a brief review of current haemocompatible biomaterials 
including the previous work done by our group will be given.  
2.1 Platelet Activation and Inhibition Mechanism 
2.1.1 Platelet Activation 
Platelet activation can be observed when platelets change their shape from disk-
like to sphere and form long extensions called pseudopodia.  Although the detailed 
pathways of platelet activation are very complicated, the pathways all involve 
interactions between agonists and the corresponding receptors in the platelet membrane 
[Ashby et al. 1990; Blockmans et al. 1995].  These responses can be categorized into 
three different patterns based on the agonists that initiate the responses [Authi et al. 
1993].   
Direct Response. Platelets are induced by thrombin and Platelet-Activating 
Factor (PAF), the latter is a potent phospholipid activator.  These agonist-receptor 
interactions can cause platelet aggregation, thromboxane A2 (TXA2) synthesis and 
secretion from all three storage granules in the platelet.  ADP then interacts with TXA2 to 
enhance platelet aggregation. 
Adhesion-dependent Response. This response is initiated when platelets interact 
with collagen fibrils and then spread on the fibrils.  This causes the secretion of TXA2 
synthesis from all three storage granules and an increase in the phosphatidylserine 
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content of the outer leaflet of the plasma membrane.  This enhanced extracellular 
exposure of phosphatidylserine triggers the formation of factor X and prothrombin 
activation complexes on the activated platelets and forms localized thrombin in the 
surrounding area of the site where platelets are exposed to collagen.  This response only 
occurs in an area of vascular damage where collagen is exposed.  If the collagen 
concentration is low, collagen alone won’t initialize this response and usually the 
response is additionally dependent upon the interaction with released products such as 
ADP and TXA2.  Thus, this response can be remarkably reduced if ADP or TXA2 is 
removed.   
Aggregation-dependent Response.  If the initial aggregation caused by agonist-
receptor interactions is not strong enough, TXA2 synthesis may be triggered and TXA2 
will be secreted from the storage granules.  This response is induced by agonists such as 
ADP, adrenaline and 5-hydroxytrytamine (5HT).  However, this response won’t lead to 
lysosomal secretion or enhanced phosphatidylserine which is unlike the direct response 
mentioned earlier.  Figure 2.2 shows different platelet agonists and responses.   
Once the receptors in the platelet membrane binds the corresponding agonists, the 
cascade of intracellular second messengers, including inositol 1,4,5-triphosphate (IP3),   
and diacylglycerol (DAG), is triggered.  IP3 causes Ca2+ secretion from the platelet dense 
tubular system, which leads to the arachidonate acid (ARA) release by phospholipase A2 
(PA2) [Brass 1991; Haynes 1993; Puri and Colman 1997].  ARA is the precursor of TXA2 
which can permeate out of cell and interact with receptors on the platelet surface and 
leads to further activation.  Meanwhile, DAG activates protein kinase C, initiating 
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granule secretion and fibrinogen receptor exposure [Savi and Herbert 1996].  Another 
important player during the platelet activation is the G protein family, which mediates  
 
Figure 2.2 Platelet agonists and responses. The “+” symbol indicates an excitatory 
agonist and the “-” symbol represents an inhibitory agonist.  [Authi et al. 
1993].  
  
16 
 
various agonist-receptor interactions [Brass et al. 1993].  G proteins were believed to 
manipulate phosphoinosititde hydrolysis and 3’,5’-monophosphate (cAMP) formation. 
They are also involved in PA2 activation, which leads to the secretion of TXA2 precursor 
formation as mentioned earlier [Haynes 1993].  
2.1.2 Platelet Inhibition 
Regulation of platelet activation is critical for the homeostasis of the vascular wall 
because excessive platelet activation can cause a thrombo-embolic phenomena, especially 
in the arterial vessels [Blockmans et al. 1995].  The activation of human platelets is 
inhibited by various chemicals, including thrombin inhibitor (e.g. hirudin) [Glusa 1991], 
ADP scavengers (e.g. apyrase) [Walsh et al. 1977], TXA2 generation inhibitors (e.g. 
aspirin) [Vane 1994] and physiological and pharmacological agents which can elevate 
intraplatelet cyclic nucleotides [Haynes 1993].   In physiological conditions, vascular 
endothelial cells synthesize and secrete various platelet inhibitors.  The most  important 
two inhibitors are prostacyclin and the endothelium-derived relaxing factor (EDRF), 
which boost levels of the cAMP and cGMP, respectively, in human platelets [Haynes 
1993; Vane 1994]. 
EDRF was first discovered by Furchgott and Zawadzki in 1980 when it was 
recognized as an endothelium-derived labile humeral substance which is responsible for 
mediating the vascular relaxations induced by acetylcholine [Furchgott and Zawadzki 
1980].  Later, EDRF was found to be a potent inhibitor of platelet aggregation [Azuma et 
al. 1986; Radomski et al. 1992] and that it elevates cGMP levels in platelets or other 
target cells [Furchgott and Zawadzki 1980; Radomski et al. 1992].  This behavior of 
EDRF was then shown to be identical to that of nitric oxide (NO) by different research 
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groups [Furchgott 1988; Ignarro et al. 1988].  Additional results confirmed this analysis 
and it is now widely accepted that NO is EDRF [Radomski and Moncada 1993]. 
2.2   Biochemistry of Nitric Oxide and S-nitrosothiol 
NO is a diffusible and extremely reactive molecular messenger with diverse 
biological functions throughout the body including the vascular, immune, and nervous 
systems due to its free radical essence [Moncada et al. 1991; Butler and Williams 1993; 
Änggård 1994; Knowles 1997; Murayama and Nomura 1998; Louis 1999; Gladwin et al. 
2003].  In the central nervous system, NO adjusts synaptic plasticity and affects brain 
development, memory formation and behaviors.  In the peripheral nervous system, NO 
acts as a neurotransmitter to regulate viscera motility, local blood flow and 
neuroendocrine function [Christopherson and Bredt 1997; Michel and Feron 1997].  NO 
is also responsible for controlling infection in which macrophages express an inducible 
NO synthase in response to immunological or inflammatory stimulation  [Nathan 1997].  
Also, the continuous generation of NO by the vascular endothelia cells is critical for the 
regulation of blood pressure and blood flow [Michel and Feron 1997; Loscalzo 2001].  
Finally, the endothelium-derived NO has a critical role in preventing premature platelet 
adhesion and aggregation [Moncada et al. 1991; Loscalzo 2001]. 
2.2.1    NO Biosynthesis 
NO is synthesized by the oxidation of the guanidinium nitrogen of amino acid L-
arginine, resulting in L-citrulline as the coproduct [Knowles and Moncada 1994; 
Williams 2003].  The mechanism is a two-stage stereo-specific reaction involving 
molecular oxygen and reduced nicotinamide adenine dinucleotide phosphate (NADPH) 
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as coenzyme, with the aid of cofactors such as calcium ions and tetrahydrobiopterin 
(Figure 2.3) [Williams 2003].  This formation of NO from L-arginine is catalyzed by NO 
synthase (NOS) [Knowles and Moncada 1994; Mayer et al. 1998].  There are three 
different NOS isoforms that have been discovered so far: 
 nNOS (neuronal NO synthase): a calcium and calmodulin (Ca-CAM)-
dependent constitutive enzyme present in neurons and skeletal muscle, which 
generates NO as a neurotransmitter [Schmidt and Walter 1994; Christopherson 
and Bredt 1997; Mayer et al. 1998]. 
 iNOS (inducible NO synthase): a calcium-independent isoform isolated from 
macrophages, vascular smooth muscle cells, and hepatocytes which is induced by 
specific cytokines such as bacterial and viral infections [Nathan 1997; Williams 
2003]. 
 eNOS (endothelial NOS): a Ca-CAM regulated constitutive form found in 
vascular endothelial cells, which produces NO and releases it into blood stream 
[Michel and Feron 1997]. 
nNOS and eNOS are also called constitutive NOS (cNOS) because they are dependent on 
calcium ion.  The distribution of these three isoforms overlaps in many tissues and cell 
types and their subcelluar locations are variable.  Meanwhile, the same isoform in 
different cells may have different biological functions, and the eNOS and nNOS are also 
inducible [Michel and Feron 1997]. 
2.2.2    Platelet Inhibition by Nitric Oxide  
One of the most distinguished properties of NO is its unspecified signaling due to 
its lipophilic and free radical properties. This is quite different from the usual signaling 
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Figure 2.3 NO biosynthesis is through oxidation of the guanidinium nitrogen of L-
arginine. This reaction catalyzed by nitric oxide synthase (NOS) with 
coenzyme NADPH. Oxygen is the electron acceptor [Williams 2003].   
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process in which signaling messengers interact with particular receptors on target cells to 
induce a specific response.  NO can diffuse to virtually anywhere to interact with many 
targets including metal- and thiol-containing molecules and soluble guanylate cyclase 
[Moncada et al. 1991; Radomski and Moncada 1993; Williams 2003].  Although this 
process may seem to be random, these unique properties of NO are critical to mediate 
many of its biological functions.   
Guanylate cyclase exists in both cytosolic and particulate fractions of cells [Brass 
1991; Ivanova et al. 1994].  Particulate guanylate cyclase is found in the plasma 
membrane of many cells and so far five isoforms have been recognized.  The soluble 
isoform of guanylate cyclase (sGC) plays a essential role in the NO-cGMP signal 
transduction pathway [Ivanova et al. 1994].  sGC is a Mn2+-dependent enzyme found in 
the cytosolic fraction of most mammalian cells and is very abundant in platelets 
[Guthmann et al. 1992].  A key characteristic of sGC is the presence of heme as a 
prosthetic group.  NO interacts with sGC through this heme group to evoke a 
conformational change that stimulates the conversion of GTP to cGMP [Radomski and 
Moncada 1993; Änggård 1994]. 
It has been well documented that the key mechanism by which NO inhibits 
platelet activation is through activation of platelet sGC to increase levels of cGMP 
[Radomski and Moncada 1993; Williams 2003].  Besides the sGC pathway, NO actions 
that are independent of cGMP production have also been described [Gordge et al. 1996].  
These include NO-mediated ADP ribosylation, inhibition of glyceraldehyde-3-phosphate 
dehydrogenase and inhibition of intracellular calcium mobilization [Dimmeler and Brüne 
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1992; Feldman 1993; Brune B. 1998].  However, the relative importance of such non-
sGC/cGMP independent actions of NO has not yet been fully understood. 
The effects of NO on platelet differ substantially from those of many other 
antiplatelet agents.  Compared to cyclooxygenase inhibitor acetylsalicylic acid (aspirin), 
which irreversibly inhibits platelet activation by preventing the formation of the pro-
aggregatory TXA2 [Vane 1994], NO inhibits platelet activation at an earlier stage and its 
effects are rapid and reversible [Radomski and Moncada 1993; Williams 2003]. Thus, in 
addition to inhibiting platelet adhesion to the vessel wall, NO also interferes with the 
initial thrombus formation by inhibiting aggregation and autocrine stimulations.  This 
interference prevents platelet recruitment to the vicinity [Freedman et al. 1995; Freedman 
et al. 1997; Williams 2003]. 
2.2.3 Nitric Oxide and S-nitrosothiol 
As a messenger molecule involving many physiological functions, NO needs to 
be transferred to various target tissues. However, due to its high reactivity with molecular 
oxygen, superoxide anion and heme/non-heme iron, its half life is less than 5 seconds in 
biological systems [Nathan 1992; Archer 1993].  In order to overcome this problem, 
biological systems develop an effective method to suppress the activity of NO, namely, 
binding NO to thiol groups.  Stamler et al. observed that NO can react with cellular thiols 
to form S-nitrosothiols (RSNO), thus extending the half-life and spatial impact of NO 
[Stamler et al. 1992b].  Stamler also suggested that RSNOs act as nitrosonium (NO+) and 
nitroxyl (NO-) donors with chemical reactivities different from those of NO, which 
donors are capable of forming and modifying proteins and are present in mammalian 
tissue [Stamler et al. 1992b].  S-nitrosothiols have also been shown to have similar 
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biological actions as NO and play an important role in many processes, including platelet 
inhibition, signal transduction, DNA repair, host defense, blood pressure control, ion 
channel regulation and neurotransmission  [Radomski et al. 1992; Lander et al. 1996; 
Gow et al. 1997; Brune B. 1998; Persichini et al. 1998].  In order to understand the S-
nitrosothiol/NO functions in the physiological conditions, the basic biochemistry of S-
nitrosothiol/NO need to be elaborated. Figure 2.4 shows a summary of the major NO 
derivatives with different redox status.   A detailed explanation of the reactions involved 
is discussed below. 
Synthesis. S-nitrosothiol can be synthesized in vitro by mixing thiol (RSH) and 
acidic nitrite via the following reactions in aqueous solution.  
2 2HNO H NO H O
                                         (2.1) 
             RSH NO RSNO H
                                                  (2.2)  
The S-nitrosation (or S-nitrosylation) reactions can be quite rapid (ranging from less than 
half minute to a few minutes) under certain circumstances [Stamler et al. 1992a; 
Williams 1996; Zhang et al. 1996].  Although this method was later shown to be 
unspecific for S-nitrosation due to its ability to nitrosate amine and hydroxyl group, it is 
still widely used for preparing S-nitrosothiols because the thiol groups have a much 
higher affinity to nitrosation agents,  thus getting nitrosated very fast [Aldred et al. 1982; 
Zhang et al. 1996].    
Nitrosation of thiols can also take place with gaseous NO in aqueous solution at 
neutral pH when oxygen exists. The mechanism involves oxygen converting NO into 
N2O3, which is a known strong nitrosation agent [Wink et al. 1993; Lewis and Deen 
1994]: 
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Figure 2.4 Summary of the chemistry of the redox-interrelated forms of NO of potential 
biological significance.  The primary reactions of NO· involve oxygen, 
superoxide, and redox metals (M).  NO- is reactive with metals and with thiols 
(RSH).  Spontaneous dimerization of NO- results in the formation of N2O.  
Nitrosation reactions involve RSH and addition to bases  (B-), including 
peroxide [Stamler and Loscalzo 1992]. 
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2 22 2  NO O NO                                                           (2.3) 
2 2 3NO NO N O                                                             (2.4)
2 3 2N O RSH RSNO NO H
                                          (2.5) 
These reaction mechanisms may serve as a pathway for in vivo S-nitrosation 
formation, although no direct evidence is provided.  Recently, it has been reported that 
even in the absence of oxygen, thiol can still be nitrosated by NO with the mediation of 
an hemoglobin-iron complex [Palmerini 2002].  On the other hand, it was also reported 
that peroxynitrite (ONOOH) may nitrosate thiols such as glutathione [Wu et al. 1994; van 
der Vliet et al. 1998] according to: 
2 2GSH ONOOH GSNO H O                                         (2.6) 
Gow et al. proposed a mechanism for the formation of RSNOs in vivo (under 
physiological conditions) [Gow, 1997].  In this mechanism, NO reacts directly with 
reduced thiol to produce a radical intermediate, RSNOH.  This intermediate then reduces 
an available electron acceptor to produce RSNO.  Under aerobic conditions, O2 acts as 
the electron acceptor and is reduced to produce superoxide (O2-). 
RSH NO RSNOH                                                          (2.7) 
2 2RSNOH O RSNO H O
                                              (2.8) 
2O NO ONOO
                                                           (2.9) 
The above reaction mechanisms clarify that RSNO can also be synthesized under a wide 
variety of physiological conditions.   
S-nitrosothiols have relatively high extinction coefficients in the range of 330-350 
nm.  This property can be used to directly measure the concentration of S-nitrosothiol at 
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sub-mM levels [Stubauer et al. 1999; Vanin et al. 2004].  Table 2.1 lists the extinction 
coefficients of some common S-nitrosothiols at 334nm [Gordge et al. 1996].  
RSNO has also been reported to be formed in vivo from many thiol compounds [Butler et 
al. 1995; Lander 1997].  S-nitrosoalbumin (AlbSNO), S-nitrosoglutathione (GSNO), or 
S-nitrosocysteine (CySNO) have been detected and quantified in vivo and their 
physiological functions has been shown to be similar to NO itself [Kluge et al. 1997].  
The single free cysteine of serum albumin, Cys-34, has been shown to be particularly 
reactive toward NO under physiological conditions, primarily because that the pKa of its 
sulfhydryl group (8.5) is close to that of cysteine itself (8.0) [Tong 2003].  Human plasma 
contains micromolar or sub-micromolar level RSNOs, of which 96% are S-
nitrosoproteins, 82% of which is accounted for by AlbSNO.  However, plasma level of 
free nitric oxide is only in the 3 nM range [Stamler et al. 1992b; Giustarini et al. 2007].  
Thus, it has been hypothesized that AlbSNO serves as a reservoir with which plasma 
levels of highly reactive, short-lived free NO can be regulated.  The chemical half-life of 
released NO is very short and is inactivated within ~0.2 s [Kelm and Schrader 1990].  On 
the other hand, RSNOs are usually very stable compounds, especially the AlbSNO which 
has a half-life of 40 min [Stamler et al. 1992a]. 
 Decomposition. The stability of most the S-nitrosothiol is much better compared 
to NO.  The thioester bond is a slightly polar covalent bond and it is not susceptible to 
homolysis to form radicals unless irradiated with strong light [Hogg 2002].  However this 
bond is very unstable due to trace metal ions contamination in solution [John McAninly 
1993; Williams 1996; Stamler and Toone 2002].  The general form of this reaction is as 
follows: 
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Table 2.1 Extinction Coefficients for Several S-nitrosothiols at 334 nm [Gordge et al. 
1996]. 
RSNO Extinction coefficients (mM-1cm-1) 
S-nitrosocysteine 0.74 
S-nitrosohomocysteine 0.73 
S-Nitroso-N-acetylpenicillamine 1.00 
S-nitroso-N-acetyl-cysteine 0.87 
S-nitrosoglutathione 0.85 
S-nitrosoalbumin 0.87 
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1     
2
RSNO NO RSSR                            (2.10) 
This instability is directly related to the metal ion concentration and it leads to sporadic 
decomposition rates due to the various contamination level of metal ions in solution 
[Hogg 2002; Stamler and Toone 2002].  For example, S-nitrosocysteine (CySNO) half-
life was reported to be 30 seconds by Meyer et al, while Arnelle and Stamler measured it 
as 60 min [Meyer et al. 1994; Arnelle and Stamler 1995].  Studies have shown that even 
at µM level, copper ions can effectively catalyze this decomposition [Williams 1996].  
Initially, Cu2+ was believed to be the active form that is responsible for the 
decomposition, but additional studies confirmed that Cu+ is the real species.  A detailed 
mechanism has been established as follows [Askew et al. 1995; Dicks et al. 1996; 
Stubauer et al. 1999]: 
2RS Cu RS Cu                                                     (2.11) 
2RSNO Cu RS Cu NO                                            (2.12) 
2RS RSSR                                                         (2.13) 
Chelating agents which can complex with Cu+ has been shown to suppress the biological 
function of RSNO to some extent [Gordge et al. 1995]. 
On the other hand, the structure of the nitrosothiol can also affect the stability of 
RSNO in solution significantly, although no direct correlation has been found [Noble and 
Williams 2000].  For example, Nobel and Williams reported that the CySNO 
decomposition rate is on the order of 103 faster than S-nitrosocysteinylglycine 
(GlyCySNO) [Noble and Williams 2000].  As for S-nitroso proteins, this stability can be 
even higher.  Pietraforte et al. (1995) showed that S-nitroso bovine serum albumin 
(BSANO) is very stable in PBS buffer at 37ºC even in absence of metal ion chelators. 
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Scorza et al. (1996) observed no NO release from BSANO within 3 hours with a chelator 
(DTPA) and thiol deactivator (NEM).  
In biological systems, RSNO concentrations, locations and bioactivities are 
usually regulated by catabolic processes rather than by synthesis.  Several enzymes have 
been shown to break down low molecular weight (LMW) RSNOs in vitro, as shown in 
Table 2.2 [Askew et al. 1995; Freedman et al. 1995; Hou et al. 1996; Trujillo et al. 
1998].  The relative distribution of these enzymes in different tissues could dramatically 
alter RSNO bioactivities.  In the lung, for example, -glutamyl transpeptidase, which 
converts GSNO to S-nitrosocysteinylglycine, may give a greater membrane permeability 
for submucosal/smooth muscle bioactivity [Hogg et al. 1997].  In addition, glutathione 
peroxidase may produce NO with the net effect of inactivating GSNO and eliminating 
NOx through NO expiration and/or reaction of NO with heme iron(II) [Freedman et al. 
1995; Hou et al. 1996].  
 RSNO decomposition can also be induced by inorganic reaction.  Intermediate 
Fe(S)NO formulation involving LMW thiol groups may result in RSNO catabolism 
[Vanin et al. 1997].  Inorganic reactions with copper are closely related to S-
nitrosocysteine decomposition in vitro as previously discussed [Singh et al. 1996a].  
Although these may seem to be less relevant in vivo, where free Cu+ concentrations are 
low, protein bound Cu+ is still capable of promoting NO release from RSNO at a 
comparatively lower speed [Dicks and Williams 1996].  It has been reported that Cu+ 
chelation results in inhibition of bioactivities, which are thought to be related to GSNO 
catabolism in platelets and cardiac myocytes [Gordge et al. 1996; Mayer et al. 1998].  
The RSNO catabolic effects of other biological transition metals are negligible compared  
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Table 2.2 Enzymes Systems that Break Down GSNO In Vitro [Askew et al. 1995; 
Freedman et al. 1995; Hou et al. 1996; Trujillo et al. 1998] 
Enzyme Nitrogen oxide product 
(Thioredoxin) Thioredoxin Reductase Nitric Oxide 
Glutathione Peroxidase Nitric Oxide 
γ-Glutamyl Transpeptidase S-nitrosocysteinylglycine 
(Xanthine) Xanthine Oxidase Peroxynitrite 
Glutathione Dependent Formaldehyde 
Dehydrogenase Hydroxylamine 
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with those of Cu and Fe [McAninly et al. 1993].  On the other hand, O2- has been shown 
to cause CySNO and GSNO breakdown with second order  reaction kinetics in RSNO 
and first order in O2- [Aleryani et al. 1998; Jourd'heuil et al. 2000].  Based on the rate 
constant k (3-6×108 M-2s-1), micromolar RSNO concentrations would be degraded only 
very slowly (~pM min-1) by these reactions in the presence of nanomolar O2- 
concentrations under physiological conditions. 
2.2.4    Transnitrosation: Transfer of Nitric Oxide between S-Nitrosothiols  
Although plasma albumin can reacts with NO to form AlbSNO in physiological 
conditions, the limited intracellular access of AlbSNO indicates that NO might be 
transferred from plasma AlbSNO pool to affect biological function.  NO exchange among 
thiols has been already reported in non-physiological conditions [Bennett et al. 1986; 
Keaney 1993].  Scharfstein et al. have demonstrated that the transnitrosation between 
AlbSNO and LMW thiols (i.e., cysteine), occurs rapidly and completely in vitro under 
physiological conditions, as shown below [Scharfstein 1994].  
AlbSNO  CySH AlbSH  CySNO            (2.14) 
After NO is transferred to LMW thiols, these smaller, more diffusible NO adducts can be 
used to transport NO more efficiently to the vascular smooth muscle cell or platelet 
surface.    
Hemoglobin can also be nitrosated by NO through its single -chain reduced Cys-
93 under conditions of high oxygen affinity and the resulting SNO-hemoglobin leads to 
LMW RSNO formation through transnitrosation reactions [Jia et al. 1996; Gow et al. 
1997; Giustarini et al. 2004].  The circulatory system may provide end organs with a 
stable supply of LMW RSNOs which can diffuse into tissues from the erythrocytes [Jia et 
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al. 1996].  Furthermore, NOS activation itself may form RSNOs, probably via 
intermediate ONOO- in the presence of thiols [Schmidt and Walter 1994; Gow et al. 
1997].  Finally, other RSNO synthetic reactions may occur in vivo, such as protein 
nitrosation by nitrous acid (HNO2) in acidic organelles, although these reactions remain 
to be verified. 
2.3   Previous Research 
 
The prevalent strategy for enhancing the haemocompatibility of biomedical 
polymers is surface modification.  Modifications include grafting anticoagulants such as 
heparin and hirudin [Marconi et al. 1996], increasing the surface hydrophilicity via 
poly(ethyleneoxide) [Amiji and Park 1993], and passivation by coupling albumin to the 
surface [De Queiroz et al. 1997].  Also, polymers that have multiple functional molecules 
have also been studied in which heparin and albumin were both immobilized to increase 
the thromboresistance of biomedical polymers [Marconi et al. 1996]. However, some 
problems still exist with such methods.  The immobilized active proteins are susceptible 
to conformational changes and enzymatic deterioration in vivo and are often suitable for 
only short-term applications.  To date, none of these methods can generate a complete 
non-thrombogenic surface. 
A new approach of haemocompatible polymer that is widely studied is a nitric 
oxide donor polymer.  As discussed earlier, NO, a small messenger molecule, serves to 
inhibit platelet adhesion, aggregation, and activation as well as relax smooth muscles and 
modulate neurotransmission. Vascular endothelial cells synthesize and release NO and 
prostacyclin to make vessel walls completely compatible with platelet. The estimated NO 
flux rate from the blood vessel is 6800 fmol·cm2·s-1 [Vaughn et al. 1998].  To mimic the 
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inner surface of the blood vessel, significant studies have been devoted to incorporate 
diazeniumdiolate NO donors into polymer surfaces to reduce platelet adhesion, 
aggregation, and the formation of thrombus on the thrombogenic surfaces [Annich G M 
2000; Bohl and West 2000; Folts 2000].  
Research on NO donor polymers demonstrates that localized NO release through 
incorporating NO donors into polymer surfaces may be an effective strategy for solving 
the haemocompatibility problems associated with blood-contacting medical devices.  
There are various NO donors incorporated in different polymers [Maalej et al. 1999; 
Annich G M 2000; Bohl and West 2000; Folts 2000].  However, some limitations of NO-
releasing polymers, including non-constant release rates and limited life span and toxic 
concerns from donor residues, are difficult or impossible to be resolved which may 
essentially limit the applications of this technology.  
2.3.1   Design of an Apparatus to Study NO Inhibition of Platelet on Surface 
In order to overcome the above limitations of the current haemocompatible 
polymers, a new design of polymer was proposed.  The first work in our research group 
was to establish valid guidelines for the local delivery of NO to reduce platelet deposition 
on biomaterials.  This included the development of a suitable NO delivery device to study 
NO inhibition of platelet-biomaterial interactions in vitro, and the development of a 
mathematical model to predict aqueous NO concentration and flux profiles required to 
inhibit platelet attachment to biomaterials [Ramamurthi and Lewis 1997; Ramamurthi 
and Lewis 1998].  
A thin-slit flow chamber device (shown in Figure 2.5) was designed to study the 
inhibition of platelet deposition on polymer surfaces under various flow conditions via 
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the local delivery of gaseous NO.  A collagen-coated polymer was exposed to a flowing 
platelet suspension while NO gas permeated through the polymer and entering into the 
solution.   The platelets were labeled with either a fluorescence dye or 51Cr in order to 
study the platelet attachment to the polymer surface either qualitatively or quantitatively.    
Perfusion rates were determined based on wall shear rate requirements.  The study 
showed that platelet-surface interactions are highly dependent on wall shear rates 
[Ramamurthi and Lewis 2000].  Although physiologically relevant shear rates range 
between 40 and 5000 s-1 [Turitto 1982],  the shear rates tested were restricted between 
125 and 500 s-1, in order to minimize surface platelet aggregation and thrombus 
formation at higher shear rate.  The wall shear rate ( in s-1) was determined from laminar 
flow analysis in a slit flow chamber according to: 
260Wb
Q
2
3 γ       (2.15) 
where Q is the volumetric flow rate (cm3 min-1), W is the slit width (cm), and b is the 
half-thickness of the flow slit (cm).  Based on the geometry of the flow slit, a volumetric 
flow rate of 1 ml min-1 corresponds to a shear rate of 250 s-1 and a Reynolds number of 2. 
 In order to predict aqueous NO spatial concentrations and fluxes profiles within 
the slit flow chamber reactor, a steady-state dimensionless continuity equation for NO 
was developed and solved numerically [Ramamurthi and Lewis 1997].  This study 
showed that the minimum surface NO concentrations and fluxes required to inhibit 
platelet deposition are 0.1 nM and 0.3-0.6 fmol·cm-2·s-1, respectively.  Comparing this 
value to the estimated NO flux from the vascular cell mentioned earlier (which is 6800 
fmol·cm-2·s-1), it is obvious that the platelets can be fully inhibited at the physiological 
NO flux rate.  For the modified polymer, since the concentration of RSNOs in plasma 
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Figure 2.5 Thin-slit flow chamber device used to investigate the inhibition of platelet 
deposition on a biomaterial surface under flow conditions via the local 
delivery of gaseous nitric oxide  [Ramamurthi and Lewis 1998]. 
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have been shown to be in the micromolar or sub-micromolar range [Giustarini et al. 
2007], there is a sufficient supply of NO that can be transferred to the surface of the 
cysteine-modified polymer by transnitrosation in order to inhibit platelet deposition on 
the surface. 
2.3.2    Cysteine Immobilization and Surface Characterization 
The next part of the research was to develop a cysteine modified surface which 
was first characterized and then used in studies involving platelets and plasma in order to 
test the design’s ability to inhibit platelet adhesion to the surface [Duan 2001; Duan and 
Lewis 2002].  The basic concept for this modified polymer involves transnitrosation 
between the S-nitroso-albumin and the immobilized cysteine followed by S-nitroso-
cysteine decomposition which releases NO to inhibit platelet adhesion to the polymer 
surface (Figure 2.6). 
Two polymers which are widely used in blood-contacting applications, 
polyurethane (PU) and polyethylene terephthalate (PET), were chosen as the model 
polymer to attach cysteine.  There are three reactive groups on cysteine that can be used 
for immobilization: the primary amine (-NH2), carboxyl (-COOH) and the thiol (-SH).  
Since a free thiol group is required for the transnitrosation reaction with RSNOs in the 
blood followed by the release of NO into surroundings to prevent platelet attachment, 
therefore, only the amino group and the carboxyl group are available for immobilization.  
The amino group of cysteine was finally chosen as the reaction group for attaching 
cysteine on polymer surface because glutaraldehyde cross-linking through amino group is 
convenient and efficient and had been widely used [Jayakrishnan and Jameela 1996; 
Marconi et al. 1996; Seifert et al. 1997].  PU and PET have inert surfaces and have to be 
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Figure 2.6 Illustration of the concept for the design that exploits endogenous NO and 
naturally-occurring mechanisms to increase the haemocompatibility of blood-
contacting surfaces.  Nitric oxide (NO) is transferred from S-nitroso serum 
albumin (AlbSNO) to cysteine (CySH), which is attached on the surface of 
polyethylene terephthalate (PET) film. This forms unstable S-nitrosocysteine 
(CySNO) which then decomposes and releases NO to inhibit platelet adhesion 
on the PET surface.  
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chemically modified to introduce reactive groups for immobilization.  Therefore, PET 
and PU were treated with ethylenediamine (ED) and 3-aminopropyltriethoxysilane 
(APTES) to form a primary amine group on the polymer surfaces.  The complete reaction 
scheme used to attach cysteine to PET and PU is shown in Figure 2.7.  Later on, this 
process was optimized and different thiol containing molecules (e.g., 2-iminothiolane, 
cysteine polypeptide) were successfully attached to PET [Fahlenkamp 2003]. 
The cysteine surface concentration was then quantified by a chemiluminescence-
based assay.  Modified polymers were first treated by acidic nitrite solution (nitrite in 
excess) so that the immobilized cysteine is nitrosated.  This step also breaks off the 
cysteine molecules from the polymers due to the unstable imine bond under acidic 
conditions [Carey and Sundberg 2007].  After nitrosation, the nitrosated cysteine the 
solution and the excess nitrite can be converted to NO by the use of reducing agents and 
measured by a NO chemiluminescence analyzer.  The reducing solutions are made up of 
acidic acid with potassium iodide and can be adjusted for measuring different nitrite 
product by adding different agents.  For assaying the total nitrite (NO2- + CySNO), an 
excess of free iodine is added in order to convert the CySNO and the excess nitrite into 
NO.  On the other hand, adding excess of cysteine to the reducing solution can suppress 
90% conversion of CySNO to NO, while exerts no effect on nitrite detection.  Therefore, 
the concentration of the nitrosated cysteine can be determined by calculating the 
difference between the measurements from the two reducing solutions [Duan 2001].  The 
detection limit for nitrite using this method was as low as 0.02 nmol per injection.  The 
intra-assay variability was less than 2% and the inter-assay variability was less than 5%.  
The calculated cysteine surface concentration on PET and PU surfaces were 8.1±1.1  
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Figure 2.7 Reaction schemes of immobilizing L-cysteine onto the surface of polyethylene 
terephthalate (PET) and polyurethane (PU) by first adding an amine group by 
the use of ethylenediamine and 3-aminopropyltriethoxysilane (APTES), 
respectively and then using glutaraldehyde as a crosslinker to attach cysteine 
on the polymer surface [Duan and Lewis 2002]. 
  
(PET)
50% Ethylenediamine
-NH-(CH2)2-NH2
1% Glutaraldehyde
40 C, 24 hrs
pH 7, 1 hr, under nitrogen
-N=CH-(CH2)3-CHO
(GA-modified Polymer)
0.2% L-Cysteine
pH 7, 3 hrs
-N=CH-(CH2)3-C=N-Cys
(L-cysteine-modified Polymer)
2% APTES in toluene
Si-(CH2)3-NH2
24 hrs, under nitrogen
(PU)
39 
 
nmol/cm2 (n=5) and 5.2 ± 0.9 nmol/cm2 (n=3), respectively.  Later, a modified reducing 
solution containing copper chloride and cysteine in phosphate buffer  (pH 7.4) was 
developed with better accuracy by Fahlenkamp [Gappa-Fahlenkamp et al. 2004].   
2.3.3   Testing the Platelet Inhibition on Modified Polymer Surface in vitro 
A preliminary experiment showed that the both cysteine modified PET and PU 
cause significant BSANO concentration decrease during incubation in PBS buffer, 
indicating that the modified polymers are capable of transferring NO from BSANO in  
After this, the two modified PET and PU polymers were tested in  both batch and flow 
conditions in order to verify their  haemocompatibility with platelets.  The platelets were 
radio-labeled with isotope 51Cr so that the amount of platelets could be quantified by 
measuring the radioactivity of the labeled platelets.  Control samples for this study were 
glycine-modified PET and PU samples under the same experimental conditions.   The 
batch test showed that the cysteine modified PET and PU samples does not have 
noticeable antiplatelet effect when no plasma presenting in the platelet suspension.  
However, when 50% plasma was present in the platelet suspension, the number of 
platelets attached to the modified polymer surfaces was reduced by ~60% and ~50%, 
respectively, as compared to the control.  In the flow test, ,similar to the batch test, the 
presence of plasma significantly reduced the number of platelets attached to the modified 
polymer to ~55% and ~25%, respectively, as compared to the control [Duan 2001].  The 
results of this study indicate that in order for the cysteine modified polymers to inhibit 
platelet adhesion on the surfaces, they must be exposed to a source of RSNOs, which are 
found in plasma, so that NO can be transferred to the surface of the material and then 
released from the surface.  
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In order to further improve the haemocompatibility of this cysteine modified 
polymer so that it can completely inhibit platelet adhesion, the NO release rate from the 
modified polymer under physiological condition needs to be quantified and compared to 
the minimum NO flux required for platelet inhibition which was mentioned earlier. 
Assessment of the release rate will help determine whether the incomplete inhibition 
results from an insufficient NO flux from the polymer surface.  
To determine the release rate, the kinetics of the transnitrosation between BSANO 
and the cysteine on the polymer, followed by CySNO decomposition, need to be 
investigated since there is no available kinetic data for the transnitrosation involving 
immobilized cysteine.  Chapters 3 and 4 focus on the transnitrosation between CySNO 
and BSA in free solution.   Stability issues of the cysteine on the polymer are addressed 
in Chapters 5.  Finally, the kinetics of transnitrosation reactions between the modified 
polymer and BSANO are discussed and a mathematical model for predicting NO flux 
from the modified polymer surface in a tubular reactor is established in Chapter 6.   In 
addition, various environmental factors are examined for their influences on the NO 
release rate from the polymer surface.      
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CHAPTER 3 
S-NITROSOCYSTEINE DECOMPOSITION IN FREE SOLUTION 
3.1 Introduction 
S-nitrosothiols (RSNOs) play a significant role in many biological processes.  As 
the main reservoir of nitric oxide (NO), RSNOs are involved in several processes 
including platelet deactivation, smooth muscle relaxation, immunosupression, neuro-
transmission, and host defense [Richardson and Benjamin 2002].  Although the 
mechanisms of RSNO interactions in vivo are complex, the biological actions of RSNOs 
are often associated with the transfer (transnitrosation) and/or release of NO [Kelm 
1999]. 
In order to analyze the kinetics of the NO flux from the cysteine modified 
polymer, the key kinetic parameter that directly controls the release rate, which is the S-
nitrosocysteine decomposition rate as mentioned in the previous chapter, must be fully 
studied first.  Although the decomposition rate for immobilized S-nitrosocysteine  might 
be different from that of free S-nitrosocysteine in solution (due to the conformation 
change after the immobilization) it has been previously shown that immobilized S-
nitrosocysteine decomposition is very susceptible to metal ions, similar to free S-
nitrosocysteine decomposition [Duan 2001].  Thus, it is possible that both the 
immobilized and free S-nitrosocysteine exert similar behaviors in response to various 
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environmental conditions such as temperature, pH, metals and light [Williams 1999; 
Stamler and Toone 2002].  Therefore, it is beneficial to study S-nitrosocysteine 
decomposition in free solution before assessing decomposition on an immobilized 
polymer. 
In this chapter, studies were focused on assessing and characterizing the free 
CySNO decomposition rate in solution over a broad pH range with various buffer purities 
for further application in the polymer modeling.  Previous studies have shown that 
CySNO is stable in acidic (pH<5) and alkaline (pH>9) pH, while in the pH range of 6-8 
CySNO decomposition occurs very rapidly [Vanin et al. 1997].  However, information 
on how the magnitude of the decomposition rate changes over the pH range of 5 to 9, 
particularly near physiological pH, is not given and such information would be beneficial 
to understand the control in which pH has on CySNO decomposition.  In addition to pH 
effects, several studies have shown that metal ions including copper [Askew et al. 1995], 
iron [McAninly et al. 1993], and mercury [Swift and Williams 1997] are responsible for 
RSNO decomposition, although several of the studies were performed at or near pH 7.4 
rather than over a wide pH range.  Analysis over a wide pH range would be beneficial for 
determining if pH effects on CySNO decomposition were similar among various buffers 
containing metal ion contaminants.     
3.2 Materials and Methods 
3.2.1    Materials 
L-cysteine, sodium nitrite, desferal (deferoxamine mesylate salt), citric acid and 
Tris-base were obtained from Sigma-Aldrich.  Low-purity sodium phosphate dibasic 
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(Certified ACS, ≥99.0%, Cat. # S374-500), low-purity sodium phosphate monobasic 
(Certified ACS, ≥98.0%, Cat # S369-500), 12 M hydrochloric acid, ferrous sulfate, 
sodium hydroxide and pH 4.0/7.0/10.0 standard buffers were purchased from Fisher 
Scientific.  High- purity sodium phosphate dibasic (Trace Select, ≥99.99%, Cat. # 71629) 
and sodium phosphate monobasic (Trace Select, ≥99.99%, Cat. # 71492) were purchased 
from Fluka.  1M NaOH and 1 M HCl were purchased from Cole-Parmer.  10× Gibco 
Phosphate-Buffered Saline (PBS), pH 7.4 was purchased from Invitrogen.  All solutions 
in this work used purified water that was prepared by passage of reverse osmosis water 
through a pretreatment filter to remove colloids and bacteria, then passaged through two 
dionization columns, and finally passaged through a column to remove organics.  This 
purified water was used for all the works in the other chapters, unless specified.   
3.2.2   CySNO and Buffer Preparation 
CySNO was made by acidic nitrosation as described in Chapter 2 (see section 
2.2.3) [Byler et al. 1983; Kuo 2003].  Briefly, in a 15 mL centrifuge tube covered with 
aluminum foil, 3 mL of a 10 mM cysteine solution was mixed with 4 mL of a 10 mM 
sodium nitrite solution in the presence of 1 mL of 1 M HCl for 5 minutes to promote 
nitrosation of cysteine at acidic conditions.  Following nitrosation, 1 mL of 1 M NaOH 
was added to neutralize the solution.  A pH test paper was used to verify that the solution 
is neutralized.  The final concentration of CySNO was approximately 3.33 mM.  For 
studies in which the chelator desferal was used, 2 mL of 5 mM desferal was added to 8 
mL of freshly-prepared CySNO.  Thus, the final concentration of CySNO was 
approximately 2.67 mM with a desferal concentration of 1 mM. 
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 Various buffers with different pH controlling ranges [Beynon 1996] were 
prepared to assess CySNO decomposition kinetics as a function of pH.  The NaH2PO4-
Na2HPO4 buffer, for controlling the pH between 5 and 8, was made by adding 100 mM 
Na2HPO4 slowly into 50 mL of 100 mM NaH2PO4 until the desired pH was obtained, 
with continuous mixing by micro-stirrer.  The pH was continuously monitored by an 
Accumet semi-micro combination pH electrode (Cole-Parmer Instrument, Vernon Hills, 
IL) connected to an Oakton pH/CON510 Benchtop meter (Oakton Instruments, Vernon 
Hills, IL).  The final phosphate concentration was 100 mM.  This buffer was prepared 
using both low-purity and high-purity sources.  The glycine-NaOH buffer, for controlling 
the pH between 7.5 and 10.5, was made similarly by slowly adding 10 M NaOH into 100 
mL of 100 mM glycine until the desired pH was obtained.  Since the NaOH volume 
added was very small (only a few droplets) compared to the glycine solution volume, the 
final glycine concentration after pH adjustment remained essentially at 100 mM. The 
glycine-HCl buffer (for pH control between 5 and 8) was similarly made by adding 12 M 
HCl into 100 mL of 100 mM glycine solution.  For the Citric acid-Tris -NaOH buffer (for 
pH control between 5 and 9), 10 M NaOH was added into 100 mL of a 100 mM Citric-
acid-Tris base solution.  For these latter two buffers, the final concentrations were 
essentially 100 mM due to the small amounts of HCl or NaOH added. 
3.2.3 CySNO Decomposition 
 Decomposition studies were performed by adding equal amounts of the CySNO 
solution with the buffer solution in either a 96-well microplate (usually 50 μL CySNO 
plus 50 μL buffer) for analyzing with a microplate reader or a semi-micro cuvette 
(usually 1 mL CySNO plus 1mL buffer was added to a 4 mL amber vial for mixing after 
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which a 1 ml sample was transferred into a semi-micro cuvette, as mixing the CySNO 
with buffer in the semi-micro cuvette directly is difficult) for analyzing with the UV-Vis 
spectrophotometer.  Thus, for most studies, the final concentrations of buffer salts and 
CySNO were 50 mM and 1.67 mM, respectively. In the case where 10× Gibco PBS  was 
used, the final total phosphate concentration of Gibco PBS was 5×, which is 
approximately 20 mM according to the product specification label.  For the desferal 
studies, the final CySNO concentration was 1.34 mM.  For the high purity buffer study 
containing added metal iron, 10 mM FeSO4 was made freshly and diluted to a final iron 
concentration of 4.57 μM with high purity buffer. This final concentration of iron was 
made to be comparable to the maximum iron level of the low purity buffer, since 1 L of 
low purity buffer (pH 7.4) was made with approximately 11.50 g of Na2HPO4 (0.002 
wt% max iron impurity) and 2.62 g of NaH2PO4 (0.001 wt% max iron impurity), which 
resulted in a potential maximum iron concentration of 4.57 M.   
Spectrophotometric absorbance changes of the mixture at 340 nm, proportional to 
the CySNO concentration, were monitored immediately after mixing using either a 
Packard® SpectraCountTM Microplate Photometer (BS10000, Packard Instrument Co., 
Meriden, IL) or a Varian UV-Vis Spectrophotometer (Cary 50 Bio, Varian, Inc., Palo 
Alto, CA).  The corresponding buffer was used as blank.  The spectrophotometer was 
used for the low-purity phosphate experiments (exemplifying faster decay) since it gives 
better consistency in assessing fast kinetics as compared to the plate reader (data not 
shown).   The chemiluminescence method was not used for these experiments because 
the concentration of S-nitrosocysteine was high enough to be measured by a 
spectrophotometer directly and S-nitrosocysteine decomposition is very fast such that a 
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rapid and easy measurement is needed.  The pH of the mixture was monitored before and 
after the decomposition studies using a micro pH electrode (PHR-146B, Lazarlab 
Research Laboratories, CA) connected to an Accumet mV/pH meter (AP62, Thermo 
Fisher Scientific Inc, Pittsburgh, PA) to assess any possible changes in pH after mixing 
the CySNO with the buffer and during the decomposition studies.  Both pH meters were 
calibrated by 3-point standardization using pH 4.0, 7.0 and 10.0 standard buffers prior to 
measurement.  
3.3       Results 
3.3.1    CySNO Decomposition Rate Constant (kobs)  
For assessing the rate at which CySNO decomposed with time, the concentration 
of CySNO was measured with time at each pH and buffer condition.  Since the 
concentration is proportional to the optical density (OD) at 340 nm, Figure 3.1 shows a 
plot of OD (divided by the initial OD) versus time for several of the low-purity 
NaH2PO4-Na2HPO4 buffer experiments.  The trend shows that CySNO disappears the 
slowest at pH 5.85, then disappears faster as the pH increases to pH 7.33 to 7.45, then 
starts to slow down again after pH 7.45. 
Since CySNO is known to decompose in the presence of metal ions [McAninly et 
al. 1993; Dicks and Williams 1996; Williams 1996; Burg et al. 2000], the CySNO 
decomposition was modeled as a pseudo first-order decay according to 
   ][][ CySNOk
dt
CySNOd
obs                    (3.1) 
where kobs is the observed first-order decomposition rate constant and [CySNO] is the 
CySNO concentration.  The metal ion concentrations contributing to the decomposition 
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rate are incorporated into kobs, which is similar to the analysis used to model the 
decomposition of S-nitrosated glutathione (GSNO) in the presence of ascorbic acid and  
 
Figure 3.1 CySNO decomposition profile as a function of pH in low-purity phosphate 
buffer. (n=2) The optical density (OD) time profile, which is proportional to 
the CySNO concentration, is shown as a function of pH in the presence of 
low-purity phosphate buffer. The solid lines are exponential fitting.  
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copper ions [Scorza et al. 1996; Smith and Dasgupta 2000].  The rate at which NO is 
generated would be represented by kobs[CySNO].  Since the OD is proportional to 
[CySNO], [CySNO] can be replaced by the OD in Equation 3.1.  Integration of Equation 
3.1 results in:  
                                 
0
obsk tOD e
OD
                                                                     (3.2)   
Thus a plot of –ln(OD/OD0) versus time from the information in Figure 3.1 would yield a 
slope equal to kobs. The lines shown in Figure 3.1 represent the model (Equation 3.2) for 
the calculated kobs values, thus confirming the correctness of the pseudo first-order decay 
model.  In all cases, the standard error of kobs obtained from the curve fit was less than 
1.5%.  Interestingly, if there was no buffer to control the pH (in water or 0.5 M NaCl 
solution), CySNO decomposition shown in Figure 3.2 did not correspond to a first-order 
decay model that was consistent with buffered solutions (phosphate or Gibco PBS). The 
lack of a first-order decay model for the non-buffered solutions was likely a result of 
changing pH since the pH changed 3-4 units throughout the experiment due to the 
formation of nitric acid from NO and oxygen [Lewis and Deen 1994].   
3.3.2     Effect of Buffer Purity on kobs  
In Figure 3.3, the values of kobs are plotted as a function of pH for three separate 
buffer solutions: a) low-purity NaH2PO4-Na2HPO4, b) high-purity NaH2PO4-Na2HPO4, 
and c) low-purity NaH2PO4-Na2HPO4 with the addition of the chelating agent desferal.  
In addition, kobs is shown for one experiment in which Fe2+ was added to high purity 
NaH2PO4-Na2HPO4 buffer (final concentration of 4.57 µM) to show the effect of a metal 
ion contaminant on kobs.  The error bars representing the standard errors for the curve fits 
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Figure 3.2 CySNO decomposition profile in non-buffer solution (water or 0.5 M NaCl) 
compared to buffer solution (in 50 mM low-purity phosphate buffer or Gibco 
5× PBS). (n=2) The decomposition profile in non-buffer solution did not 
correlate with the first order decay model shown.  
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Figure 3.3 First-order decay constant (kobs) for CySNO decomposition in various 
phosphate buffers.  kobs, as calculated from Equation 3.2 using experimental 
time data, is shown as a function of pH for low-purity phosphate buffer, low-
purity phosphate buffer in the presence of the chelator desferal, high-purity 
phosphate buffer, and 4.57 M Fe2+ in high-purity phosphate buffer. 
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are not shown since they were less than 1.5% for all points.  As shown in Figure 3.3, kobs 
maximizes near physiological pH and approaches zero near pH 6 for the low-purity 
buffer.  Thus at pH 6 and below, CySNO decomposition (or the release of NO) does not 
occur.  There is no data for pH >8 since this buffer is only capable of controlling the pH 
in the 5.5 to 8 range.  For each pH experiment, the pH of the solution was well controlled 
during the decomposition- the pH only varied within ± 0.02.    
As compared to the low-purity buffer, both 1 mM desferal and high-purity buffer 
significantly reduced the decomposition of CySNO, essentially showing little 
decomposition over the entire pH range.  According to product specifications (Table 3.1), 
the low-purity phosphate buffer contained phosphate salts that had iron contamination up 
to 0.002 wt% and heavy metals contamination (Ag, As, Bi, Cd, Cu, Hg, Mo, Pb, Sb, and 
Sn [Schmidt et al. 2005]) up to 0.001 wt%.  For the desferal study, the desferal reduced 
the metal ion contaminants (particularly Fe3+ [Vanin et al. 1997]) in the low-purity 
phosphate buffer via chelating action.  Similarly, the high-purity phosphate buffer was 
made of much purer phosphate salts with iron contamination less than 0.000005 wt% and 
heavy metals less than 0.00002 wt% (Table 3.1).  With the addition of Fe2+ to the high-
purity phosphate buffer at pH 7.44 to obtain an iron concentration similar to the 
maximum iron content in the low-purity phosphate salts, kobs increased significantly and 
was close to the kobs for the low-purity phosphate buffer (the small difference may be due 
to other metal ion contaminants).  These results demonstrate the importance of metal ions 
in CySNO decomposition and that the metal ions for this study came from the phosphate 
salts.  The importance of metal ions in CySNO was previously observed although the 
effects of pH on the process were not assessed [Burg et al. 2000; Vanin et al. 2004]. 
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Table 3.1 Metal Contamination level for low and high purity salts (wt%)  
 Low Purity Salts High Purity Salts 
Contaminant Na2HPO4 NaH2PO4 Na2HPO4 NaH2PO4 
Fe ≤0.002  ≤0.001  ≤0.000005  ≤0.000005  
Heavy Metals ≤0.001 (as Pb)* ≤0.001 (as Pb)* 0.000018** 0.000013** 
 
Note. * Fisher Scientific did not have detailed compositions regarding the heavy metal 
content.  Usually, heavy metals concentration is determined by adding Na2S into the 
solution and comparing the darkness of the solution with a standard Pb solution mixed 
with Na2S (sulfide ion reacts with heavy metals to develop darkness).  A common list of 
heavy metals includes Ag, As, Bi, Cd, Cu, Hg, Mo, Pb, Sb, and Sn [Schmidt et al. 2005].  
Contaminant levels were obtained from the label. 
          ** Sigma-Aldrich provides detailed concentration levels for each metal on the 
label, thus this value is calculated by adding up the corresponding heavy metal 
concentrations. 
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3.3.3     Effect of pH on kobs    
Although Figure 3.3 showed that kobs was negligible below pH 6 and increased to 
a maximum near physiological pH, further studies were performed to assess the pH effect 
on kobs over a wider pH range and in the presence of other buffers.  Since the phosphate 
buffer is not as efficient above pH 8, a citric acid-Tris-NaOH buffer, a glycine-HCl 
buffer, and a glycine-NaOH buffer were also evaluated to assess the effects of CySNO 
decomposition over a wider pH range.  Figure 3.4 shows kobs as a function of pH for the 
three buffers.  Similar to the phosphate buffer studies in Figure 3.3, kobs maximized near 
physiological pH and approached zero for pH <6 and >9.5.  The citric acid-Tris-NaOH 
buffer had higher values of kobs compared to the glycine buffers, which is likely a result 
of greater metal ion contamination in the chemicals used to prepare the buffer.  The citric 
acid-Tris-NaOH buffer results were similar to those of the low-purity phosphate buffer, 
suggesting that contaminants rather than key buffer ingredients contribute to CySNO 
decomposition. 
3.4  Discussion  
The major findings from this chapter showed that the rate constant characterizing 
CySNO decomposition maximized near physiological pH (independent of the type of 
buffer), the rate constant dropped off rapidly within approximately ±1.5 pH units, and the 
metal ion contamination of the buffers affected the rate constant.   It is interesting to note 
that the greatest decomposition occurred near physiological pH and that the release rate is 
controlled within a narrow pH band regardless of the metal ion content.  Although the 
NO chemistry in biological systems is complex, the maximum release of NO from  
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Figure 3.4 First-order decay constant (kobs) for CySNO decomposition in non-phosphate 
buffers.  kobs, as calculated from Equation 3.2 using experimental time data, is 
shown as a function of pH for citric acid-Tris-NaOH buffer, glycine-HCl 
buffer, and glycine-NaOH buffer.  
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CySNO would thus occur near physiological pH.  It would be beneficial to assess 
whether other RSNOs show similar trends. 
 The question arises as to why the decomposition rate maximizes near 
physiological pH.  Previous studies assessing the decomposition rate of nitrosated 
glutathione in the presence of ascorbic acid showed that the decomposition rate was 
negligible below pH 5.5 but increased with increasing pH up to pH 7.7 [Smith and 
Dasgupta 2000].  The results showed evidence that the species promoting the greatest NO 
release was the ascorbic acid dianion.  Equilibrium analysis that included the other two 
forms of ascorbic acid (ascorbic acid monoanion and ascorbic acid) showed that the 
dianion fraction of the total ascorbic acid increased as the pH increased, leading to a 
higher decomposition rate.  Studies were not performed above pH 7.7 so an upper limit of 
the decomposition rate was not observed -- although the dianion fraction should 
theoretically reach unity and the decomposition rate should maintain a maximum level 
above a certain pH.  However, these findings differ from the CySNO decomposition 
results where CySNO maximizes near physiological pH with metal ions and then 
decreases as the pH is increased or decreased.  The action of Cu2+ on glutathione 
decomposition was also assessed but only at pH 7.45.  Nevertheless, similar to this work 
that showed increasing the buffer impurity increased the decomposition rate, increasing 
the Cu2+ concentration increased the glutathione decomposition rate.   
 Recently, the effect of pH on CySNO decomposition in the absence of metal ions, 
but in the presence of excess cysteine, showed a maximum decomposition rate at 
approximately pH 8 with decreasing rates as the pH increased or decreased from pH 8 
[Adam et al. 2005].  Thus, the results showed a similar effect of pH on the decomposition 
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rate as reported in this work.  The mechanistic explanation for the pH effect involved an 
equilibrium model of several forms of cysteine.  The decomposition mechanism was 
independent of metal ions and generated nitrogen gas instead of NO.  In this work, excess 
cysteine was not present such that the decomposition mechanism would not be 
applicable.  In addition, this decomposition pathway requires excessive cysteine at the 
mM amounts and estimates of the cysteine concentration in human plasma is less than 
100 μM [Richie et al. 1996]. Therefore, this mechanism may not be as applicable in the 
physiological environment as compared to metal catalyzed decomposition—although 
further experiments would need to be performed to assess the dominating pathways 
leading to CySNO decomposition in a physiological environment.   
Unlike the two mechanisms mentioned above involving either excess cysteine 
with CySNO or ascorbic acid with nitrosated glutathione, the results of this work provide 
a plausible explanation that several species of a metal ion contaminant (such as copper or 
iron) exist in equilibrium and that the dominant species at physiological pH (rather than 
the species at high pH in the case of ascorbic acid) is the species involved in the CySNO 
decomposition.  For example, various forms of a metal contaminant (ex. Cu2+, Cu+, and 
Cu represented as A, B and C) could exist in equilibrium such that: 
    HBA            (3.3) 
    HCB            (3.4) 
At equilibrium, CA = CBCH+/K1 and CC = K2CB/CH+ where K1 and K2 are the equilibrium 
constants for the reactions in Equations 3.3 and 3.4, respectively.  If only species B 
contributed to the decomposition, the fraction of B (fB=CB/(CA+CB+CC)) contributing to 
decomposition would be pH dependent according to   
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       HHB CKKCf //1
1
21
                
(3.5) 
In Equation 3.5, activity coefficients are considered unity.  If kobs was represented as kCB 
= kfBCT where CT is the total species of copper present in solution (which is independent 
of pH) and k is the true first-order decomposition rate constant (also independent of pH), 
then a plot of fB versus pH would yield the same curvature as kobs versus pH for a given 
combination of K1 and K2 values. For instance, with K2>>K1, at low pH the term K2/CH+ 
would dominate the denominator in Equation 3.5 leading to fB (and thus kobs) approaching 
zero.  Similarly at high pH, the term CH+/K1 would dominate the denominator such that fB 
(or kobs) also approaches zero.  At an intermediate pH, fB would reach a maximum.           
 An alternative model would be the dissolution of a single metal contaminant in 
solution such as was shown for the complete dissolution of cuprous oxide (represented as 
D below) in water to generate three forms of Cu+ [Palmer et al. 2004] - again noting that 
Cu+ is the species that has been shown to contribute to RSNO decomposition [Williams 
1996; Burg et al. 2000].  In this scenario,   
   OHAHD 25.05.0            (3.6) 
   BOHD  25.05.0           (3.7) 
    HCOHD 25.15.0          (3.8) 
where A, B, and C represent the three forms of Cu+ in solution.  At equilibrium, the 
fraction of B in solution (fB) is  
    4 3 5 4
1
1 / ( / ) ( / ) /B H H
f
C K K K K C 
         (3.9) 
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where K3, K4, and K5 are the equilibrium constants for Equations 3.6, 3.7 and 3.8, 
respectively.  It is noteworthy that Equation 3.9 is of the same form as Equation 3.5.  
Therefore, similar to the scenario presented for Equation 3.5 above, it is feasible to have 
fB (or kobs) approach zero at low and high pH and to maximize at an intermediate pH.  For 
such a scenario to occur, K5/K4 must be much greater than K4/K3.   
Figure 3.5 shows fB versus pH for a variety of K1 and K2 values (or similarly, K4/K3 and 
K5/K4 values).  The curvature, with values approaching zero at low and high pH, is 
similar to that shown in Figures 3.3 and 3.4, demonstrating the feasibility that species B 
in equilibrium with several other species is one plausible explanation for the effect of pH 
on CySNO decomposition involving metal ions.  For both models presented above, 
species A or C participating in the CySNO decomposition would not lead to kobs 
approaching zero at both pH extremes while maximizing at an intermediate pH.  For 
K2/K1 = 104, it can be seen that decreasing K2 shifts the fB maximum from a lower pH to 
a higher pH while maintaining the same maximum value.  When keeping K1 constant (for 
example, K1=10-9), decreasing the ratio of K2/K1 increases the maximum value of fB and 
slightly increases the pH at which the maximum occurs.  Since kobs = fBkCT, kobs has a 
similar pH profile as fB except the height of the curve depends upon the constant factor 
kCT which is independent of pH.  kCT is constant and independent of pH since k is the 
true first-order decomposition rate constant and CT is the total concentration of ion 
impurities.  Although beyond the scope of this article, further studies need to be 
performed to confirm the appropriate model (i.e. multiple scenarios were given above) 
and determine the model parameters once the metal ion contaminant(s) are determined. 
59 
 
The maximum decomposition occurring near physiological pH (between 7.35 and 
7.45 [Cooney 1976]) indicates that blood naturally provides an optimized condition to 
decompose CySNO, leading to optimal release of NO.  Under acidosis conditions 
 
Figure 3.5 Fraction of species B (fB) as a function of pH.  Equation 3.5, representing the 
fraction of one form of ion species in equilibrium with other forms of the 
same ion species, is plotted as a function of equilibrium constants for the 
equilibrium reactions given in Equations 3.3 and 3.4.  
  
0.000
0.005
0.010
0.015
0.020
0.025
0.030
4 5 6 7 8 9 10
pH
f B
K1=10-8, K2=10-4
K1=10-9, K2=10-5
K1=10-10, K2=10-6
K1=10-9, K2=7×10-7
K1=10-9, K2=3×10-7
60 
 
(pH<7.35), the decomposition rate is relatively stable until the pH drops below 6.8.  
However, since the reported life-compatible pH range for blood is between 6.3 and 8.0 
[Hinderling and Hartmann 2005], the CySNO decomposition rate can be reduced up to 
50% at these pH extremes.   Therefore, any physiological process involving CySNO 
decomposition in blood can potentially be affected under extreme acidosis/alkalosis 
conditions.   
Another physiological process that can be affected by CySNO decomposition 
involves neurotransmission in which the localized environment in the synaptosomes is 
maintained at pH 7.04 ± 0.07 by bicarbonate ion [Richardson and Benjamin 2002].  
According to this study, this pH indicates that CySNO decomposition (and NO release) is 
maximized when NO is involved in modulating the neurotransmission [Murayama and 
Nomura 1998].  In the event that pH control by bicarbonate is diminished such that the 
localized pH decreases below 7, NO release can also be diminished and potentially affect 
neurotransmission. 
Finally, studies involving CySNO decomposition must be carefully performed 
and evaluated since pH and buffer purity contribute significantly to the decomposition 
rate.  Knowledge of the decomposition rate is important for assessing the kinetics of the 
cysteine modified polymer and providing helpful information for temporarily preserving 
the CySNO solution and avoid any experimental error arising from CySNO 
decomposition during the measurement in the later chapters.   
3.5 Conclusions  
In this chapter, the CySNO decomposition rate was studied in different buffers 
(with varying metal ion impurities) at varying pH conditions. A chelator (deferoxamine 
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mesylate salt) was also used to assess how scavenging metal ions affects the 
decomposition rate over a wide pH range.  The kinetic rate constant, characterizing the 
rate at which CySNO decomposes with time, was measured at each condition (pH and 
buffer content) with results showing that the rate constant maximized near physiological 
pH under all buffer solutions studied.  An equilibrium model of metal ions as a function 
of pH provides a plausible explanation for the pH dependence on the experimental 
decomposition rate.  The results of this work validate reasons for apparent discrepancies 
in RSNO decomposition studies [Mathews and Kerr 1993; Meyer et al. 1994; Pietraforte 
1995; Scorza et al. 1996] and demonstrate the strong correlation between physiological 
pH and the maximum CySNO decomposition rate. 
The important findings are:  
1) CySNO decomposition maximizes near physiological pH regardless of the 
buffer, since trace metal ion exists in all buffer salts. 
2) The model presented above gives a representative curvature similar to 
experimental observations and provides a plausible explanation for the pH dependence on 
CySNO decomposition,  
3) CySNO decomposition can be very sensitive to environmental conditions, 
especially near the physiological pH, thus an accurate spectroscopy instrument, like Cary 
50 UV-Vis spectrophotometer, is recommended. 
4) The buffer purity (or CT) greatly affects the decomposition rate, especially at 
near physiological pH.  
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CHAPTER 4 
S-NITROSO BOVINE SERUM ALBUMIN (BSANO) TRANSNITROSATION 
WITH FREE CYSTEINE 
4.1 Introduction 
In biological systems, transnitrosation can occur with constituents containing at 
least one of two functioning groups, amines and thiols [Loeppky et al. 1987; Park 1988; 
Yanagimoto et al. 2007]. Transnitrosation reactions facilitate many signal transmissions 
in biological systems [Butler et al. 1994; Gaston et al. 2003; Marozkina et al. 2008]. As 
mentioned in Chapter 2, S-transnitrosation, which is the transfer of an NO moiety 
between two thiol molecules, is a key reaction involved in the mechanism of cysteine-
modified polymers used to minimize platelet adhesion. The transnitrosation reaction is: 
' 'RSNO R SH RSH R SNO                                   (4.1) 
One possible mechanism for Equation 4.1 is [Hu and Chou 2006]:  
         ' 'R SH R S H
                                         (4.2) 
' 'R S RSNO RS R SNO                                             (4.3) 
In order to conduct a kinetic analysis of transnitrosation, the reactants and the 
products need to be separated at a given point in the reaction and then measured.  An 
63 
 
HPLC method has been used by several research groups to achieve this goal [Hogg 1999; 
Tsikas et al. 1999; Hu and Chou 2006].  The reaction is a second order reversible 
reaction, as determined by monitoring the concentration changes for RSNO and R'SH 
[Meyer et al. 1994; Hogg 1999].  Additionally, kinetic data for reactions between 
different thiols and S-nitrosothiols were acquired using different methods [Wang et al. 
2001; Hu and Chou 2006]. However, not much kinetic analysis has been done for the 
transnitrosation between S-nitroso protein (such as S-nitroso bovine albumin) and low 
molecular weight thiols (such as cysteine).  
Table 4.1 gives a recent summary of the transnitrosation kinetic data for S-nitroso 
albumin and low molecular weight thiols. From this list, it is evident that the current 
kinetic data is very limited with some inconsistencies.  The kinetic data obtained was 
mostly acquired from spectrophotometric measurements which are not very sensitive 
compared to chemiluminescence methods [Samouilov and Zweier 1998; MacArthur et al. 
2007].  Since this work involves transnitrosation between S-nitroso bovine albumin 
(BSANO) and cysteine (CySH), it would be beneficial to evaluate the kinetic constants 
for the transnitrosation between BSANO and free CySH before studying the 
transnitrosation kinetics of the cysteine modified polymer.  
In this chapter, transnitrosation kinetics between BSANO and cysteine in solution, 
followed by S-nitrosocysteine (CySNO) decomposition, were evaluated using a 
molecular weight separation method coupled with a KI/I2-based chemiluminescence 
analysis of RSNO (either BSANO or CySNO).  Additionally, ascorbic acid (AA) effects 
on transnitrosation and NO release were identified since ascorbic acid has been found to  
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Table 4.1 Kinetic data for transnitrosation between S-nitroso albumin (RSNO) and thiols 
(RSH). 
RSNO RSH kf (μM-1hr-1) kr(μM-1hr-1) Keq Method Reference
BSANO 
CySH 2.203×10
-4   OD335 [Wang et al. 2001] 
 0.0468  OD412 w/ DTNB [Zhang and Means 1996] 
GSH 
0.068±0.08 0.692±0.049 0.120 HPLC, A336 [Hogg 1999] 
6.048×10-3   OD330-370 and OD500-600 [Wang et al. 2001] 
 0.208  
OD340, Griess Method 
and spectral 
deconvolution 
[Rossi et al. 1997] 
 0.1872  OD412 w/ DTNB [Zhang and Means 1996] 
HSANO 
CySH 0.0328   OD334 [Meyer et al. 1994]   0.75 HPLC, OD333 [Tsikas et al. 1999] 
GSH 0.01152   OD334 [Meyer et al. 1994]   0.59 HPLC, OD333 [Tsikas et al. 1999] 
 
Abbreviations: GSH, glutathione; CySH, L-cysteine; BSANO, S-nitroso-bovine serum 
albumin; HSANO, S-nitroso-human albumin; kf, forward reaction rate constant; kr, 
reverse reaction rate constant; Keq, equilibrium constant. Axxx, Spectrophotometric 
measurement at wave length of xxx nm; HPLC, High-performance liquid 
chromatography; DTNB, 5,5’-dithio-(2-nitrobenzoate). 
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promote the NO release from S-nitrosothiols [Holmes and Williams 2000; Smith and 
Dasgupta 2000; Xu et al. 2000; Aquart and Dasgupta 2004] and is contained abundantly 
on transnitrosation and NO release were identified since ascorbic acid has been found to 
promote the NO release from S-nitrosothiols [Holmes and Williams 2000; Smith and 
Dasgupta 2000; Xu et al. 2000; Aquart and Dasgupta 2004] and is contained abundantly 
in human plasma (ranging from 20 µM to 60 µM) [Khaw et al. 2001; Jamaati et al. 
2006]. 
4.2 Materials and Methods 
4.2.1.   Materials   
Glacial acetic acid, potassium iodide, and sodium nitrite were purchased from 
Fisher Scientific (Fairlawn, NJ). Low-purity sodium phosphate dibasic (Certified ACS, 
≥99.0%, Cat. # S374-500), low-purity sodium phosphate monobasic (Certified ACS, 
≥98.0%, Cat # S369-500), 12 M hydrochloric acid and sodium hydroxide were 
purchased from Fisher Scientific. 1M NaOH and 1 M HCl were purchased from Cole-
Parmer. Bovine serum albumin (BSA), ammonia sulfamate, sulfanilamide, iodine, L-
cysteine (CySH), N-ethylmaleimide (NEM), 5,5-dithiobis (2-nitrobenzoic acid) (DTNB) 
and all the other reagents were purchased from Sigma Chemical Co. (St. Louis, MO).  
NANOSEP 500 µL microcentrifuge filter tubes with a cutoff molecular weight of 10k 
were purchased from PALL Corporation. Kimble 4mL and 1.8 mL amber vials were 
purchased from VWR. 
4.2.2.   BSANO Preparation 
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The BSANO solution was made similarly as the CySNO described in Chapter 3. 
Briefly, 2 mM BSA was made freshly by dissolving BSANO using the HPLC water in a 
15mL centrifuge tube. Then, 1760 µL of 2 mM BSA solution was mixed with 640 µL of 
4mM NaNO2.  This solution can be made and stored at 4 ºC for a few months. The total 
moles of BSA is less than the NaNO2 because the BSA usually contains around 0.6 thiol 
groups per molecule [Wang et al. 2001].  To initiate nitrosation, 800 µL 1M HCl was 
added to the BSA solution and the tube was set on a hand-motion shaker (Cole-Parmer, 
Vernon Hills, IL) shaking at 60 times/min at room temperature.  After 10 minutes, the 
nitrosation reaction was terminated by adding 15 µL 5% ammonium sulfamate for 5 
minutes to scavenge the excess nitrite.  Prolonged nitrosation is not recommended as 
excess nitrite can react with primary amine groups in the BSA molecule to slowly form 
N-nitrosation products [Zhang et al. 1996] which are not desirable because N-nitroso 
albumin can also have transnitrosation reactions with other thiols [Yanagimoto et al. 
2007].  Finally, 800 µL 1M NaOH was added to the solution to neutralize the acid and 
make the pH near 7. This freshly made BSANO solution was further mixed with 5985 µL 
HPLC water and 10 mL 100 mM NaH2PO4-Na2HPO4 (pH=7.4, low purity) buffer to 
bring the final volume to 20 mL containing 50mM NaH2PO4-Na2HPO4 buffer.  This final 
mixture is referred to as the BSANO solution in the following sections.  The BSANO 
final concentration was usually around 100 µM although, in some cases, BSANO was 
diluted further to around 60 µM. 
4.2.3.   BSANO Transnitrosation with Free Cysteine.   
To initiate transnitrosation, BSANO solution (4mL) was added to a 4mL amber 
vial and then 20.1 μL of 10mM cysteine solution (freshly made) was added so that the 
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final cysteine concentration was approximately 50 μM. In the case where AA effects 
were studied, 10mM freshly made AA was added into corresponding vials to achieve a 
desired final AA concentration ranging between 20 and 500 M. The control sample that 
did not contain cysteine was made by adding HPLC water with a volume equal to the 
cysteine solution added.  In the case of AA being involved, the same amount of AA was 
added into the control sample.  All the vials were set on a hand-motion shaker at room 
temperature, shaking at 60 times/min for a couple of hours.  All experiments were 
duplicated and performed at 25 ºC.   
During the reaction, at specific times (usually 5 to 6 times), 300μL sample 
solution was drawn using a pipette and added into a microcentrifuge filter tube with a 
MW cutoff of 10kDa (see Section 4.2.4) to separate CySNO from BSANO for detection.  
In each filter tube, 50 μL of 100 μM NEM was added and mixed by hand for 30 sec to 
quench the thiol so that transnitrosation stopped [Mochizuki et al. 2005].  Afterwards, 50 
μL of 1N HCl was added in order to inhibit CySNO decomposition.  The centrifuge filter 
tubes were then centrifuged at 13000 rpm for 8 min in order to obtain a retentate solution 
of BSANO, CySNO, and NO2- (which formed during the CySNO decomposition) and a 
filtrate solution of  CySNO and NO2- (these two species freely flowed through the filter).  
The filtrate (200 μL), containing the CySNO, was moved into another tube and mixed 
with 50μL of 0.33% ammonium sulfamate in order to quench the residual NO2- .  The 
mixed solution (20 μL) was then measured by a KI/I2-based chemiluminescence method 
(see Section 4.2.5) to determine the CySNO concentration.  At the same time, 25 μL 
unfiltered sample was also treated with 50 μL of 100 μM NEM and 175μL 0.33% acidic 
ammonium sulfamate solution. The sample was then measured immediately by a KI/I2-
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based chemiluminescence method to determine the total S-nitrosothiol (BSANO + 
CySNO) concentration.  In all cases, dilution effects were taken into account to obtain the 
true CySNO and BSANO concentrations during transnitrosation.  
4.2.4.   BSANO Separation Test 
Since microcentrifuge filter tubes were used in the process to separate BSANO 
from CySNO following transnitrosation studies, it was important to test how well 
BSANO could be retained in the retentate solution.  Therefore, 400 μL of a BSANO 
solution (without ammonium sulfamate treatment) was added into two microcentrifuge 
tubes.  The centrifuge filter tubes were then centrifuged at 13000 rpm for 8 minutes using 
a Spectrafuge 16M Microcentrifuge (Labnet International, Inc, Woodbridge, NJ) in order 
to separate NO2- (remaining from BSANO preparation) from BSANO.  Following 
filtration, 25 μL filtrate was collected from each filter tube and transferred into another 
regular centrifuge tube containing an equal volume of HPLC water.  Finally, the filtrate 
sample was immediately measured by the Saville method (see Section 4.2.6) to measure 
both the NO2- concentration and total nitrite (NO2- + BSANO) concentration.  It is 
expected that the NO2- concentration and total nitrite concentration should be the same 
since BSANO should not go through the filter. Meanwhile, another 20 μL un-filtered 
sample, which was collected directly from BSANO solution, was diluted to the same 
ratio as the filtrate sample and measured by the Saville method to assess the retained the 
NO2- concentration and total nitrite (NO2-+BSANO) concentration.  The BSANO 
concentration was calculated by subtracting the measured NO2- concentration from the 
measured total nitrite concentration.   
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4.2.5.   Chemiluminescence Method 
For transnitrosation studies, it was important to measure the CySNO and BSANO 
concentrations with time.  The chemiluminescence method has been widely used for 
RSNO detection for the past twenty years [Walters 1987; Conboy 1989; Samouilov and 
Zweier 1998; Marley R et al. 2000; Rassaf et al. 2002; MacArthur et al. 2007]. Its most 
distinguished advantage is high sensitivity and accuracy [Walters 1987; Conboy 1989; 
MacArthur et al. 2007].   
The mechanism of the chemiluminescence method is based on the reaction 
between nitric oxide (NO) and ozone leading to the formation of an excited form of NO2 
(denoted NO2*), which subsequently releases electromagnetic radiation of characteristic 
frequency, as shown in the reaction steps below: 
*
3 2 2NO  O NO  O                   (4.4) 
*
2 2NO NO hv            (4.5) 
Emission from NO*2 is in the red and near-infrared region of the spectrum and is detected 
by a thermoelectrically-cooled, red-sensitive photomultiplier tube (PMT).  NO from the 
sample and ozone produced in the electrical discharge of the detector are mixed in the 
chemiluminescence reaction cell.  A red cut-off filter between the reaction cell and the 
PMT selectively transmits the light emitted by the NO/O3 reaction for detection by a 
recorder. 
For a liquid sample containing NO2- and RSNO, a reducing solution is required to 
convert NO2- and RSNO into NO so that the NO can be detected by chemiluminescence. 
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One most commonly used reducing solution is a tri-iodide based reducing solution (KI/I2) 
which is made by mixing 2.5 mL 0.2 M KI in saturated I2 solution with 7.5 mL glacial 
acetic acid. The reaction is rapid and stoichiometric [MacArthur et al. 2007].  This 
reducing solution is capable of reducing both NO2- and RSNO to NO for detection.  The 
mechanism to produce NO is [Samouilov and Zweier 1998]: 
                      
–
2 3I I I
                                                                 (4.6) 
2 2 22 2 4 2 2NO I H NO I H O
                                             (4.7) 
32 2 3RSNO I NO I RSSR
                                        (4.8) 
22 2 2I NO I NO
                                                       (4.9) 
Figure 4.1 shows the chemiluminescence experimental set-up that was used 
throughout this project. Briefly, it contains a purging vial with the reducing solution 
connected to a Sievers 270B chemiluminescence NO analyzer (Sievers Corporation, 
Boulder, CO).  After the reducing solution was added to the purging vial (D  H: 20 mm 
 70 mm), the solution was purged by nitrogen via a fritted disk (Pore Diameter: 25-50 
m) at the bottom of the vial.   Aqueous samples from the experiments were obtaining 
using a gas-tight syringe (Hamilton Company, Reno, NV) and then injected into 10 ml of 
the reducing solution.  The NO released from the sample was carried with the nitrogen 
purge to the detector.  The volume of each sample varied between 20 and 200 l 
depending on the detection limits.  The output signal from the detector was sent to an HP 
3396 integrator (Agilent Technologies, Inc., Santa Clara, CA) that calculated the area 
under each sample peak.  The areas were compared to NO2- standards for quantification. 
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In order to measure CySNO in the filtrate following centrifugation of 
transnitrosation samples or BSANO + CySNO in the unfiltered sample, the sample of  
 
 
 
Figure 4.1 Chemiluminescence experiment setup. Samples were injected into the purge 
vessel containing reducing solution. The NO released from the samples is 
carried by the nitrogen gas through an ice trap to remove the acetic acid which 
is harmful for the NOA analyzer. NOA generates ozone to react with NO 
which produces emission that can be detected by the photomultiplier tube. The 
signal was transferred to an integrator which can calculate the peak area of the 
signal. Figure modified from MacArthur et al., 2007. 
  
Nitrogen  
Gas  
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interest was treated with acidic ammonium sulfamate to scavenge NO2- (without affecting 
the RSNO concentration) via the following reaction mechanism. 
2 4 3 2 4 4 2 2NO H NH SO NH NH HSO N H O
                               (4.10) 
After all the NO2- was consumed, the sample was then measured using the KI/I2-based 
chemiluminescence method as previously described to give the RSNO concentration in 
the sample.  If needed, another portion of the sample without ammonium sulfamate 
treatment could be measured using the same reducing solution to obtain the total nitrite 
(NO2- and RSNO) concentration.  The NO2- concentration could then be calculated by 
subtracting the RSNO concentration from the total nitrite concentration.  However, this 
work only reports the CySNO and BSANO concentrations during transnitrosation.  In 
this work, the above chemiluminescence method was used in order to simplify the 
measurement and minimize the error propagation since the RSNO could be measured 
directly.   
An alternative method to indirectly measure the RSNO concentration is to use two 
reducing solutions.  In addition to the  KI/I2 reducing solution mentioned above, a 
KI/cysteine reducing solution can be made to scavenge I2 and thus prevent I3- formation 
and NO release from the RSNO (see Equation 4.6 and 4.8) such that [Pietraforte 1995; 
Robak et al. 1997]: 
22 - 2CySH I CyS SCy HI                                               (4.11) 
Thus, this reducing solution can only liberate NO from NO2-.  By using the KI/I2 solution 
(without acidic ammonium sulfamate addition to scavenge NO2-) to measure total nitrite 
and the KI/cysteine solution to measure just NO2-, the RSNO concentration could be 
obtained by the difference [Duan 2001].  However, this method was found to be more 
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complicated and less accurate since the RSNO concentration is measured by a difference 
in two measurements.   
In addition, one method to measure the RSNO directly which was used previously 
in the lab is using Cu+/cysteine modified reducing solution (not acidic condition) 
[Fahlenkamp 2003]. Unfortunately, this method only works well with low molecular 
weight RSNO, such as CySNO, because when S-nitroso-protein is injected into the purge 
vessel, significant bubbling occurs (even using antifoam agent) due to the denaturing of 
the protein.  However, this foaming was mostly suppressed when using acetic acid-based 
reducing solution probably due to the reason that the acid can break the macrostructure 
of the protein to reduce foaming.  Therefore this Cu+/cysteine reducing solution was not 
used for this work.      
4.2.6   Saville Method  
This test was used in some of the experiments in order to make a quick test of 
either free nitrite (NO2-) or RSNO concentration where a low nitrite/S-nitrosothiol 
detection is not required [Jocelyn 1987].  Compared to the chemiluminescence method, 
the Saville test is easier to set up.  However, the lower detection limit for the Saville test 
is around 100 nM [Huang et al. 2007], while the chemiluminescence method can detect 
to as low as 1 nM [Jobgen et al. 2007].  The mechanism of the Saville test is described by 
Equations 4.12 through Eq. 4.14 [Stamler and Feelisch 1996].   
2
2 -RSNO Hg H O HONO RS Hg H
                         (4.12) 
2 22HONO ArNH H ArN N H O
                               (4.13) 
' - = - 'Ar ArN N Ar N N Ar                                     (4.14) 
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Briefly, NO2- alone or NO2- released from S-nitrosothiols (due to decomposition 
catalyzed by Hg2+) react with sulphanilamide (aromatic amine, Ar) to yield the 
corresponding diazonium salt which couples with N-1-naphthylethylenediamine (second 
aromatic amine, Ar') to form an intensely colored azo dye for colorimetric assay at OD540.  
The detailed experimental procedure is as follows. 50 µL to 100 µL samples were 
added into a well in a 96-well microplate, then equal volumes of Saville solution A (1% 
sulfanilamide in 0.5M HCl) to detect NO2- or Saville solution B (Saville A with 0.2% 
HgCl2) to detect total nitrite (S-nitrosothiol + NO2-) were added to the well. The plate was 
maintained at room temperature for 5 min in order to complete the diazonium formation 
(Equation 4.13). Finally, equal volumes of Saville C (0.02% N-1-
naphthylethylenediamine in 0.5M HCl) were added into the well. After 5 min, the 
mixture was measured by a Packard® SpectraCountTM Microplate Photometer (BS10000, 
Packard Instrument Co., Meriden, IL) at 540 nm wavelength.  The RSNO concentration 
was obtained by subtracting the NO2- concentration from the total nitrite concentration.  
20 µM NaNO2 was made freshly for the standard. By comparing the OD540 reading from 
the samples to the one from standard NaNO2 solution, the total nitrite concentration or 
the free nitrite concentrations in the samples were calculated. 
4.2.7  Cysteine Self-oxidation Assay by Ellman’s Method 
 Ellman’s assay [Jocelyn 1987] was used to test the cysteine self-oxidation test in 
the solution without transnitrosation.  Briefly, 25 μM cysteine solution was freshly 
prepared using 50 mM low purity NaH2PO4-Na2HPO4 (pH=7.4) buffer or deionized 
water and then 4 mL of cysteine solution was added into a 4 mL amber vial.  One group 
of the vials was maintained on the hand motion shaker at room temperature while the 
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other one was maintained at 4ºC.  Also, one group of vials with 25 μM cysteine was 
prepared using 50 mM NaH2PO4-Na2HPO4 and 50 μM AA and this one was also 
maintained on the hand motion shaker at room temperature.  At specific time intervals, 50 
μL samples were drawn from each vial and mixed with 50 μL Ellman’s reagent in a 96-
well microplate for 5 minutes and then measured at 410 nm using a Packard® 
SpectraCountTM Microplate Photometer (BS10000, Packard Instrument Co., Meriden, 
IL). A 25 μM cysteine in deionized water was made freshly as the standard.  By 
comparing the OD410 reading from the samples to the one from standard CySH solution, 
the CySH concentrations in the samples were calculated. 
Ellman’s reagent was made by dissolving DTNB (final concentration 5mM) in a 
100 mM NaH2PO4-Na2HPO4 solution (pH 7.2) with 0.1 mM EDTA.  This solution is 
stable for greater than 2 months if stored in the dark between 0-5°C [Sigma-Aldrich 
2002]. 
4.3 Results  
4.3.1   BSANO Nitrosation and Separation Test 
Figure 4.2 shows the concentration of free nitrite (NO2-), total nitrite (BSANO + 
NO2-), and BSANO in the filtrate and the unfiltered sample following utilization of the 
microcentrifuge tube.  As previously mentioned, the BSANO concentration was 
calculated according to: 
       BSANO Total nitrite Free nitrite                                  (4.15) 
Since the solution prior to separation was not treated by acidic ammonium sulfamate to 
quench NO2-, and the NO2- was slightly in excess, some free NO2- was detected as  
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Figure 4.2 Results for microcentrifuge filter analysis. The BSANO concentration is 
calculated by subtracting the free nitrite data from the total nitrite data. (n=2)  
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expected. This NO2- concentration remained virtually the same in both the filtrate and un-
filtered samples, indicating that NO2- is not separated but is equally distributed in both 
the filtrate and retentate.  BSANO only existed in the un-filtered sample, indicating that 
BSANO cannot penetrate through the filter.  The molecular weight (MW) cut-off of the 
filter is 10k Da which is much less than the MW of BSA/BSANO (66.43k Da).   
Another important piece of information given by this result is that the measured 
BSANO concentration was around 93 μM.  Based on this value and comparison with the 
maximum BSANO that could be made (176 M BSA was nitrosated), the BSANO yield 
per mol of BSA was calculated as 0.53, which is consistent with the literature value of 
0.6 [Zhang and Means 1996].  This incomplete nitrosation is due to the fact that 35–40% 
of the BSA is in the disulfide form [Carter and Ho 1994].  On the other hand, the 
measured total nitrite (BSANO + NO2-) was around 124 μM, which is about 97% of the 
moles of NaNO2 added, indicating that most of the original nitrite was accounted for in 
either BSANO or excess nitrite (negligible N-nitrosation products formed). The 3% that 
was unaccounted for is probably due to the HNO2 breaking down and forming NO, which 
quickly escapes from the solution into the headspace during nitrosation. 
4.3.2 Transnitrosation Kinetics 
The time profiles of the BSANO and CySNO concentrations during 
transnitrosation, with or without AA at various concentrations, are shown in Figures 4.3 
through Figure 4.7.  By fitting the BSANO self-decomposition (no CySH present) to a 
first-order kinetic model (exponential decay) according to:  
[ ] [ ]db
d BSANO k BSANO
dt
                                                         (4.16) 
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Figure 4.3 BSANO and CySNO concentration time profiles following the initiation of 
transnitrosation. (n=2) Initial conditions were 102 µM BSANO and 50 µM 
CySH without ascorbic acid. The solid line and the exponential equation 
represents first order self-decomposition model described by Equation 4.16.  
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the BSANO self-decomposition rate constant, kdb, can be evaluated.  The associated kdb is 
shown in each of the figures.  In Figure 4.3, in the absence of ascorbic acid, BSANO is 
very stable even in the low purity phosphate buffer. There is virtually no BSANO 
decomposition within 24 hours.  The kdb value in the absence of AA is 0.002 hr-1.  In the 
presence of AA, kdb values ranged from 0.008 to 0.011 hr-1 (see Figures 4.4-4.7).  In 
general, the results indicate that BSANO is relatively stable during the transnitrosation 
studies.  Its self-decomposition rate did not appear to depend on the AA concentration, 
although the rate was relatively faster in the presence of AA as compared to no AA, 
possibly due to the fact that more reduced copper/iron is generated by AA and can 
catalyze BSANO decomposition [Smith and Dasgupta 2000].  
When CySH was added to the BSANO solution, the BSANO concentration 
dropped drastically within 1 hour for all the experiments (with or without AA), indicating 
a very fast forward transnitrosation reaction. This was confirmed from the CySNO data 
which showed a rapid increase of CySNO during the first hour.  In the absence of AA, the 
BSANO decrease was initially rapid and then essentially leveled off.  In the presence of 
AA, the BSANO decrease was also initially rapid and then the decrease continued, with 
the decrease going faster with increasing AA concentration. Table 4.2 summarizes this 
aspect, showing the percentage of BSANO lost after 10 min and 4 hours as a function of 
the AA concentration. The data for 50 µM and 500 µM are not included because the 
starting BSANO concentration is much lower than the others due to a different dilution 
method mentioned earlier in Section 4.2.2.   
As for the amount of NO transferred from BSANO to CysH, the studies without 
AA showed that approximately 30 µM NO was transferred within 15 minutes from  
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Table 4.2 Percentage of BSANO transnitrosated after 10 min or 4 hours with different 
ascorbic acid concentrations (0 to 198 M). 
Ascorbic Acid Conc.
Reaction Time 0 µM 20 µM 148 µM 198 µM 
10 min 33% 36% 49%* 46%* 
4 hours 36% 52% 94% 98% 
 
Note: *Data were acquired after 15 min. 
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Figure 4.4 BSANO and CySNO concentration time profiles following the initiation of 
transnitrosation. (n=2) Initial conditions were 88µM BSANO and 50 µM 
CySH with (circle) or without 20µM (triangle) ascorbic acid.  The solid line 
and the exponential equation represents first order self-decomposition model 
described by Equation 4.16. 
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Figure 4.5 BSANO and CySNO concentration time profiles following the initiation of 
transnitrosation. (n=2) Initial conditions were 88µM BSANO and 50 µM 
CySH with 150 µM (square) or 200 µM (circle) ascorbic acid. The solid line 
and the exponential equation represents first order self-decomposition model 
described by Equation 4.16.   
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Figure 4.6 BSANO and CySNO concentration time profiles following the initiation of 
transnitrosation. (n=2) Initial conditions were 62.27 µM BSANO and 50 µM 
CySH with 50 µM (circle) or 500 µM (triangle) ascorbic acid. The solid line 
and the exponential equation represents first order self-decomposition model 
described by Equation 4.16. 
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Figure 4.7 BSANO and CySNO concentration time profiles following the initiation of 
transnitrosation. (n=2) Initial conditions were 116.5 µM BSANO and 25 µM 
CySH with 200 µM (triangle) ascorbic acid. The solid line and the exponential 
equation represents first order self-decomposition model described by 
Equation 4.16. 
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BSANO to cysteine (in the form of CySNO) while the BSANO concentration decreased 
by approximately 30 µM (Figure 4.3 & 4.4).   However, essentially no additional NO was 
transferred during the remainder of the experiment.  Since the initial CySH was 50 M, 
the amount of NO transferred was less than the initial CySH added, suggesting that CySH 
was not continually involved in transnitrosation.  One possible explanation is that 
cysteine was oxidized by the oxygen in the solution with the help of metal ions [Bagiyan 
et al. 2003; Bagiyan et al. 2004].  Thus, there was a point where no more transnitrosation 
could occur since all of the CySH became oxidized.   
In order to study the kinetics of cysteine autoxidation, an experiment for cysteine 
oxidation in buffer was conducted.  The results are shown in Figure 4.8.  It is evident that 
increasing temperature can accelerate this oxidation process and the decomposition 
appears to be a zero order reaction, which is consistent with literature [Ehrenberg et al. 
1989; Bagiyan et al. 2004]. The zero order reaction rate constant, koo, was calculated by a 
linear fit of the data.  Thus, at 25 ºC, in 50 mM low purity NaH2PO4-Na2HPO4, pH=7.4 
buffer, the zero order decomposition rate constant was 0.7103 µM·hr-1.  This result also 
showed that 50 µM AA cannot stop this self-oxidation at all.  This can be explained by 
the redox potential of dehydroascorbic acid/ascorbic acid (58 mV) is much higher than 
cystine/cysteine (-340 mV) [Fasman 1976] which means that AA cannot reduce cystine to 
form cysteine spontaneously.  
For the transnitrosation studies with AA, more than 50 µM of NO was transferred 
depending on the concentration of the AA in the solution (Figures 4.4-4.6).   Since the 
initial CySH was 50 M, this showed that more NO was transferred than the initial 
amount of CySH.  Thus, CySH oxidation did not completely occur following  
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Figure 4.8 Cysteine self-oxidation in buffers (50 mM low purity NaH2PO4-Na2HPO4, 
pH=7.4) and deionized water at 4 ºC and 25 ºC. (n=2) Initial cysteine 
concentration was 25 µM. Open diamond: in deionized water at 4 ºC.  Solid 
square: in buffer at 4 º C. Solid triangle: in deionized water at 25 ºC. Open 
square: in buffer at 25 ºC. Cross: in buffer with 50 µM ascorbic acid at 25 ºC. 
The solid line and the linear equation represents zero order autoxidation 
model reported earlier [Ehrenberg et al. 1989; Bagiyan et al. 2004]. 
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transnitrosation and NO release, such that CySH could be regenerated during the 
transnitrosation process.  Also CySH autoxidatioin might not be significant in this time 
frame because transnitrosation was completed within a few hours, whereas it takes more 
than 28 hours for 25 µM CySH to be fully oxidized as shown in Figure 4.8.   
In order to further test the AA effect on the transnitrosation reaction, a study using 
less initial CySH (25 µM, compared to 50 µM previously) and 200 µM ascorbic acid was 
performed.   In Figure 4.7, approximately 60 µM NO was transferred from BSANO, 
more than twice the initial amount of CySH.  However, the transfer rate started to 
decrease after a few hours, indicating that CySH autoxidation eventually consumes most 
of the CySH after about 4 hours, thus no CySH is available for transnitrosation.  
Additionally, the CySNO concentration dropped to almost zero at approximately 4 hours, 
which also confirms that transnitrosation essentially stopped.  
4.3.3  Transnitrosation/Decomposition Reactions and Modeling Setup 
As discussed earlier (see Equations 4.2 & 4.3), the main reactions involved in 
transnitrosation and decomposition are: 
f
r
k
k
BSANO CyS CySNO BSA  
                                      
(4.17)
 
2dbkBSANO Cu BSA NO Cu                                           (4.18) 
                    
- 2     dckCu CySNO CyS Cu NO                                     (4.19) 
Since CyS- is important in the transnitrosation reaction, it is important to understand the 
fate of CyS-, which can be complicated due to various environmental conditions.   
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If there is no reducing agent, such as AA, Cu2+ in solution (which can initially be 
present or be formed according to Equation 4.19) can oxidize thiol anions to form a 
disulfide bond and generate Cu+ according to [Smith and Dasgupta 2000]: 
2 1   -  
2
ockCu CyS CyS CyS Cu                                        (4.20) 
This disulfide cysteine (CyS-CyS) is stable and would thus reduce the CyS- available for 
transnitrosation.  This is likely what happened in the studies without AA where 
transnitrosation stopped occurring. If a reducing agent is present, the reducing agent can 
suppress the available Cu2+, keeping the thiol anion in the reduced form and minimizing 
the formation of disulfide bonds.  For example, AA can react with Cu2+ (including Cu2+ 
generated from Equation 4.19) and form dehydroascorbic acid (DHA) and Cu+ [Holmes 
and Williams 2000; Smith and Dasgupta 2000; Aquart and Dasgupta 2004]: 
2 oakAA Cu Cu DHA                                           (4.21) 
Thus, reducing agents can allow for the continual progression of transnitrosation by 
inhibiting the formation of disulfide bonds.  However, AA itself can react directly with 
CySNO, causing CySNO decomposition and the associated release of NO without the 
dependence on copper [Holmes and Williams 2000].  The reaction is 
-    dakAA CySNO CyS NO DHA                               (4.22) 
Finally, CySH can also be oxidized by molecular oxygen (autoxidation) in a solution 
containing Cu+ according to [Ehrenberg et al. 1989]:   
2 24 2 - 2
koo
Cu
CySH O CyS CyS H O                                 (4.23)          
The value of koo measured for this work was previously shown in Section 4.3.2.   
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As shown in all transnitrosation results (Figure 4.3-4.7), the BSANO self-
decomposition (Equation 4.18) is extremely slow and can likely be neglected compared 
to the transnitrosation reactions that diminish the BSANO concentration.  The CySNO 
decomposition reactions in which NO is released (Equations 4.19 and 4.22) are the key 
reactions that drive the transnitrosation (Equation 4.17) towards the right hand side and 
keep equilibrium from being established.   
 Though thiol anions are the actual reactants or products in the above reactions, 
the rate of reaction can still be written in the form of the total thiol concentration in the 
solution based on a rapid equilibrium assumption where: 
,a CKCySH CySH H                                          (4.24) 
such that, 
,
[ ][ ]
[ ]a C
CyS HK
CySH
 

                                                      
(4.25)
   
At a certain pH: 
,
10 [ ][ ]
pH
a C
CySCySH
K
 
                                              
(4.26)
 
Thus,  
,
,
(10 ) [ ]
[ ] [ ]
pH
a C
T C
a C
K CyS
CySH K CyS
K
 
                                    (4.27) 
where [CySH]T denotes the total cysteine which includes both [CySH] and [CyS-].  
Assuming that Equation 4.24 is always at equilibrium (fast equilibrium), any 
concentration change in the CyS- will result in a proportional change in the total CySH.  
Thus, all reaction rate equations involving CyS- can be written in the form of total 
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Cysteine, although the rate constant used in a reaction would include the term KC shown 
in Equation 4.27.  A similar situation can also apply to BSA. 
From the reactions given above, the mass balance for all species, assuming a well-
mixed system, can be written as follows:  
[ ] [ ][ ] [ ][ ] [ ]f T r T db
d BSANO k BSANO CySH k CySNO BSA k BSANO
dt
                  (4.28) 
[ ] [ ] [ ][ ] [ ][ ]
                     [ ] [ ]
d c da r T
f T
d CySNO k CySNO k AA CySNO k CySNO BSA
dt
k CySH BSANO
   

                          
(4.29)
 
[ ] [ ][ ] [ ][ ] [ ]f T r T db
d BSA k BSANO CySH k CySNO BSA k BSANO
dt
                              (4.30) 
[ ] [ ][ ] [ ] [ ] [ ]
                   [ ][ ] [ ]
r T f T oo oc T
da dc
d CySH k CySNO BSA k CySH BSANO k k CySH
dt
k AA CySNO k CySNO
   
 
                  
(4.31)
  
   
[ ] [ ][ ] [ ]da oa
d AA k AA CySNO k AA
dt
                                                                            (4.32) 
The above equations assume that Cu2+ and Cu+ remain at constant values.  Since the total 
copper concentration is very low compared to the other species in the system, and both 
copper species are constantly being consumed and regenerated, the change in the copper 
concentration of both species was assumed to be negligible.   Therefore, kdc, koc, and koa 
are actually pseudo rate constants which include the Cu2+ or Cu+ concentrations.   
4.3.4  Determination of Rate Parameters 
From the above equations, there are a total of eight kinetic parameters: 
 RSNO decomposition: kda, kdc, kdb  
 Transnitrosation: kf, kr 
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 CySH and ascorbic acid oxidation: koo, koc, koa  
Rate constants, kdb and koo were measured from experimental studies shown in 
Section 4.3.2.  The value of kda has previously been studied with a predicted value of 
0.00094 hr-1 [Holmes and Williams 2000].  Although kdc has been measured and reported 
in Chapter 3, different AA concentrations will affect the Cu+ and Cu2+ due to the reaction 
shown in Equation 4.21.  Therefore, the value from Chapter 3 cannot be used.  Based on 
the above analysis, there are five rate parameters left that needed to be determined from 
the experimental data.    
In order to determine the above kinetic rate constants, Scientist 3.0 (Micromath, 
Saint Louis, MO) was initially used to fit the experiment data of Figures 4.3 to 4.7 to the 
ordinary differential equations (ODEs; Equations 4.28-4.32).  A least square fit algorithm 
was used during the fitting.  However, since there are five unknown parameters, some 
experimental results did not have enough data points for fitting (less than five) since 
BSANO disappeared completely within a few hours (see Figure 4.5).  Thus, in order to 
reduce the number of kinetics parameters for fitting, a parameter sensitivity analysis was 
performed to find out if there were any parameters that could be considered negligible.  
MathCAD (PTC, Needham MA) was used to solve the ODEs numerically to simulate the 
BSANO concentration profile. 
 The base case for the parameter sensitivity analysis assumed an initial condition 
of 116.48 µM BSANO, 200 µM AA and 25 µM CySH. The following base-case kinetic 
rate constants were obtained using the previously determined values of kdb and koo, the 
reported value of kda noted above, and a least square fit of the 25 µM CySH + 116.48 µM 
BSANO +200 µM AA study.  The base-case values are: 
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Through changing the kinetic parameters by plus or minus 10 fold and plotting the 
BSANO concentration profile, the model sensitivity level regarding each parameter was 
determined.  The results are shown in Figures 4.9 through 4.13.  These figures also 
include the base-case experimental data and the associated fit.  According to the figures, a 
changing koa had the least effect on the BSANO concentration profile. Thus, the potential 
for neglecting the reaction incorporating this parameter (Equation 4.21) was considered 
based on the additional analysis shown below.   
The detailed kinetics of ascorbic acid oxidation by copper (Equation 4.21) has 
been established earlier as follows [Hayakawa et al. 1973]: 
2 2 2 2 2
1 2
[ ] [ ] [ ] [ ] [ ]d AA k Cu AA k Cu AA
dt

                              (4.33) 
where k1=3.1×104 M-2s-1 and k2=6.1×1010 M-2s-1.  AA- and AA2- are different dissociated 
forms of AA according to: 
1KAA AA H                                                        (4.34) 
2 2KAA AA H                                                        (4.35)  
From the AA pKa values (pK1=4.04 and pK2=11.34) and assuming fast equilibrium, the 
following results can be calculated (at pH=7.4): 
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Figure 4.9 Simulated BSANO concentration profiles using the base-case kinetic 
parameters along with variations in the kf parameter.  The transnitrosation 
experimental data for the base-case scenario is also shown (solid squares).  
 
 
 
Figure 4.10 Simulated BSANO concentration profiles using the base-case kinetic 
parameters along with variations in the kr parameter.  The transnitrosation 
experimental data for the base-case scenario is also shown (solid squares).  
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Figure 4.11 Simulated BSANO concentration profiles using the base-case kinetic 
parameters along with variations in the koc parameter.  The transnitrosation 
experimental data for the base-case scenario is also shown (solid squares). 
 
 
Figure 4.12 Simulated BSANO concentration profiles using the base-case kinetic 
parameters along with variations in the koa parameter.  The transnitrosation 
experimental data for the base-case scenario is also shown (solid squares). 
  
µM
hrs
0
20
40
60
80
100
120
0 2 4 6 8 10 12 14
koc
koc/10
koc*10
Experimental Data
µM
hrs
0
20
40
60
80
100
120
0 2 4 6 8 10 12 14
koa
koa/10
koa*10
Experimental Data
95 
 
 
Figure 4.13 Simulated BSANO concentration profiles using the base-case kinetic 
parameters along with variations in the kdc parameter.  The transnitrosation 
experimental data for the base-case scenario is also shown (solid squares).  
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[AA-]=2290[AA]                                                             (4.36) 
[AA2-]=0.2630[AA]                                                           (4.37) 
Plugging Equations 4.36 and 4.37 into 4.33 gives: 
2 2[ ] [ ] [ ]d AA k Cu AA
dt
 
                                                     
(4.38) 
where k=0.0253 µM-2hr-1.  Comparison with Equation 4.32 in the absence of the CySNO 
decomposition term shows that koa is equivalent to k[Cu2+]2.   
For a low-purity phosphate buffer which was used in the study, the total heavy 
metal ion contamination in the salts is around 0.001%wt (based on a Pb analysis) 
according to the product label.  Although Fisher Scientific does not provide detailed 
compositions regarding the heavy metal content, a common list of heavy metals includes 
Ag, As, Bi, Cd, Cu, Hg, Mo, Pb, Sb, and Sn [Schmidt et al. 2005].  However, according 
to the Sigma-Aldrich product label, the total Cu is around 5.5%wt and7.7%wt of the total 
heavy metal ion contamination for high-purity Na2HPO4 and NaH2PO4 salts, respectively.   
Thus, in 50 mM low purity buffer (which contains approximately 11.50 g of Na2HPO4 
and 2.62 g of NaH2PO4 in 1L of 100 mM buffer), the total copper concentration is 
calculated to be 0.067 µM if the same impurity levels as shown in high-purity phosphates 
salts is used.  If all of this was Cu2+, then the maximum value for koa would be 1.14 ×10-4 
hr-1.  It is very likely that the maximum rate would be much lower if AA is present since 
AA would lead to most of the copper being in the form of Cu+ instead of Cu2+.   
Comparing the maximum value of koa with kda[CySNO], since both terms are 
shown in Equation 4.32 interacting with AA, provides valuable guidance as to whether 
koa can be neglected in the kinetic analysis.  Since the CySNO concentration was often 
higher than 5 µM during the transnitrosation studies (unless BSANO was almost 
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consumed and transnitrosation almost halted as observed with high AA concentration 
studies), kda[CySNO] would have a minimum value of 4.7 x 10-3 hr-1 based on the 
reported value of kda=0.000941 µM-1hr-1 at the corresponding pH [Holmes and Williams 
2000].  Thus, the maximum value of koa appears to be more than one order of magnitude 
smaller than the minimum value of kda[CySNO].  Therefore, it was concluded that 
kinetics involving koa in Equation 4.32 could be considered negligible.  This reduced the 
unknown kinetic parameters to four (kf, kr, kdc, koc).   
With the values of the four parameters as unknowns, all transnitrosation 
experimental data was fit to Equations 4.28-4.32 using Scientist 3.0.  The best fit values 
for kf and kr are listed in Table 4.3.  Figure 4.14 shows an example of the model fit for 50 
µM CySH, 62.27 µMBSANO and 500 µM AA.  The value of kf ranged from 0.142 to 
0.995 M-1hr-1 with an average of 0.332 ± 0.272 M-1hr-1.  The value of kr ranged from 
0.164 to 0.822 M-1hr-1 with an average of 0.504 ± 0.226 M-1hr-1.  As shown in Figure 
4.15, kf and kr show no correlation with the AA concentration as expected.   
Since kf and kr are supposed to be independent of the experiments, the average kf 
and kr were then used to again fit the experimental data to obtain values for kdc and koc.  
These two parameters, with fitted values for all experiments shown in Table 4.4, should 
be functions of AA since they both are pseudo rate constants which include the Cu2+ or 
Cu+ concentrations affected by the amount of AA.  As noted in the table, both the R2 and 
correlation values are above 0.97 for the combined fitting of BSANO and CySNO data, 
indicating that the model fits the data quite well.  The model predictions of BSANO and 
CySNO are shown for all sets of data in Figure 4.16 through 4.23.  In summary, the 
values used for the model predictions are 0.332 M-1hr-1 (average) for kf, 0.504 M-1hr-1 
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Table 4.3 Values of kf and kr for transnitrosation experiments in low purity phosphate 
buffer at pH=7.4 with different ascorbic acid concentrations. 
Ascorbic Acid 
concentration (µM)  
0 20 50 148 198 200 500 Avg. Stdv.Run #1 Run #2 Run #1Run #2
kf (µM-1hr-1) 0.235 0.229 0.142 0.995 0.362 0.484 0.200 0.160 0.179 0.332 0.272
kr (µM-1hr-1) 0.548 0.308 0.164 0.706 0.822 0.485 0.234 0.595 0.678 0.504 0.226
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Figure 4.14 Scientist 3.0 regression result graphic output for the transnitrosation with 500 
µM AA and 50 µM CySH with initial BSANO concentration at 62.27 µM. 
The lines are the fitted model and the solid and open square markers are the 
experiment data for BSANO and CySNO concentration respectively.  
 
 
 
 
 
 
 
 
100 
 
 
Figure 4.15 Result of data fitting for variable k
f
 (open diamond) and k
r
 (solid square) 
showed that there is no sign of correlation between the two constant and 
ascorbic acid concentration.  Also, the range of the kinetic constant are within 
0.1 to 0.7 µM
-1
hr
-1 
, except a few outliers, which indicating a good 
consistency of the data fitting.  
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Table 4.4 Values of kdc and koc, with fixed average kf and kr values (as shown in Table 
4.3), for transnitrosation experiments in low purity phosphate buffer at pH=7.4 with 
different ascorbic acid concentrations. 
Ascorbic Acid 
concentration (µM)  
0 20 50 148 198 200 500 Run #1 Run #2 Run #1Run #2
kdc (hr-1) 0.225 0.207 0.423 3.07 1.729 2.775 3.031 0.957 6.596
koc (hr-1) 0.6192 0.4932 0.4868 0.3144 0.9042 0.319 0.1064 0.1522 0.0348
R2 0.999 0.999 0.999 0.986 0.990 0.987 0.993 0.998 0.977
Correlation 0.999 0.998 0.998 0.990 0.990 0.990 0.995 0.999 0.985
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Figure 4.16 Scientist 3.0 regression result graphic output for the transnitrosation with 0 
µM AA and 50 µM CySH (Run #1). The lines are the fitted model and the 
solid and open square markers are the experiment data for BSANO and 
CySNO concentration respectively.  
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Figure 4.17 Scientist 3.0 regression result graphic output for the transnitrosation with 0 
µM AA and 50 µM CySH (Run #2). The lines are the fitted model and the 
solid and open square markers are the experiment data for BSANO and 
CySNO concentration respectively.  
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Figure 4.18 Scientist 3.0 regression result graphic output for the transnitrosation with 50 
µM AA and 50 µM CySH (Run #1). The lines are the fitted model and the 
solid and open square markers are the experiment data for BSANO and 
CySNO concentration respectively.  
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Figure 4.19 Scientist 3.0 regression result graphic output for the transnitrosation with 50 
µM AA and 50 µM CySH (Run #2). The lines are the fitted model and the 
solid and open square markers are the experiment data for BSANO and 
CySNO concentration respectively.  
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Figure 4.20 Scientist 3.0 regression result graphic output for the transnitrosation with 148 
µM AA and 50 µM CySH. The lines are the fitted model and the solid and 
open square markers are the experiment data for BSANO and CySNO 
concentration respectively.  
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Figure 4.21 Scientist 3.0 regression result graphic output for the transnitrosation with 198 
µM AA and 50 µM CySH. The lines are the fitted model and the solid and 
open square markers are the experiment data for BSANO and CySNO 
concentration respectively.  
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Figure 4.22 Scientist 3.0 regression result graphic output for the transnitrosation with 200 
µM AA and 25 µM CySH. The lines are the fitted model and the solid and 
open square markers are the experiment data for BSANO and CySNO 
concentration respectively.  
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Figure 4.23 Scientist 3.0 regression result graphic output for the transnitrosation with 500 
µM AA and 50 µM CySH. The lines are the fitted model and the solid and 
open square markers are the experiment data for BSANO and CySNO 
concentration respectively. 
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(average) for kr, 0.00094 hr-1 for kda,  0.002 to 0.011 hr-1 (the value determined for each 
experiment) for kdb, 0.7103 µM·hr-1 for koo, and the fitted parameters for kdc and koc.  As 
previously noted, the reaction involving koa was assumed negligible.    
Further analysis of kdc and koc with regards to the AA concentration is shown in 
Figures 4.24 and 4.25, respectively. Figure 4.24 shows a general trend (with the 
exception of a few outliers) in which kdc increases as the AA concentration increases.  
Since kdc is a pseudo parameter that includes the Cu+ concentration, this trend is 
consistent since AA contributes to the conversion of Cu2+ to Cu+.  Figure 4.25 shows a 
general trend (with the exception of a few outliers) in which koc decreases as the AA 
concentration increases.  Since koc is a pseudo parameter that includes the Cu2+ 
concentration, this trend is consistent since AA contributes to the conversion of Cu2+ to 
Cu+.     
4.4   Discussion  
Two methods for detecting NO2- or S-nitrosothiols were evaluated in this chapter, 
namely the Saville method and the Chemiluminescence method.  Both techniques are 
robust as they usually give very small standard error.  However, the Saville test is not as 
sensitive as the chemiluminescence method as described earlier and it also has the 
potential for interference problems with low molecular weight S-nitrosothiol detection 
[Tashimo et al. 2003].  Thus, it should only be used when a quick and semi-quantitive 
analysis is needed.  
The transnitrosation results showed that transnitrosation is not as simple as 
previously thought, especially when there is ascorbic acid present. The key reactant of  
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Figure 4.24 Result of data fitting for CySNO decomposition kinetic parameter kdc versus 
ascorbic concentration (with fixed transnitrosation kinetic parameter kf and 
kr).  
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Figure 4.25 Result of data fitting for CySH oxidation (by copper ion) kinetic parameter 
koc versus ascorbic concentration (with fixed transnitrosation kinetic 
parameter kf and kr).  
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transnitrosation, CySH, can be affected by various reductants or oxidants, thus changing 
the kinetics drastically.  Oxygen is one of the key oxidants that oxidizes CySH and makes 
it less effective for transnitrosation.  Since in this work all reactions were performed in 
aerobic conditions, the experimental results showed that transnitrosation was affected by 
CySH oxidation.  In physiological conditions, it is possible that this autoxidation might 
be counter played by various reducing agents in the blood such as glutathione [Flagg et 
al. 1993; Guan et al. 2003].  On the other hand, although the kinetic study showed zero 
order for the CySH autoxidation, it is feasible that a lower oxygen concentration can 
result in different kinetics.  Ehrenberg et al. found that the oxygen pressure did affect the 
pseudo zero order rate constant [Ehrenberg et al. 1989].  In blood vessels, the oxygen 
partial pressure (95 mmHg) [Martin 1999] is much lower than the atmosphere oxygen 
partial pressure (159.6 mmHg), thus the autoxidation rate can also be reduced and more 
cysteine can be kept in the reduced form.  Copper is another oxidant that plays an 
important role during the CySNO decomposition.  As Cu+ needs to be regenerated to 
cause decomposition of CySNO, two reactions (reaction 4.20 and 4.21) compete with 
each other to scavenge Cu2+ and convert it back to Cu+.  When the ascorbic acid 
concentration is high, more CySH can be saved from oxidization by Cu2+, thus more 
BSANO will be transnitrosated with CySH.  This effect was shown by the decrease of the 
koc value with increasing concentration of ascorbic acid as shown in Figure 4.25. On the 
other hand, as Cu2+ decreases, Cu+ increases which causes an increase in kdc as shown in 
Figure 4.24.  However, the kdc value at 0 µM ascorbic acid concentration during 
transnitrosation (~0.2 hr-1) is much lower than the result from Chapter 3 (~7.2 hr-1) which 
measured kdc in the absence of transnitrosation (no BSANO present).  As noted 
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previously, kdc is a pseudo rate constant which includes the Cu+ concentration.  In the 
presence of BSA, it has been shown that BSA can chelate the copper ion [Dicks and 
Williams 1996].  Therefore, in the presence of BSA, the kdc value should be smaller than 
in the absence of BSA.   
From a modeling standpoint, the high correlation value calculated from least 
square fitting at all ascorbic concentrations indicated that the model described the 
transnitrosation mechanism quite well. However, compared to the kf and kr values 
reported in literature for transnitrosation involving CySH (see Table 4.1), the values 
reported in this work are at least an order of magnitude higher due to unknown reasons.  
However, the calculated equilibrium transnitrosation constant K=kf/kr obtained in this 
work (0.657) is similar to the literature value of HSANO and CySH transnitrosation 
(0.75) as shown in Table 4.1. 
It should be noted that the model was based on the assumption that the Cu+/Cu2+ 
ratio remained constant during the reaction.  This requires that the ascorbic acid 
concentration remains virtually stable during the reaction because AA can react with Cu2+ 
to form Cu+ as showed in Equation 4.21.  In order assess this aspect, a simulation for the 
AA concentration for 25 µM CySH, 200 µM AA and 116.48 µM BSANO was 
performed.  The result showed that the AA concentration decreased less than 5% within 
15 hours (graph not shown), thus demonstrating that the AA was essentially constant for 
the timeframe of modeling.  However, it would be better to experimentally measure the 
oxidized ascorbic acid (DHA) concentration to further prove this assumption.  
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4.5   Conclusions  
 In this chapter, transnitrosation between BSANO and free CySH (not 
immobilized CySH) was studied and a mathematic model was successfully developed to 
model the experimental data.  The major achievements are: 
1) An improved nitrite/S-nitrosothiol detection method based on ammonium 
sulfamate treatment and KI/I2 based chemiluminescence method was established, 
which gives less standard error and more data consistency. 
2) Transnitrosation between BSANO and free CySH was found to be sensitive to 
various reductants and oxidants.  Oxygen and Cu2+ both can oxidize CySH, while 
ascorbic acid can react with Cu2+ so that less CySH will be oxidized.  The NO 
transferred from BSANO increases significantly when the ascorbic acid 
concentration increases.   
3) A mathematic model which includes transnitrosation between BSANO and CySH, 
CySNO decomposition and CySH oxidation was developed to model the 
experimental data.  The results showed that the model described the 
transnitrosation reactions very well.  
4) Experimental results showed that ascorbic acid increases the CySNO 
decomposition rate constant kdc value and reduces the CySH oxidation rate 
constant koc, which is consistent with the reaction mechanisms. 
5) Model sensitivity analysis showed that the transnitrosation rate constants kf and kr; 
and the CySNO decomposition rate constant kdc have the most impact on the 
BSANO concentration time profile, while the ascorbic acid oxidation rate 
constant koa has less influence. 
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CHAPTER 5 
IMMOBILIZATION OF L-CYSTEINE ON PET SURFACE 
 
5.1       Introduction 
In order to utilize endogenous NO to improve the haemocompatibility of polymer 
surfaces as proposed in Chapter 2, L-cysteine (CySH) needs to be attached to the polymer 
surface.  Currently, polyethylene terephthalate (PET) has been widely used in the 
biomedical field, especially blood contacting applications such as vascular grafts, heart 
valves and surgical mesh [Vinard et al. 1988; Tweden et al. 1997] because of its 
relatively good haemocompatibility, good mechanical properties and good biochemical 
stability in vivo [Bùi et al. 1993; Greenwald et al. 1994].  Thus, it is ideal to use PET as 
the model polymer for surface modifications as an example.  Previously, researchers in 
this group have established a protocol for covalently attaching CySH or related thiol 
molecules onto the PET surface [Duan and Lewis 2002; Gappa-Fahlenkamp and Lewis 
2005].  
Surface modifications have been widely used to immobilize diverse molecules 
such as antibodies, peptide and proteins, and even cells onto different material surface in 
order to change the surface properties, such as improving blood compatibility, altering 
cell adhesion and growth, changing the hydrophilicity or lubricity and enhancing 
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corrosion resistance all while retaining the key bulk properties of the material [Ratner and 
Castner 1997].  
Immobilization can be mainly divided into two categories based on the interaction 
between the immobilized molecules/cells and the supporting material: non-covalent and 
covalent.  Non-covalent immobilization is basically physical absorption of a chemical on 
the material surface which is usually for short term applications. It, however, does have 
the advantage of a high degree of order and uniformity [Whitesides et al. 1991; Knobler 
2007].  Covalent immobilization usually involves chemical bond formation.  This can be 
achieved by either physical methods (such as plasma or UV radiation treatment) or 
chemical treatments [Jiao and Cui 2007].  For polymer surface modifications, chemical 
treatments are usually considered first as the process is relatively easy to control (less 
side reactions) and less expensive (no special equipments needed).  
As an inert polymer, PET needs to be activated first to form reactive groups, so 
that CySH can form covalent bonds with the surface.  As introduced earlier in Chapter 2, 
PET films were treated with ethylenediamine to introduce primary amine groups on the 
surface.  The formation of a primary amine occurs via a polymer chain breakage as 
illustrated in Figure 5.1 [Avny and Ludwig Rebenfeld 1986].  The amine group was then 
used to react with glutaraldehyde (GA) to introduce the aldehyde group via imine bond (-
C=N-) formation. Finally, another unreacted aldehyde group of the GA was used to react 
with the amine group of CySH [Duan and Lewis 2002; Fahlenkamp 2003].  However, the 
imine formation reaction is reversible in aqueous solution and can be catalyzed by acid 
[Carey and Sundberg 2007].  The imine involved in the modified polymer has already 
been shown to be susceptible to acid as CySH gets detached from the polymer completely  
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Figure 5.1 Reaction scheme for PET aminolysis by ethylenediamine. The reaction leads 
to chain breakage in the ester bond and the formation of a primary amine 
group.  
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within one hour in acidic nitrite solution [Duan 2001].  Therefore, the stability of the 
imine bond in neutral solution can be questionable, as water itself can serve as a weak 
acid.  Although glutaraldehyde cross-linking has been widely used for immobilizing 
functional groups on different biomaterials for a long time [Bùi et al. 1993; Marconi et 
al. 1996; Seifert et al. 1997; Liu et al. 2008], the stability of the imine bond has rarely 
been addressed in these applications.  However, a study done by Vazquez et al. reveals 
that the structure of the imine compound can significantly improve the stability of the 
imine bond due to the lack of ionic groups or the existence of bulky hydrophobic 
substituent groups near the imine bond [Vazquez et al. 1990].  Thus, for the imine bonds 
between CySH and GA or the imine bond between GA and ethylenediamine on the 
polymer, the bonds either lack one or both of the above two stabilizing factors which 
makes it highly possible that CySH can be detached from the polymer easily even at 
neutral pH.  Another drawback of this modified polymer is the polymer bulk property 
changes after ethylendiamine treatment.  As mentioned earlier, ethylenediamine causes 
polymer chain scission when inserting itself into the polymer, thus this treatment 
weakens the mechanical properties of the polymer [Avny and Ludwig Rebenfeld 1986].   
  In order to overcome the above problems, a new surface modification 
carboxylation treatment is introduced in this chapter and amide bond (-C-NH-) formation 
is used to attaching CySH to the polymer surface. For attaching via the amide bond, there 
are two functional groups on CySH that can be used: the carboxyl group and the amine 
group.  Thus, PET needs to be activated to acquire amine or carboxyl groups on the 
surface, respectively, in order for attachment to occur.  The amine group can be 
introduced by the aminolysis method as discussed above using ethylenediamine although 
O 
║
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the polymer can be weakened.   In contrast, the carboxylation treatment can add a 
carboxyl group on the benzene ring of PET without breaking the polymer chain (Figure 
5.2) [Löfås and Johnsson 1990; Massia and Hubbell 1990].  Peptide bond formation is 
also a widely used method for immobilization [Hermanson 1996].  Although peptide 
bonds can also be hydrolyzed in neutral pH and the reaction is thermodynamically 
favored (equilibrium constant is around 103-104), the hydrolysis is kinetically unfavored 
under physiological conditions with a reaction half life of years. Thus, peptide bonds are 
still considered to be stable in physiological time scale [Aslam and Dent 1998].  In this 
chapter, two different surface modification methods (imine bond and amide bond) were 
evaluated and their potential stability problems were also studied in detail.  In addition, 
polymer surface changes were briefly characterized after different modifications. 
In addition to the bond stability of modified PET, the stability of CySH itself, 
particularly the thiol (-SH) group, is critical for the long term performance of a CySH-
modified polymer in biomedical applications.  Thiol groups have been reported to be 
sensitive to light, oxygen and ozone in either dry conditions or aqueous conditions 
[Gerdes et al. 1999; Ferris and Rowlen 2000].  Although the applications of modified 
PET are mostly in aqueous conditions and without light (in vivo), studying the behavior 
of CySH on PET without exposure to aqueous solution is beneficial for determining an 
optimized storage condition for CySH-modified PET.  Therefore, this work also 
evaluated the stability of CySH following attachment to PET.  
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5.2 Materials and Methods 
5.2.1    Materials 
 Polyethylene terephthalate (PET) was generously provided by DuPont (Hopewell, 
VA).  Glacial acetic acid, potassium iodide, tetrahydrofuran (THF) acetone, 
formaldehyde and sodium nitrite were purchased from Fisher Scientific (Fairlawn, NJ).  
10× Gibco Phosphate-Buffered Saline (PBS), pH 7.4 was purchased from Invitrogen. 1M 
NaOH and 1 M HCl were purchased from Cole-Parmer (Vernon Hills, IL).  
ethylenediamine (ED), ammonia sulfamate, sulfanilamide, iodine, L-cysteine (CySH), 1-
ethyl-3-(3-dimethylaminopropyl)-carbodiimide hydrochloride (EDC),  glutaraldehyde, 
bromoacetic acid, N,N'-dicyclohexylcarbodiimide (DCCI), N-(tert-butoxycarbonyl)-S-
trityl-L-cysteine [Boc-Cys(Trt)-OH], 1-hydroxybenzotriazole (HOBt), 4-
Ethylmorpholine,  2-(N-morpholino)ethanesulfonic acid (MES), 5,5-dithiobis (2-
nitrobenzoic acid) (DTNB) and all the other reagents were purchased from Sigma 
Chemical Co. (St. Louis, MO).  Kimble 4 mL and 1.8 mL amber vials were purchased 
from VWR (West Chester, PA).  
5.2.2    PET Modification 
 PET film was cut into 1×5 cm size and soaked in acetone for 24 hours followed 
by drying in petri dishes for 12 hours before any surface modification.  The acetone 
treatment is for removing possible surface contaminants.   
 Two surface modifications: aminolysis and carboxylation were used to add either 
amine or carboxyl groups on the PET surface, respectively. 
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 Aminolysis: Acetone treated PET was placed in an 8 mL glass culture tube and 
then 5 mL 40% or 60% ED solution was added into the tube to cover the entire polymer. 
Then, the tube was placed in a 40 ˚C water bath and shaken at 130 times/min for 24 hours 
[Gappa-Fahlenkamp and Lewis 2005].  The polymer was then washed by DI water in 
culture tubes for 3 cycles, each cycle consisting of three quick rinses (using 5 mL DI 
water each time) followed by one soaking for 5 min (in 5 mL DI water).  Finally, the 
aminolyzed PET (PET-NH2) was placed in a nitrogen glove box for 12 hours to let it dry. 
Carboxylation: PET was carboxylated using the protocol described by Yang et al. 
[Yang et al. 2000]. Briefly acetone treated PET was placed in the culture dish and 5 mL 
18.5% formaldehyde solution in 1 M acetic acid was added to cover the entire polymer. 
The tubes were then set on the hand motion shaker, shaking for 4 hours followed by DI 
water wash as previously described.  This process hydroxylates the PET surface by 
adding a methanol residue on the benzene ring [Massia and Hubbell 1990] (Figure 5.2). 
After drying the hydroxylated PET (PET-OH) for 12 hours in the nitrogen glove box, 
PET-OH was then treated with 5 mL 1 M bromoacetic acid solution in 2 M sodium 
hydroxide in a glass culture tube for 16 hours followed by DI water rinsing and drying in 
a nitrogen glove box for 12 hours.  This finally introduced the carboxyl group to the PET 
surface (PET-COOH) [Löfås and Johnsson 1990].  
5.2.3    CySH Immobilization 
After PET surface activation, cysteine can then be attaching using different 
methods.  Three different approaches were attempted as follows. 
Glutaraldehyde cross-linking (imine bond): This method was based on the 
previous works done by Fahlenkamp [Fahlenkamp 2003].  PET-NH2 was put into a  
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Figure 5.2 Reaction scheme for PET carboxylation. The reaction adds a carboxyl group 
on the benzene ring without causing chain breakage.  
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glass tube filled with 5 mL 0.02% GA in Gibco 1×PBS (pH 7.4) buffer. Then, the tube 
was set on the hand motion shaker, shaking at 1 time/sec while blowing nitrogen into the 
tubes slowly for 15 min followed by DI water rinsing.  This formed the glutaraldehyde 
modified polymer (PET-GA).  Then PET-GA was placed in a new glass tube filled with 5 
mL 0.2% CySH in Gibco 1×PBS (pH 7.4) buffer.  Finally, the tube was set on the hand 
motion shaker, shaking at 1 time/sec for 12 hours, followed by DI water rinsing.  This 
modified polymer with CySH on the aminolyzed PET via the imine bond is denoted as 
PET-N(i)-CySH. 
DCCI coupling (amide bond): This method was modified from M. Bodanszky and 
A. Bodanszky [Bodanszky and Bodanszky 1994].  Briefly, PET-NH2 was put into a glass 
culture tube and then 5 mL 4˚C THF mixture (including 20 mM of HOBt, EMP, Boc-
Cys(Trt)-OH and 22 mM DCCI) was added into the tube, followed by shaking on a hand 
motion shaker for 1 hour at 4 ˚C and 1 hour at room temperature.  The DCCI was slightly 
in excess because it is the coupling reagent.  The CySH had a protecting group on both its 
amine and thiol groups, thus preventing CySH self-polymerization and also keeping the 
thiol from reacting with DCCI [Hermanson 1996].  Another experiment using higher 
concentration reactant (200 mM) was also made accordingly.  During the reaction, white 
precipitate was observed which was due to the formation of dicyclohexylurea [Barany 
and Merrifield 1979].  After coupling, the modified polymer was rinsed by THF for 3 
cycles similarly to DI water rinsing.  Then, the thiol of the cysteine was de-protected by 
incubating the modified polymer in 80 mM I2 dissolved in methanol for 1 hour at room 
temperature.  Finally, the modified polymer was incubated in 1M Na2S2O3 solution to 
remove the excess iodine on the polymer surface (The color of the polymer turn from 
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brown to white), followed by 3 cycles of DI water rinsing.  A brief summary of these 
steps is illustrated in Figure 5.3.  This modified polymer with CySH on the aminolyzed 
PET via the amide bond is denoted as PET-N(a)-CySH.  A Boc-glycine modified PET 
was also made similarly as the blank sample and it is denoted as PET-N(a)-Gly.  
EDC coupling (amide bond): This method was modified from Wissink et al.  
Briefly, PET-COOH was incubated with 0.25 M EDC and 0.25 M CySH in 0.1 M 
phosphate buffer (pH 6.8) in a culture tube which was shaken on a hand motion shaker 
for 16 h at 4 ˚C, followed by 1 cycle of 1 M NaCl solution rinsing and 3 cycles of DI 
water rinsing at 4˚C [Wissink et al. 2001]. The CySH used here was unprotected since 
the thiol protected CySH used in the DCCI method was not water soluble and EDC is 
preferred to be used in aqueous solution [Hermanson 1996].   The only water soluble 
thiol protected cysteine commercially available is extremely expensive and currently 
there is no known method to deprotect it.  However, a carboxyl group protected CySH — 
cysteine ethyl ester (CySH(E)) was also immobilized using the similar method in order to 
study the self-polymerization effect on immobilization.  These two modified PET had an 
amide bond between the carboxyl group on the PET-COOH and the amine group on 
cysteine and they are denoted as PET-C(a)-CySH and PET-C(a)-CySH(E), respectively.  
In addition, a set of experiments with lower reactant concentrations (0.1 M EDC and 
0.1M CySH) were performed in order to study the concentration effect on 
immobilization.  A modified polymer in which glycine, rather than cysteine, was attached 
served as a control.  This polymer is denoted as PET-C(a)-Gly. 
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EDC coupling was also used for ethylenediamine treated PET for attaching 
CySH. The immobilization is similar to the above protocol, except that 100 mM MES 
buffer (pH  
  
Figure 5.3 CySH immobilization on the aminolyzed PET using DCCI coupling.  The 
amide bond forms between the carboxyl group of CySH and the amine group 
on PET-NH2. The thiol group was de-protected after coupling.  
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5.5) was used instead of 100 mM Na2HPO4-NaH2PO4 buffer (pH 6.8).  This polymer is 
denoted as PET-N(a,e)-CySH. 
5.2.4    Cysteine Surface Concentration Analysis 
Immobilization of cysteine on PET-N(i)-CySH was verified using a protocol 
modified from Duan and Lewis [Duan and Lewis 2002].  Briefly, the polymer was cut 
into a 1×1 cm piece and put in a 1.8mL amber vial.  Then, 250 µL 1 N HCl and 750 µL 
100 µM NaNO2 was added into the vial followed by hand motion shaking for 1 hour at 
room temperature.  After that, 500 µL 200 µM ammonium sulfamate was added into the 
vial with continued shaking for 5 min to quench the excess nitrite.  In this process, 
cysteine detaches and is nitrosated to form S-nitrosocysteine. S-nitrosocysteine was then 
measured by a Sievers NO chemiluminescence analyzer NOA 270B (Sievers Medical 
Instruments, Inc., Boulder, CO) using a potassium iodide/iodine (KI/I2) reducing solution 
as mentioned in Chapter 4, Section 4.2.5.  Since the excess nitrite is removed, only 
CySNO was measured. The surface cysteine concentration was calculated as follows: 
[CySH]surface = [CySNO]solution • V / A                                   (5.1) 
where [CySNO]solution is the CySNO concentration in the solution measured via 
chemiluminescence, V is the volume of the solution, and A is the surface area of the 
polymer film.  
 For the cysteine modified polymer via the amide bond (PET-N(a)-CySH and 
PET-C(a)-CySH) the amide bond is stable in the acidic condition and the above method 
cannot detect any S-nitrosocysteine in the solution.  Therefore, an indirect method was 
used.  Briefly, the modified polymer was incubated with 500 µL 100 μM NaNO2 and 500 
µL 1 N HCl for 30 min followed by 500 µL 1N NaOH neutralization. This reaction 
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reduces the nitrite concentration in the solution since the thiols on the surface are 
nitrosated.  Meanwhile, a similar acidic nitrite solution was prepared, without exposure to 
a polymer, to be used as a blank since during the nitrosation some of the nitric acid can 
decompose to form NO and be released into the head space of the vial which can also 
cause a decrease of total nitrite in the solution. Then, 20 μL samples were taken from 
both the polymer-exposed solution and the blank solution and the nitrite concentration 
was measured by the KI/I2-based chemiluminescence method as previously described. 
The surface cysteine concentration was estimated by the following equation: 
[CySH]surface = ([NO2-]blank – [NO2-]sample) • V / A                         (5.2) 
where [NO2-]blank is the nitrite concentration of the blank solution, [NO2-]sample is the 
nitrite concentration of the solution containing the modified PET, V is the volume of the 
solution and A is the area of the polymer film.  
In addition to measuring the surface cysteine concentration, cysteine 
concentration in solution was measured during some studies using Ellman’s method 
[Ellman 1959; Rootwelt 1967] as mentioned in the Chapter 4, Section 4.2.7.  Briefly, a 
100 µL sample solution was mixed with an equal volume of Ellman’s reagent (5 mM 
DTNB in 100 mM pH 7.2 phosphate buffer and 0.1 mM EDTA) in a 96-well microplate 
(Falcon 353228, BD, Franklin Lakes, NJ).  After 10 min, the absorbance of the solution 
was measured at 410 nm using a Packard® SpectraCountTM Microplate Photometer 
BS10000 (Packard Instrument Co., Meriden, IL). 
5.2.5 Imine Bond and Amide Bond Stability Test 
 All three polymers, PET-N(i)-CySH, PET-N(a)-CySH and PET-C(a)-CySH, were 
cut into a smaller size (usually 1×1 cm) and placed in an 4 mL amber vial which was 
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filled with 1.5 mL 50 mM low purity NaH2PO4-Na2HPO4 buffer (pH=7.4).  All the vials 
were set on the hand motion shaker, shaking at 30 times/min at either room temperature 
or in a 37 ˚C incubator.  At specific times, sample polymers were taken out of the vials, 
wiped by tissue paper and then measured by the chemiluminescence method mentioned 
earlier. The liquid samples were measured by Ellman’s method as previously mentioned. 
5.2.6    Cysteine Modified Polymer Surface Property Analysis 
 The modified polymer surface was briefly characterized by scanning electron 
microscope (SEM) using a Jeol JSM 6360 scanning electron microscope (Jeol USA, Inc., 
Peabody, MA). Images of the surface were taken for unmodified polymer, aminolyzed 
PET (treated by different concentration of ethylenediamine) and carboxylated PET. Also, 
the polymer thickness change after aminolysis was analyzed by micrometer calipers. 
5.2.7 Light and Air Effect on CySH Modified Polymer and Long Term Storage Test 
 CySH-modified PET was made by ethylenediamine treated PET followed by 
glutaraldehyde cross-linking immobilization as previously described.  The reason for 
using this unstable polymer for this oxidation test was because 1) the oxidation test was 
under dry conditions which does not have the potential problem arising from the imine 
bond breakage; 2) This method was the easiest and fastest one to make the CySH 
modified PET; 3) This method can introduce more cysteine on the PET surface than the 
other methods, which will make it easier to detect the change in the surface 
concentration.  
 The PET-N(i)-CySH was cut into 1×1 cm pieces and divided into three petri 
dishes. One of the petri dishes was placed in the nitrogen glove box with a 60 W 
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incandescent light bulb turning on constantly at the distance of 20 cm.   This experiment 
will show only the light effect on the modified PET.  The other two petri dishes were 
exposed to air but with one of them covered with aluminum foil and one placed under a 
constant 60 W incandescent light bulb at a distance of 20 cm.  Therefore, these two petri 
dishes were used for studying CySH modified PET oxidation in air only and in light + 
air, respectively.  At specific times, one piece of the modified polymer was removed from 
each petri dish and treated with acidic nitrite, followed by KI/I2 based 
chemiluminescence analysis as previously mentioned.  
 In order to study the possibility of long term storage of the modified polymer 
under dry conditions, one piece of a 1×5 cm polymer was placed in a 4 mL amber vial 
and the vial was placed in the -20 ˚C freezer for 62 days.  Then, the polymer was cut into 
1×1 cm pieces and measured by the same method which was used to analyze the PET-
N(i)-CySH polymer as above. 
 The CySH surface concentration for oxidation in air only, light only and air + 
light were plotted versus time.  Since the kinetic mechanism of the oxidation is unknown 
for the modified polymer, TableCurve2D v5.01 (Systat Software, Inc, Chicago, IL) was 
used to fit the graph with various embedded kinetic models in the software and then a 
best fit model was determined. 
5.3        Results 
5.3.1 Cysteine Surface Concentration Measurement 
 The chemiluminescence analysis for all three modified polymer showed that 
cysteine was attached. The surface concentrations are shown in Figure 5.4.  However, the 
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surface concentrations are not consistent among different modification methods.  The 
surface concentrations ranged from around 2 nmol/cm2 to 20 nmol/cm2, with PET-N(i)-
CySH having the highest concentration and the PET-C(a)-CySH showing the lowest 
value.  This is probably due to surface area changes or cross-linking effect, which will be 
addressed later.  On the other hand, it is evident that increasing the reactant concentration 
during the carbodiimide coupling (DCCI method and EDC method) leads to a higher 
surface concentration of CySH (PET-N(a)-CySH (20 mM) versus PET-N(a)-CySH (200 
mM) and PET-C(a)-CySH (0.1 M) versus PET-C(a)-CySH (0.25 M)).  However, for 
DCCI coupling, since the protected CySH is relative expensive, only a 200 mM reactant 
concentration was tried. 
For EDC coupling, two different treated PET were assessed: aminolyzed PET and 
carboxylated PET.  The resulting surface concentrations are much lower (below 5 
nmol/cm2) compared to PET-N(i)-CySH and PET-N(a)-CySH, with the modified PET 
coupled with cysteine ethyl ester (CySH(E)) having a relatively higher surface 
concentration.  Also, it was also observed that a higher (around 0.5 M) concentration of 
CySH during the coupling is not recommended because when large amount of CySH is 
oxidized during the reaction, it forms a substantial amount of white precipitation 
(disulfide CySH) which can stick on the polymer surface and significantly interfere with 
coupling reaction (data not shown). 
As expected, two blank polymer using glycine as the reactant: PET-N(a)-Gly and 
PET-C(a)-Gly showed virtually zero CySH surface concentration (data not shown). 
5.3.2 Stability of Imine Bond and Amide Bond 
 Although the polymer using the ethylenediamine treatment and glutaraldehyde 
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Figure 5.4 CySH surface concentrations on PET modified by different methods. PET-
N(i)-CySH: PET treated by ethylenediamine, followed by glutaraldehyde 
cross-linking with CySH. PET-N(a)-CySH: PET treated by ethylenediamine, 
followed by DCCI coupling. PET-C(a)-CySH: PET treated by carboxylation, 
followed by EDC coupling. PET-C(a)-CySH(E) same as PET-C(a)-CySH, but 
cysteine ethyl ester was used instead of cysteine. Concentrations in the 
parenthesis are the reactant concentrations during the coupling reaction.  
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cross-linking yielded the highest CySH surface concentration, the imine bond was not 
stable even at neutral pH.  Figure 5.5 shows that cysteine detached from the polymer 
surface and went into the solution (The total cysteine loss is more than 70% at 37 ˚C and 
less than 50% at 25 ˚C).  Notice that the y axis of Figure 5.5 is the total moles of cysteine 
on the polymer (or in the solution) instead of the CySH surface concentration (nmol/cm2) 
as shown in Figure 5.4.  Thus, it is easy to find show that CySH loss from the polymer 
and the CySH increase in the solution are virtually comparable if considering the factor 
that some of the CySH (either on polymer or in solution) is oxidized due to the reasons 
which were discussed in the previous chapter.  Figure 5.5 also showed that the hydrolysis 
is initially fast (within 5 hours) and then slows down.  Increasing the temperature only 
increased the initial imine bond hydrolysis and the free CySH oxidation in the solution 
but exerted no noticeable effect on CySH detachment after 5 hours.  This is evident since 
two curves showed the same trend of CySH surface concentration loss which is probably 
due to oxidation and not imine bond hydrolysis.  
  For the CySH modified polymer made by aminolysis followed by DCCI coupling 
through an amide bond (PET-N(a)-CySH), the polymer showed good stability in acidic 
condition as mentioned earlier.  However, at neutral pH, there was still significant CySH 
detachment from the polymer as shown in Figure 5.6.  The detaching trend was similar to 
the modified polymer using an imine bond (PET-N(i)-CySH). Ellman’s method again 
detected that there was CySH existing in the solution and the amount was comparable to 
the CySH amount lost from the polymer surface. 
For the polymer made by carboxyl modification followed by EDC coupling 
(amide bond), PET-C(a)-CySH also showed significant CySH surface concentration loss 
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Figure 5.5 CySH surface amount and amount in the solution when the modified polymer 
(PET-N(i)-CySH) was incubated in low purity phosphate buffer at 25 ˚C and 
37 ˚C. (n=2) The cysteine is slowly detached from the polymer (compared to 
acidic condition).  An increase in temperature can accelerate this imine bond 
hydrolysis within the initial 5 hours.  
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as shown in Figure 5.7 (more than 80% of the CySH detached from the polymer surface).  
Again, CySH was detected in the solution. However, the total CySH amount in the 
solution was more than the amount on the polymer (almost 3 times).  This inconsistency 
of the data will be discussed in detail later.  As shown in Figure 5.8, the carboxyl group 
protected CySH showed instability similar to the unprotected polymer.  
 For the polymer made by ethylenediamine modification followed by EDC 
coupling (amide bond), PET-N(a,e)-CySH showed that the bond between CySH and the  
polymer had much better stability as shown in Figure 5.9.  The CySH surface 
concentration decrease was probably due to oxidation, which is consistent with previous 
results (virtually zero order oxidation as shown in Figure 5.5 after 5 hours).  Ellman’s 
method could not detect any CySH in the solution, thus confirming that there was no 
CySH detached from the polymer.  
5.3.3 Polymer Surface Change after Modification 
 SEM images (Figure 5.10) showed that the original PET surface is quite smooth 
with only minor defects (some dots and lines).   The carboxylated polymer also showed 
no polymer surface deterioration.  However, for the ethylenediamine (ED) treated PET, 
there were many cracks formed and the size of the cracks increased with increasing ED 
concentration (The entire dark part of Figure 5.10(d) is one crack with a width around 5 
µm while in Figure 5.10(c), the width of the cracks are less than 1 µm).  The polymer 
thickness for the ED treated polymer also changed significantly after modification, 
reducing from 0.0855±0.0053 mm to 0.0525±0.0039 mm with about 60% loss after 60% 
ethylenediamine treatment. 
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Figure 5.6 CySH surface amount and amount in the solution when the modified polymer 
(PET-N(a)-CySH) was incubated in low purity phosphate buffer at 25 ˚C. 
(n=2) The cysteine was detached from the polymer similar to PET-N(i)-CySH, 
indicating that the bond was unstable. 
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Figure 5.7 CySH surface amount and amount in the solution when the modified polymer 
(PET-C(a)-CySH) was incubated in low purity phosphate buffer at 25 ˚C. 
(n=2) The cysteine was detached from the polymer similarly to PET-N(i)-
CySH, indicating that the bond was still unstable. However, the CySH lost 
from the polymer was not consistent with the CySH observed in solution. 
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Figure 5.8 CySH surface concentration when the modified polymer (PET-C(a)-CySH(E) 
was incubated in low purity phosphate buffer at 25 ˚C. (n=2) The cysteine was 
detached from the polymer similarly to PET-N(i)-CySH, indicating that the 
bond was still unstable.  The solution CySH was not measured in this case. 
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Figure 5.9 CySH surface concentration when the modified polymer (PET-N(a,e)-CySH 
was incubated in low purity phosphate buffer at 25 ˚C. (n=2) CySH surface 
concentration was reduced mostly by oxidation because there was no 
detectable CySH in the solution (data not shown).   
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Figure 5.10 SEM image of PET surface change after different treatment. (a) untreated 
PET, (b) carboxylated PET, (c) 40% ethylenediamine treatment, (d) 60% 
ethylendiamine treatment.  The carboxylated PET showed similar surface as 
the original one while the ethylenediamine treated PET showed many cracks 
and the size of the cracks increased with higher ethylenediamine 
concentrations. 
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5.3.4 Light and Air Effect on CySH Modified Polymer and Long Term Storage Test. 
The results shown in Figure 5.11 with only light + air treatment showed 
significant CySH oxidation (40% loss within 110 hours) while light or air alone virtually 
did not show any CySH oxidation (<10% within 110 hours).  A 3rd-order simple decay 
model (Equation 5.3) fit the data the best with R2 of 0.999: 
0
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                                                         (5.3) 
where C0 is the initial CySH surface concentration, k is the 3rd-order decay rate constant.  
The fitting gives the value of C0=26.07 nmol/cm2 and k=(3.32±0.1)×10-5 nmol-2·cm4·hr-1. 
Long term freezer storage (Figure 5.12) showed that the CySH surface concentration 
remained stable at -20 ˚C freezer for 62 days.  
5.4 Discussion 
The theoretical maximum cysteine surface concentration can be estimated by 
assuming a tightly packed monolayer of spherical cysteine molecules on the polymer 
surface.  The following equation can be used to estimate the radius of cysteine molecule 
[Fournier 1999]: 
1
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                                                     (5.4) 
where, M is the molecular weight of the molecule (121.16 g/mol for cysteine) and ρ is the 
density of the molecule (1.523 g/cm3). Thus, the calculated cysteine molecule radius is 
0.32 nm and the maximum surface concentration is 0.52 nmol/cm2.  The ethylenediamine 
treated PET followed by glutaraldehyde cross-linking or DCCI coupling showed a much  
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Figure 5.11 PET-N(i)-CySH oxidation under different storage condition. (n=2) The light 
or air treatment virtually did not cause oxidation, only light combined with 
air caused CySH oxidation.  The solid line is a 3
rd
-order decay model 
(Equation 5.3) for fitting the light + air scenario.  
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Figure 5.12 PET-N(i)-CySH long term storage test. (n=3) CySH surface concentration 
remained virtually the same after 62 days in a -20 ˚C freezer.  
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higher value than the theoretical limit.  There are two possible reasons for this 
phenomenon.  First, the cracks formed can significantly increase the active surface area 
for immobilization; second, glutaraldehyde can self polymerize in aqueous solution to 
form long chains with multiple aldehyde groups [Migneault et al. 2004].  On the other 
hand, aminolyzed PET using the EDC method for coupling did not show a high cysteine 
surface concentration which was probably due to the fact that EDC was mostly consumed 
by CySH self-polymerization (because the unprotect CySH can react with each other to 
form a complex compound, therefore less CySH can be attached to aminolyzed PET).   
The instability of the imine bond was verified and the possible reason was 
discussed above.  However, there is a method to improve the imine stability by reducing 
the imine bond (-C=N-) to an amine bond (-C-NH-) by a strong reducing agent (e.g. 
NaCNBH3) [Hermanson 1996].  However, this work was not pursued.   
The amide bond was supposed to be stable according to many published applications 
[Hermanson 1996; Aslam and Dent 1998]. However, among the various modified PET 
that were made in this study using the amide bond, most of them (e.g. PET-N(a)-CySH, 
PET-C(a)-CySH and PET-C(a)-CySH(E)) appeared to be stable only in acidic conditions, 
only one (PET-N(a,e)-CySH) was stable at both neutral and acidic pH.  One possible 
reason is the thiol group on the CySH.  In EDC coupling, the –SH group can react with 
the COOH group during the EDC coupling to form a thiol ester bond [Hermanson 1996].  
This bond is stable in acidic solution according to Saburo [Saburo 1999], but it is not as 
stable as the amide bond and can be hydrolyzed in neutral pH. Also, the activated –
COOH will preferably react with a NH2 group, even there is a SH group at the same 
concentration level [Hermanson 1996].  Therefore, during coupling, since the CySH 
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concentration is quite high, CySH will first react with each other to form a chain of CySH 
instead of reacting with the activated –COOH on the PET as shown in Figure 5.13(a).  
Thus, for this molecule (Figure 5.13(a)), it is easier to react with the activated –COOH on 
the PET via the –SH rather than the –NH2 group because the –SH is now dominant (see 
Figure 5.13(b)). Therefore, when this thiol ester polymer is put into the solution, the thiol 
ester bond will be broken and all the cysteine will be quickly lost. However, in the acidic 
nitrite condition, the –SH can be nitrosated and the bond is stable. Therefore, –SH can be 
detected.  
On another note, it has been documented that phosphate can also be activated to react 
with amine to form a phosphoramidate bond [Hermanson 1996], although the stability of 
this bond is not clear and there is no literature regarding whether activated phosphate can 
react with the thiol group or not.  Similar reactions can still occur even if the carboxyl 
group of CySH is protected which is in the case of EDC coupling with CySH ethyl ester, 
because CySH ethyl ester might be hydrolyzed to form unprotected CySH during the 
long coupling process (16 hours).  For EDC coupling using aminolyzed PET and CySH, 
since there is no thiol ester bond formation between PET and CySH (no carboxyl group 
on PET), all the CySH are coupled to PET via an amide bond to form a stable CySH-
modified PET. This can also be used to explain the reason why in the case of PET-C(a)-
CySH, a higher CySH was detected in the solution than the loss of CySH on the polymer, 
because the CySH chain might form a complex 3-D formation on the PET surface to 
prevent the thiols from reacting with acidic nitrite. Therefore, when the thiol ester bond is 
hydrolyzed, the chain is detached from the polymer and all of the thiol groups are 
exposed to Ellman’s reagent. This leads to more CySH detected by Ellman’s method as  
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Figure 5.13 Possible CySH chain formation (a) and thiol ester bond formation between 
the thiol group on the CySH chain and carboxyl group on the PET (b).  
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compared to the chemiluminescence method. 
However, the above mechanism cannot explain why in the DCCI coupling, even 
when the CySH had both its thiol group and amine group protected, the resulting 
modified polymer was still unstable. The only explanation could be that the 
ethylenediamine treated polymer became more unstable after the DCCI coupling which 
involved a lot of different organic solvent treatments. 
Although one CySH modified polymer with a stable bond (PET-N(a,e)-CySH) 
was finally synthesized, there were still potential problems with this polymer.  The 
aminolyzed PET showed significant surface deterioration as shown by SEM analysis due 
to the reason that ethylenediamine can diffuse into the polymer fiber to cause further 
damage of the polymer microstructure [Avny and Ludwig Rebenfeld 1986].  Meanwhile 
the mechanical properties were significantly weakened as the polymer thickness reduced 
significantly after 60% ethylenediamine treatment. Thus, it is ideal to find a method to 
introduce an amine group on the PET surface without breaking the polymer chain or find 
a water soluble thiol protected CySH which can be deprotected easily. 
The CySH surface concentration time profiles (Figure 5.5-5.8) for the unstable 
polymers (PET-N(i)-CySH, PET-N(a)-CySH, PET-C(a)-CySH and PET-C(a)-CySH(E)) 
were almost similar, with a fast initial decreasing step within a few hours and then 
slowing down.  The first stage was likely due to bond breakage while the second stage 
was likely due to cysteine oxidation. By fitting the second stage of Figure 5.5 with zero 
order kinetics, the decay constant is 0.280 nmol/(cm2·hr).  However, by fitting the data in 
Figure 5.9, the decay constant is 0.0433 nmol/(cm2·hr). The inconsistencies between 
these two constants indicate that different binding can affect the CySH oxidation decay 
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constant.  However, the decay constant might not be affected by the temperature as 
shown in Figure 5.5, which is different from the free cysteine oxidation in solution 
mentioned in the Chapter 4.  
The light and air influence study showed that except for the bond stability issue, 
CySH on the surface can also be oxidized in the dry condition when light and oxygen are 
both present, but under light or air alone, no significant oxidation occurs.  A possible 
explanation for this phenomenon is that light serves as the energy to activate the electron 
in the thiol group and oxygen serves as the electron acceptor.  Thiol photooxidation in 
dry conditions or in non-aqueous solutions has previously been studied.  There is a 
postulated intermediate for this oxidation in both gas or liquid phase, which involves the 
thiylperoxyl radical [Robert-Banchereau et al. 1997]: 
2R-S  + O   R-S-O-O   Oxidation products                                  (5.5) 
where the thiol radical might be generated under light activation. However, this work 
showed a 3rd-order decay reaction, which is different from photooxidation occurring in 
aqueous conditions (first or zero order reaction) [Robert-Banchereau et al. 1997; Ferris 
and Rowlen 2000; Bagiyan et al. 2003].  Therefore, further studies need to be performed 
to test whether this is a unique reaction mechanism for CySH photooxidation of a 
modified polymer. 
  Cysteine-modified PET long term storage tests showed that when kept at low 
temperature (-20 ˚C), no CySH oxidation was observed for about two month.  This 
finding is beneficial for future experiments since large amounts of CySH-modified 
polymer can be made in one batch and kept in the freezer for a long time.  This could 
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potentially reduce possible inter-experimental errors for CySH surface concentration 
studies.  
5.5 Conclusions 
 Cysteine immobilization using different methods was evaluated and the stability 
of the bond in buffer as well as cysteine oxidation in both aqueous and dry conditions 
were studied. The important findings are: 
1) The previous protocol for making PET-N(i)-CySH lead to an unstable polymer 
due to imine bond breakage between either CySH and glutaraldehyde or 
glutaraldehyde and the amine on PET. 
2) Amide bond formation using DCCI or EDC coupling increased the stability of the 
modified polymer in acidic condition. However at neutral pH, some of the 
modified polymer still showed bond breakage and only one of the newly 
developed polymers (ethylenediamine treatment followed by EDC coupling) 
showed good bond stability in both acidic and neutral pH. 
3) Cysteine on all the polymers can also be oxidized slowly just as the free cysteine 
oxidation which followed the zero order kinetics in solution.  Different 
immobilization methods appear to have a significant effect on the oxidation rate 
constant. 
4) Ethylenediamine treatment can cause substantial amounts of cracks on PET 
surfaces and the higher concentration of ethylenediamine used, the bigger the 
cracks. Also, the PET thickness is reduced significantly after ethylenediamine 
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treatment which potentially affects the mechanical properties or the stability of the 
modified polymer.   
5) Immobilized CySH on PET-N(i)-CySH polymer is susceptible to light and air 
under dry conditions. However light or air alone does not cause CySH oxidation.  
This oxidation was found to be represented by a 3rd-order decay reaction with 
regard to the CySH surface concentration, but a detailed mechanism remains 
unsolved.  CySH modified PET can be stored in an amber vial at -20 ˚C for about 
2 months without noticeable oxidation. 
As noted in this chapter, a modified polymer that had both structural integrity and 
stable bonds was not achieved.  In order to make a polymer with both good mechanical 
integrity and bond stability, two approaches can be attempted in the future: a) introduce 
amine group on the PET without destroying the polymer and then do the EDC coupling; 
b) find a water soluble thiol protected CySH (which can later be deprotected) and attach 
it to carboxylated PET using the EDC method.  
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CHAPTER 6 
BSANO TRANSNITROSATION WITH CYSH MODIFIED PET AND 
MODELING IN FLOW SYSTEM 
6.1 Introduction 
 As described in Chapter 1, the ultimate goal of this work is to develop a kinetic 
model to predict the NO flux from a CySH-modified polymer surface exposed to 
BSANO.  A model will aid in evaluating the performance of a CySH-modified polymer 
under various physiological conditions.   In addition, by comparing the predicted NO flux 
to the minimum NO flux for platelet inhibition reported by Ramamurthi and Lewis 
[Ramamurthi and Lewis 2000], the reason for previously incomplete platelet inhibition 
might be explained. 
 Although transnitrosation reaction kinetics in free solution were studied in 
Chapter 4, it is unknown whether the rate constants will change after immobilization as 
many enzyme activities have been found to be significantly altered after immobilization 
[Ollis et al. 1976; Jerzy et al. 1981; Bickerstaff 1997; Mateo et al. 2007].  Thus, in this 
work, the kinetics of transnitrosation between the immobilized CySH and BSANO in the 
solution was studied and the key parameters of the transnitrosation reaction, namely kf 
and kr, and kdc, were calculated based on the experimental data.   
152 
 
One potential difficulty of evaluating the kinetics for most CySH-modified 
polymers addressed in Chapter 5 (e.g. PET-N(i)-CySH) is that the bond stability was not 
very good.  Thus, kinetic parameters could be masked by continual loss of CySH from 
the polymer.  As noted in Chapter 5, only the modified polymer made via aminolysis 
followed by EDC coupling method (PET-N(a,e)-CySH) had good bond stability 
(although not good mechanical strength). However, this modified polymer had a very low 
CySH (~1 nmol/cm2) surface concentration compared to the modified PET made by 
aminolysis followed by glutaraldehyde cross-linking (PET-N(i)-CySH) or DCCI coupling 
(PET-N(a)-CySH) (~20 nmol/cm2).  The low cysteine surface concentration would be 
difficult for kinetic studies as the BSANO concentration change due to transnitrosation 
might be too small to be measured accurately. The modified PET made via aminolysis 
followed by glutaraldehyde cross-linking (PET-N(i)-CySH) showed only a 10% loss of 
CySH due to imine bond hydrolysis within the first hour at 25 ˚C (Figure 5.5).  
Therefore, this CySH-modified polymer developed via aminolysis could still provide 
valuable information regarding the values of kf and kr for an immobilized system since 
these parameters could be estimated from initial transnitrosation data within the first 
hour.   Although these parameters could vary between different types of immobilized 
CySH polymers, having an estimate of the parameters for one CySH-modified polymer 
could still provide insights regarding transnitrosation with a modified polymer.  
Therefore, in this chapter, transnitrosation kinetic studies between immobilized CySH 
(prepared via aminolysis followed by glutaraldehyde cross-linking) and BSANO were 
performed. 
kf and kr can be estimated from experimental data according to [Duan 2001]: 
153 
 
0 0 0
0
[ ] [ ] [ ] [ ]f db
d BSANO Sk BSANO CySH k BSANO
dt V
                                      (6.1) 
where the left side of Equation 6.1 is the initial slop of the BSANO concentration time 
profile, [BSANO]0 and [CySH]0 are the initial concentration of BSANO and CySH, 
respectively, S is the total area of the modified polymer and V is the total volume of the 
solution.  Knowledge of the initial conditions and the value of kdb (obtained from 
BSANO decomposition studies in the absence of polymer—see Chapter 4, Section 4.3.2) 
enables the calculation of kf from Equation 6.1.  If the equilibrium constant does not 
change with immobilization, kr can be calculated by using the free solution 
transnitrosation equilibrium constant calculated in Chapter 4.   
Once the transnitrosation studies were performed to evaluate the kf and kr 
constants following immobilization, a dimensionless mathematical model for predicting 
transnitrosation and the resulting NO flux was developed to mimic a CySH-modified 
biomaterial that could be used in a tubular system (e.g. catheters and vascular graft).  A 
laminar flow pattern was used for the model since most of the blood flow in the human 
body is laminar, except in the aorta which is turbulent flow [Brant 2001].  The model was 
simplified according to a few assumptions as noted below.  Using the model, an 
assessment of the BSANO concentration, CySH surface concentration and other factors 
was performed to determine the resulting influence on the NO flux.  The predicted NO 
flux was compared to the minimum NO flux required to minimize platelet adhesion. 
6.2 Materials and Methods 
6.2.1 Materials 
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Polyethylene terephthalate (PET) was provided by DuPont (Hopewell, VA).  
Glacial acetic acid, potassium iodide, acetone and sodium nitrite were purchased from 
Fisher Scientific (Fairlawn, NJ).  1M NaOH and 1 M HCl were purchased from Cole-
Parmer (Vernon Hills, IL).  Ethylenediamine (ED), ammonia sulfamate, iodine, L-
cysteine (CySH), glutaraldehyde and all the other reagents were purchased from Sigma 
Chemical Co. (St. Louis, MO).  Kimble 4mL and 1.8mL amber vials were purchased 
from VWR (West Chester, PA). 
6.2.2 Transnitrosation Reaction Between PET-N(i)-CySH and BSANO Solution 
 PET-N(i)-CySH was prepared using the protocol described in Chapter 5.  The 
BSANO solution was prepared using the protocol described in Chapter 4.  CySH-
modified PET was cut into 1×1 cm pieces and each piece was placed in a 4 mL amber 
vial filled with 2 mL BSANO to cover the entire polymer.  Several vials were prepared.  
The vials were then set on a hand-motion shaker, shaking at 30 times/min at 25 ˚C.  At 
specific time interval, two vials (duplicate samples) were removed from the hand motion 
shaker and the polymer samples were taken out of the vials to stop transnitrosation.   
The polymer was wiped by tissue paper and treated with acidic nitrite to nitrosate 
the CySH on the polymer to form CySNO).  During acidic treatment, CySNO is also 
detached from the polymer.  The resulting CySNO was then measured using KI/I2-based 
chemiluminescence analysis, as previously described in Chapter 5, Section 5.2.4, to 
obtain the CySH concentration on the surface.  In addition to un-nitrosated CySH on the 
polymer, there would also be CySNO on the polymer as a result of the BSANO 
transnitrosation. However, preliminary experiments showed that after pulling a polymer 
out of solution, CySNO was not detectable via chemiluminescence when the polymer 
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was exposed to an acidic solution (although not acidic nitrite such that any CySH was not 
nitrosated). Therefore, it appears that once the polymer is pulled out of solution, CySNO 
on the polymer perhaps undergoes decomposition and is no longer detectable but CySH 
can still be detected once placed back in solution and nitrosated.  Therefore, the method 
used in this study appears to measure the CySH, but not the CySNO, on the polymer 
surface.   
 Meanwhile, 20 µL of the sample BSANO solution was withdrawn from the vials 
and treated by ammonium sulfamate to scavenge any NO2-.  The sample was analyzed for 
BSANO using the KI/I2-based chemiluminescence method described in Chapter 4, 
Section 4.2.5  It should be noted that in the solution sample, an unknown concentration of 
CySNO could be present due to a small amount of CySNO release as a result of bond 
instability (although less than 10% in first hour).  However, this CySNO concentration 
likely would have a negligible contribution to the BSANO analysis since CySNO 
decomposes very fast with half life of only 6 min at pH 7.4 (as shown in Chapter 3, 
Figure 3.1) and not all of the detached thiol will be CySNO (some will likely be CySH).  
This assumption was implied for the experimental results in Section 6.3.1. 
6.2.3 Data Analysis and Modeling 
 The total RSNO concentration in solution (BSANO and CySNO—although most 
should be BSANO) and the total CySH surface concentration were plotted against time.  
The kf value was estimated using the first two data points of RSNO versus time according 
to Equation 6.1.  Since the transnitrosation reaction equilibrium constant is related to the 
Gibbs free energy which is independent of immobilization, the free solution 
transnitrosation equilibrium constant calculated in Chapter 4 was used to predict kr from 
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the kf value.  Additionally, kdc, which represents NO release from CySNO, was also 
evaluated.     
 The modeling of transnitrosation and NO release in a tubular system through 
which a fluid continually flows is derived as follows.  First, if CySH is maintained in a 
fully reduced state (i.e. never oxidized due to either CySNO decomposition or 
autoxidation), the CySNO surface concentration will reach a steady state value since the 
rate at which CySNO is generated would be a constant as a result of continuously 
replenished S-nitroso human serum albumin (HSANO) in a flowing system.  This 
assumption was validated after one hour (see Figure 6.1) for CySNO in a solution using 
the solution transnitrosation model described in Chapter 4.  It is very possible for CySH 
to remain in the reduced state since blood contains abundant ascorbic acid [Khaw et al. 
2001; Jamaati et al. 2006] and glutathione [Svardal et al. 1990; Lim et al. 1995; 
Abukhalaf et al. 2002; Elena Sbrana 2004]. Ascorbic acid can keep CySH in the reduced 
form after CySNO decomposition according to Chapter 4 and glutathione can reduce the 
cystine back to cysteine [Conrad 2009].    Based on these assumptions, the following 
model was developed. 
Similar to section 4.3.3, the transnitrosation reaction between HSANO and 
immobilized CySH, followed by CySNO decomposition can be illustrated as follows: 
HSANO CyS   HSA  + CySNOf
r
k
k
                                   (6.2) 
C yS N O   C yS +N Odck                                          (6.3) 
C yS N O  +  A A   C yS  +  D H A  +  N Odak                   (6.4) 
 The major difference between these reactions and the reactions in Chapter 4 is that both 
CyS- and CySNO are immobilized on the polymer rather than in solution.  Additionally, 
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the oxidation reactions (Equations 4.20 and 4.23) of CyS- were ignored since, as 
mentioned above, CyS- oxidation is not as likely in a blood system due to reducing 
agents.  
 
Figure 6.1 Simulation of CySNO surface concentration time profile when PET-CySH 
contacts a constant concentration of HSANO.  A continuously reduced CySH 
was assumed.  
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According to the above reactions, the rate of [CySNO] change is:  
[ ] [ ][ ] [ ][ ] [ ] [ ][ ]f T r T dc da
d CySNO k HSANO CySH k CySNO HSA k CySNO k CySNO AA
dt
                           
(6.5) 
where [CySH]T and [HSA]T are the total thiol concentrations composed of both the thiol 
and thiol anions that are in equilibrium (see Chapter 4, section 4.3.3).  It should be noted 
that [HSANO] and [HSA] are volumetric concentrations while [CySH] and [CySNO] are 
surface concentrations.  Based on a kda value of 0.00094 µM-1hr-1 [Holmes and Williams 
2000] and a maximum AA physiological concentration of 60 µM [Khaw et al. 2001; 
Jamaati et al. 2006], kda[AA]max is 0.0564 hr-1.  For kdc of 2.4 hr-1 in the presence of 50 
M AA (which is the blood concentration), kdc >> kda[AA]max.  Thus, the kda term is 
negligible and Equation 6.5 can be simplified to: 
[ ] [ ][ ] [ ][ ] [ ]f T r T dc
d CySNO k HSANO CySH k CySNO HSA k CySNO
dt
          (6.6) 
When CySNO is at steady state as discussed above, Equation 6.6 becomes: 
[ ][ ] [ ][ ] [ ] 0f T r T dck HSANO CySH k CySNO HSA k CySNO                (6.7) 
Because the mass balance for cysteine is: 
0[ ] [ ] [ ]TCySH CySH CySNO                                                    (6.8) 
where [CySH]0 is the initial CySH concentration, Equation 6.8 can be substituted into 
Equation 6.7 to give: 
159 
 
0[ ] ([ ] [ ]) [ ][ ] [ ] 0f T r T dck HSANO CYSH CySNO k CySNO HSA k CySNO        (6.9) 
 Rearrangement provides an estimate for the steady state CySNO concentration as 
a function of the original CySH loading on the polymer ([CySH]0) and the amount of S-
nitroso albumin (HSANO) or albumin (HSA) in blood according to: 
0[ ][ ] [ ]1
[ ] [ ]
dcr T
f f
CySHCySNO kk HSA
k HSANO k HSANO

 
                               (6.10)                   
To further simplify Equation 6.10, the total albumin concentration (HSANO + 
HAS) in blood is approximately 44g/L [Rodriguez-Segade et al. 2005] and [HSANO] is 
below 0.2 M [MacArthur et al. 2007].  Accordingly, [HSA] is approximately 667 M.  
(based on HSA MW of 66 kDa [Zunszain et al. 2003]).  As shown in Chapter 4, kf is of 
the same order as kr, thus 
[ ] 1
[ ]
r
f
k HSA
k HSANO
 .   Therefore, Equation 6.10 can be 
simplified to: 
0[ ][ ] [ ][ ] dc
f
CySHCySNO HSANOkHSA
K k


                                    (6.11) 
where K is the equilibrium constant, equal to kf/kr, for the reversible transnitrosation. 
Once CySNO can be approximated, the approximation can be using in the 
HSANO balance which is: 
[ ] [ ][ ] [ ][ ] [ ]f T r T db
d HSANO S Sk HSANO CySH k CySNO HSA k HSANO
dt V V
                             
(6.12) 
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where S denotes the surface area and V denotes the volume of the liquid.  Substituting 
Equation 6.7 into Equation 6.12 followed by substituting Equation 6.11 into the resulting 
equation gives: 
0[ ][ ] [HSANO] [ ][ ] 1 db
dc f
CySHd HSANO S k HSANOHSAdt V
K k k
    

                  (6.13) 
Since [HSA]>>[HSANO], HSA will likely remain at the concentration in blood due to 
rapid equilibrium between HSANO and HSA during transnitrosation.  Thus, Equation 
6.13 can be simplified to 
, ,
[ ] [ ]A S A S
d HSANO V k HSANO R
dt S
                                   (6.14) 
where 0,
[ ]
[ ] 1A S db
dc f
CySH Vk kHSA S
K k k
 

.                                                        
The first term of kA,S is the polymer surface consumption rate of HSANO and the 
second term is the self-decomposition consumption rate of HSANO in the bulk solution. 
The total consumption rate is RA,S (in mol/(area·time)).  As noted, RA,S can be 
approximated as a first-order irreversible reaction for HSANO under physiological 
conditions.  As shown below for the model conditions, the second term of kA,S is 
negligible such that kA,S represents only the consumption at the surface. 
For modeling transnitrosation and NO release in a tube through which a solution 
continuously flows, the model is described by a tube which has CySH coated on the inner 
wall.  A mixture of HSANO and HSA passes through the tube (Figure 6.2). The reactions 
(Equations 6.2 through 6.4) only occur on the surface. Thus, the consumption of HSANO 
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(Equation 6.14) appears only in the boundary condition, not in the mass balance equation 
of the bulk liquid.  
Thus, for HSANO in the bulk solution, the continuity equation is [Bird et al. 
2006]:  
2 2
2 2 2
1 1
      (1)        (2)            (3)                                                               (3)         (4) 
A A A A A A A
r z A A
vC C C C C C Cv v D r r
t r r z r r r r z
  
                               
    (5)        
(6.15) 
where CA denotes the HSANO concentration, ρ is the density of the fluid and DA is 
molecular diffusivity of HSANO. The following assumptions were made to simplify 
Equation 6.15: 
1) Steady State for CA: 0A
C
t
  .  
2) No convective transport of reactant toward the wall: vr = 0. 
3) Reactant concentration profile is angularly symmetric: 0
AC

  .  
4) Axial diffusion can be neglected compared to axial convection: 
2
2 0
AC

  . 
5) No reaction in the bulk liquid: rA = 0. Convective transport vanishes on the 
stationary surface.  Thus, the mass transfer of A towards the inner wall of the tube 
equals the consumption rate of A on the surface.  
6) Constant ρ and DA. 
Based on the above assumptions, the fives terms which are underscored can be 
neglected, resulting in the following partial differential equation (PDE): 
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1A A
z A
C Cv D r
z r r r
                                                               (6.16) 
For laminar flow, the velocity profile is a function of the radius location in the tubes 
[Polyanin et al. 2001]: 
2
( ) 2 1z
rv r v
R
                                                   (6.17) 
where vz is the axial velocity, R is the inner radius of the tube, and v is the average 
velocity within the tube.  Substituting Equation 6.17 into Equation 6.16 gives: 
 
Figure 6.2 Modeling geometry. A round tube with CySH coated on the inner war of the 
tube was assumed with blood flowing inside the tube with a laminar flow 
pattern of velocity v.  A cylindrical coordinate system with z for the axial axis 
and r for the radius axis is used.  
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2 2
2
12 1  A A AA
C C Crv D
R z r r r
                                                               (6.18) 
Rearrangement gives: 
2
2 2
2 2
2A A A A
A
C C D CvD R r
r R z r r
                                                         (6.19) 
The boundary equations to solve Equation 6.19 are: 
At z=0 and r>0, CA(r) = CA0 = 2×10-4 mol/m3 (the concentration of HSANO in blood)  
At r=R and z>0,
 
,
A
A s A A
Ck C D
r
    
At r=0 and z>0, CA(z) = CA0 = 0.2 μmol/m3.  This latter boundary condition was initially 
assumed and then validated with the modeling results.  Generally, this assumption 
implies that very little HSANO is consumed in the bulk solution.   
When solving a model, it is best to use a non-dimensional form of the model.  
With r=γR, CA=φCA0 and z=ζL, Equation 6.19 becomes: 
 2 22 11                                                                    (6.20) 
where,
 
22
A
vR
D L
 
 
The associated boundary conditions become: 
at ζ=0 and γ>0, φ(γ)=φ0= 1 
at γ=1 and ζ>0,
 
,
A
A s
Dk
R
 
    
Since γ cannot be 0 in the second term on the right hand side of Equation 6.20, a very 
small value of γ was chosen as the boundary condition for γ=0:  
at γ=0.000001 and ζ>0, ( ) 1   . 
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By solving the above PDE numerically in MathCAD (PTC, Needham, MA), the 
CA concentration profile within the tube can be predicted as a function of γ and ζ.  The 
surface concentration of CA can then be used to calculate the CySNO surface 
concentration by Equation 6.11. Finally, the estimated NO flux can be calculated 
according to: 
[NO]flux = kdc[CySNO]                                                    (6.21) 
The following parameters were used for the model. Since BSA has a diffusivity of 
5×10-7 cm2/s  [Cha and Beissinger 1996] and BSA has a similar molecular structure as 
HSANO, the diffusivity of HSANO was assumed to be the same.  The radius was chosen 
to be similar to an artery with a radius of 0.2 cm.  For this size of an artery, the average 
velocity is around 10 cm/s [Stoner et al. 2004].  The length of the polymer tube was 
chosen as 1 m.  Although this length is extremely long for polymer applications, this 
length would give a good idea as to how the HSANO concentration and NO flux change 
through the polymer tube. Based on the above information, in Equation 6.20 is 16,000.  
To estimate kA,S (Equation 6.14) used in the boundary condition, the constant 
cysteine surface concentration, [CySNO]0, was chosen as 4 nmol/cm2, which was a 
typical value shown in Chapter 5 and was also a typical surface concentration used in 
previous platelet inhibition studies in which incomplete inhibition was observed [Duan 
and Lewis 2002; Gappa-Fahlenkamp and Lewis 2005].  [HSA] was assumed to be the 
typical value in blood which is 667 M.  K was assumed to be 0.66 as measured from the 
free solution transnitrosation studies in Chapter 4.  The value of kdc was assumed to be 
2.4 hr-1, which was the average value for the free transnitrosation studies in Chapter 4 
involving 50 μM AA (which is the typical concentration in blood).  The validity of this 
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assumption is shown in Section 6.3.1.  The kdb value is 0.001 hr-1 from experimental 
conditions as shown in section 6.3.1.  Finally, kf = 0.33 μM-1hr-1 from the free 
transnitrosation studies of Chapter 4 was used (see discussion section to validate this 
reasoning).  Based on these values, kA,S is approximately 0.0096 cm/hr of which the kdb 
term of Equation 6.14 only contributed to 1% of the value.  Thus, the kA,S term is 
representative of just the consumption of HSANO at the polymer surface, which was 
assumed for the boundary condition.  As an additional point, the kf contribution was 
negligible such that kA,S is only strongly dependent upon K, [HSA], and kdc.   
6.3 Results 
6.3.1 Transnitrosation between BSANO and Immobilized CySH 
Figure 6.3 shows the BSANO concentration profile when BSANO was incubated 
with CySH-modified PET. Also, the BSANO concentration time profile (without CySH 
modified PET) is also shown in the graph for comparison.  The BSANO profile without 
the polymer showed a first order decay constant, kdb, of 0.001 hr-1, which is consistent 
with previous results in Chapter 4 (0.002 hr-1).  However, the BSANO concentration 
decreased significantly when CySH-modified PET existed in the system, indicating that 
transnitrosation followed by CySNO decomposition (on surface or in solution) played an 
important role. 
As shown in Figure 6.4, the CySH surface concentration during transnitrosation 
dropped very fast within the first 6 hours (about 60% loss) and then began to stabilize.  
According to Figure 5.5 where no transnitrosation occurred, the CySH loss from bond 
instability appeared to be only 30%.  Therefore, the “apparent” increase in CySH loss 
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during transnitrosation may be a result of some of the CySH on the polymer being 
converted to CySNO and this CySNO is likely not detected by the chemiluminescence 
method as mentioned in section 6.2.2.   
When the CySH surface concentration remained approximately constant (between 
7 and 60 hours), the BSANO concentration showed a decrease with a constant slope of 
0.446 μM/hr. This constant slope indicates a pseudo-steady state CySNO (and CySH) 
concentration which is similar to the simulation in Figure 6.1.   It should be noted that 
although bond instability was observed at early times in Chapter 5, bond instability was 
not as appreciable between 6 and 30 hours, leading to the possibility of CySNO reaching 
pseudo-steady state value. At this point, all of the change in BSANO would be equivalent 
to the NO release rate, such that   
[ ] [ ]dc
d BSANO Sk CySNO
dt V
                                                          (6.22) 
The NO release rate was obtained from Equation 6.22.  The left side of Equation 6.22 is 
the constant slope of -0.446 μM/hr noted above.  S is 2 cm2 and V is 2 mL.  To 
approximate [CySNO], the [CySH] value of 7 nmol/cm2 (see Figure 6.4) was used.  Since 
the polymer initially had 24 nmol/cm2, and approximately 60% is lost after 30 hours due 
to hydrolysis (see Figure 5.5), then that should leave 9.6 nmol/cm2 on the surface.  
Therefore, [CySNO] should be approximately 2.6 nmol/cm2.  Based on this, kdc is 
calculated to be 0.17 hr-1. This is very close to the value of 0.22 hr-1 observed in Chapter 
4 for free transnitrosation in the absence of AA (see Table 4.4).  Thus, it appears that 
immobilization doesn’t significantly change the constant.  Therefore, the value of kdc 
used in the model, based on 50 M AA, was assumed to be the same as observed in 
Chapter 4 for free transnitrosation.   
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Figure 6.3 BSANO concentration change during transnitrosation with immobilized 
cysteine (using PET-N(i)-CySH). (n=2) Solid diamond: BSANO without PET-
N(i)-CySH, Solid square: BSANO with PET-N(i)-CySH, dashed line is the 
first order decay model for the data based on Equation 4.16.   
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Figure 6.4 CySH surface concentration (PET-N(i)-CySH ) change during transnitrosation 
with BSANO. (n=2) The CySH surface concentration dropped very fast 
within the first 6 hours and then slowed down. CySH loss within 6 hours 
(~60%) is more than that of Figure 5.5 (~30%).  
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  From this study, the initial surface concentration of CySH was measured as 24 
nmol/cm2.  Based on Equation 6.1 and the initial slop of the BSANO concentration 
profile, together with the initial BSANO concentration, kf was calculated to be 0.0037 
μM-1hr-1.  This value is much lower than the value for free solution transnitrosation as 
calculated in Chapter 4 (0.33 μM-1hr-1) but is within the wide range reported in Table 4.1.  
The significantly lower value suggests that immobilization reduced the effectiveness of 
transnitrosation.  As noted in the discussion section, the reduced effectiveness may have 
been due to mass transfer limitations. 
6.3.2 Transnitrosation Modeling in Flow System 
 The results for the model simulation are shown in Figure 6.5. The dimensionless 
HSANO concentration is also indicated by the darkness of the grey color (the deeper 
color for higher concentration).  It shows that concentration drops slightly near the wall 
and the outlet of the tube has a greater concentration gradient than the inlet of the tube.  
In order to get a more detailed concentration profile near the wall, a contour graph of the 
dimensionless concentration focusing on the dimensionless radius range from 0.9 to 1 
(Figure 6.6) shows the concentration drop between the bulk solution and the surface. The 
maximum concentration drop is around 5%, which occurs at the outlet of the tube.  As 
noted, the concentration in the bulk solution remains the same as the inlet, thus validating 
the boundary condition at r=0. 
Based on the dimensionless HSANO concentration profile near the wall, the NO 
flux was calculated by Equation 6.11 and 6.21.  Figure 6.7 shows the NO flux based on 
the simulated HSANO concentration profile near the inner wall of the tube.  The NO flux 
is virtually constant throughout the entire tube, a little higher than 5.2×10-12 mol/(m2·s), 
170 
 
 
Figure 6.5 Dimensionless simulation of Human Serum albumin (HSANO) concentration 
profile within a tube with inner surface covered with Cysteine (CySH). The 
graph shows only the concentration near the wall (0.8≤ γ≤1), since the 
concentration is essentially constant throughout the tube except near the wall.  
The depth of grayscale indicates the dimensionless concentration (the darker 
for the lower concentration).  
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while the minimum NO flux to inhibit platelet adhesion is around 3-6×10-12 mol/(m2·s) 
[Ramamurthi and Lewis 2000].  Therefore, the polymer used in previous experiments 
may have been sufficient to minimize platelet adhesion. However, uncertainties in 
physiological conditions, such as the HSANO concentration (as shown in Table 6.1), 
exert significant impact on the NO flux, leading to possible insufficient NO flux as 
discussed in detail later.     
6.4 Discussion 
6.4.1 Transnitrosation Reaction between BSANO and Immobilized CySH 
Although the CySH modified polymer used for this analysis is an unstable polymer with 
CySH detaching from the polymer surface with time, it still showed that the modified 
polymer is capable of continuously transferring NO.  For instance, according to Figure 
6.3, 90 nmol of BSANO was transferred in the 2 ml solution compared to the 48 nmol of 
initial CySH on the polymer.  Thus, even without ascorbic acid, CySH on the polymer 
performs better than free CySH in solution since CySH in solution only could transfer 
less NO than the amount of CySH.  This finding is probably due to the reason that 
immobilized CySH, even if it forms a thiol radical (which is the oxidation product of 
thiol anion by either Cu2+ [Dicks et al. 1996] or O2 [Ehrenberg et al. 1989]), may not be 
easy to react with each other as a result of steric hindrance to form a disulfide bond (CyS-
CyS).  Instead, the unreacted thiol may be reduced from other molecules (e.g. free thiol 
group on BSA) to form reduced cysteine.  
As noted above, the transnitrosation kinetics data was different between the free 
solution study and the immobilized study. The value of kf for the immobilized study was  
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Figure 6.6 2-D contour (with concentration gradient) graph for dimensionless simulation 
of HSANO concentration profile within a tube with inner surface covered 
with CySH.  The depth of the darkness indicates the concentration (lighter for 
higher concentration and darker for lower concentration). The graph shows 
part of the tube which is near the wall (dimensionless radius from 0.9 to 1). 
The number on the contour line is the dimensionless concentration.  
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Figure 6.7 NO flux profile along the length of the tube at the inner wall surface (γ=1) of 
the tube calculated from the dimensionless simulation of Human Serum 
albumin (HSANO) concentration profile within a tube with the inner surface 
covered with Cysteine (CySH).  
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Table 6.1 S-nitroso human serum albumin (HSANO) concentration in plasma. 
Concentration Method Reference Note 
181±150 nM GC-MS + HgCl2 [Tsikas et al. 1999]  
4.2±1 μM Fluorometric Assay [Tyurin et al. 2001] non-pregnancy women 
156±64 nM GC-MS + HgCl2 [Tsikas et al. 2002]  
205±96 nM GC-MS + cysteine/CuSO4 
[Tsikas et al. 2002]  
62±24 nM HPLC + Saville [Jourd'heuil et al. 2000]  
7.2±1.1 nM Chemiluminescence [Rassaf et al. 2003]  
0.59±0.31 nM Chemiluminescence [Wang et al. 2004]  
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approximately two orders of magnitude smaller than the free solution value.  One 
possibility of the lower value, compared to free transnitrosation, is that mass transfer is 
controlling the rate rather than kinetics.  Since BSANO is a large molecule and the 
nitrosated cysteine residue (Cys-34) is located in the center of the BSA molecule [Gryboś 
et al. 2005], the immobilized CySH within the cracks of the polymer (ethylenediamine 
forms crack on PET) might not be able to easily come in contact with BSANO.   
According to Equation 6.1 and the measured initial values and slope, the far right 
side of the equation (self decomposition) is negligible.  Thus, Equation 6.1 can be 
rewritten as: 
     000
0
][ BSANOkCySHBSANOk
dt
BSANOd
f 

   (6.23) 
where k=kf[CySH]0.  It is interesting to note that Equation 6.23 is also consistent with a 
model for mass transfer limitations where k is the volumetric mass transfer coefficient for 
BSANO.  In other words, mass transfer limitations could result in an “apparent” kf that is 
lower than a “true” kf and the apparent kf would be related to the slower mass transfer 
rate.  This appears to be a likely explanation for the lower kf and further work would need 
to be performed to test this hypothesis.  From a modeling standpoint, the model 
parameters noted at the end of Section 6.2 assumed a kf of 0.33 μM-1hr-1 (from free 
transnitrosation) rather than the apparent value shown above.  The reason is that the 
model must include the “true” value of kf to accurately represent the reaction at the 
surface as the diffusivity of the HSANO has already been included in the model.   
Unlike the transnitrosation kinetics, the NO release (i.e., CySNO decomposition) 
rate constant was similar to the free CySNO decomposition rate constant.  This seems 
176 
 
feasible since the rate is primarily a function of the copper ion which should easily be 
able to come into contact with the polymer due to its small size.  
6.4.2 Factors that influence NO flux from the CySH modified polymer 
There are numerous environmental factors that can affect the NO flux from the 
polymer.  The HSANO concentration might be the most important one according to 
Equations 6.11 and 6.21 which shows that the predicted HSANO concentration will 
significantly affect the NO flux.  So far there are still significant inconsistencies 
regarding the HSANO concentration in blood [Rassaf et al. 2003; Giustarini et al. 2007]. 
Table 6.1 shows recent results with the range from sub-nM to μM.  Thus, if the HSANO 
concentration is lower than the simulation value (200 nM), the NO flux will decrease 
significantly.  For example, if assuming the HSANO concentration is one-tenth of 200 
nM (20 nM), the NO flux would be reduced to around 0.52×10-12 mol/(m2·s), although 
the NO flux will still remain almost constant throughout the tube (figure not shown here).  
This NO flux is one order of magnitude less than the minimum required NO flux to 
inhibit platelet inhibition.  According to Table 6.1, most of the reported HSANO 
concentrations are below 200 nM, with an average concentration of 102 nM (not 
including the 4.2 μM value, because of the potential artifact reported for this flurorimetric 
analysis [Giustarini et al. 2007]). Therefore, with this average value, the predicted NO 
flux is estimated to be 2.6 ×10-12 mol/(m2·s), which will likely still cause incomplete 
platelet inhibition. Thus, for the previous incomplete inhibition, the possible reason could 
be the low HSANO concentration in the blood.  However, this assumption needs to be 
verified in the future.  
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Another important parameter in the model is the initial surface CySH 
concentration. The 4 nmol/cm2 used in the simulation is the ethylenediamine treated 
polymer used by Duan and Fahlenkamp [Duan and Lewis 2002; Fahlenkamp 2003], 
which had a lot of cracks to increase the cysteine surface concentration. The theoretical 
CySH concentration on the polymer should be around 1 nmol/cm2, unless a branch 
structure can be formed on the polymer by attaching a molecule with multiple thiol 
groups.  Under the condition of 1 nmol/cm2 CySH initial concentration, the NO flux 
would be around 1.3×10-12 mol/(m2·s), which is much less than the minimum required 
flux.  Therefore, in order to make a polymer with complete platelet inhibition and good 
mechanical and chemical stability, attaching a compound with multiple thiol groups or 
forming branches with multiple activation sites on the polymer surface might be the 
direction for future research.  
To test the sensitivity of the decomposition rate constant kdc effect on NO flux, the 
value of kdc was set to 6.6 hr-1 which was the highest value measured previously in 
Chapter 4, Table 4.4., the NO flux will be around 13×10-12 mol/(m2·s) throughout the 
tube.  Compared to the NO flux prediction (kdc= 5.2 ×10-12 mol/(m2·s)) at the base value 
(2.4 hr-1), the model is also sensitive to kdc which is also a strong function of the copper 
ion concentration.  Under physiological conditions, metal ions are usually in bound form. 
For example, the majority of the copper is bound to ceruloplasmin while the rest is bound 
to serum albumin or amino acid [Twomey et al. 2005].  Although the bound copper can 
still catalyze NO release from CySNO, the catalyzing rate is significantly reduced [Dicks 
and Williams 1996].  Therefore, the kdc could be much lower in vivo compared to the 
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value measured in chapter 4 which could be a potential problem for the modified 
polymer.  
For the flow rate and tube diameter, these parameters only affected the HSANO 
concentration profile (figure not shown here) within the tube but not on the surface of the 
wall (which is reasonable because reaction takes place on the wall).  
6.5 Conclusions 
 In this chapter, BSANO transnitrosation with immobilized CySH was studied in a 
batch system using the polymer (PET-N(i)-CySH).  A mathematical model for predicting 
the NO flux from the modified polymer surface in a tubular flow system was established 
and various factors which can influence the NO flux were evaluated. The key findings 
are: 
1) Cysteine on the polymer performs better (transferring more NO from BSANO) 
than cysteine in the solution even without the help of ascorbic acid. 
2) The immobilized transnitrosation reaction appeared to be mass transfer limiting, 
likely due to the cracks on the polymer, as the kf value was two orders of 
magnitude smaller than the free solution transnitrosation value.  This may be a 
result of BSANO being a large molecule and cannot easily diffuse into the cracks. 
However, these cracks do no effect the surface CySNO decomposition since kdc 
remained almost the same compared to the free transnitrosation studies. 
3) Modeling showed that HSANO and CySH have the most significant effect on the 
NO flux.  Increasing either of them will cause a significant NO flux increase.  
Also the kinetic constant of kdc could also affect the NO flux rate.  However, the 
179 
 
flow rate and tube diameter does no effect the NO flux, they only change the bulk 
HSANO concentration profile. 
4) The modeling results indicate that previous incomplete platelet inhibition by a 
CySH modified polymer (PET-N(i)-CySH) may likely be due to the low HSANO 
concentration in blood since the reported HSANO level in the plasma has a wide 
range (about two orders of magnitude).  As the HSANO concentration decreases, 
the NO flux becomes insufficient if the actual HSANO concentration is about half 
of the 200 nM value. However, it is still possible to make a successful platelet-
inhibiting polymer with good chemical and mechanic stability by attaching a 
compound with multiple thiol groups or introducing branch structures with 
multiple activation sites on the polymer for attaching thiol molecules.  Such 
action could increase the NO flux significantly.  
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CHAPTER 7 
CONCLUSIONS AND FUTURE WORK 
 
The haemocompatibility of biomaterials has always been a major issue which 
interferes with the performance of a medical device and causes severe health threat for 
patients, especially for the long term applications, as a result of platelet adhesion and 
aggregation on the material surface.  Current treatment of this problem includes 
systematic administration of heparin and material surface modification with functional 
groups.  Both of these two methods have their own limitations or side effects.  For 
example, heparin treatment can cause side effects, such as platelet depletion, which can 
lead to thrombocytopenia and hemorrhage [Annich et al. 2000].  On the other hand, 
surface modifications with functional groups always suffer from incomplete platelet 
inhibition or short term performance [Bamford and Al-Lamee 1992].  Nitric oxide (NO), 
a small signal messenger, has been found to be a key player for platelet inhibition.  NO is 
naturally secreted by endothelia cells to prevent platelet adhesion to the blood vessel 
[Feldman 1993; Vaughn et al. 1998].  Thus, in order to mimic this unique property of 
blood vessels, a L-cysteine (CySH)-modified polymer was previously developed which 
can utilize endogenous NO to inhibit platelet adhesion through transnitrosation followed 
by fast S-nitrosocysteine (CySNO) decomposition.  However, the experimental results 
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showed only 60% inhibition, rather than complete inhibition [Duan and Lewis 2002; 
Gappa-Fahlenkamp and Lewis 2005].  
In this work, in order to reveal the reason for the incomplete platelet inhibition, 
the mechanism of transnitrosation followed by decomposition, as well as the stability of 
the polymer, was studied in detail.  Several alternative immobilization methods were also 
evaluated and compared to the previous method.  Finally, a kinetic model for predicting 
the NO flux from the polymer surface was established and various environmental effects 
on the NO flux were evaluated and compared to the previously identified minimum NO 
flux required for platelet inhibition [Ramamurthi and Lewis 2000].  
7.1 Major Accomplishments of the Study 
 The ultimate goal of this work was to study the transnitrosation kinetics between 
BSANO in solution and immobilized CySH, as well as the NO release from immobilized 
CySNO.  Following the experimental studies, a mathematical model was developed to 
predict the NO flux from the CySH-modified polymer under various conditions.  By 
comparing the predicted NO flux with the minimum required NO flux established earlier, 
the direction for future improvement of the polymer could be established.  The significant 
findings from this work are listed as follows. 
 CySNO decomposition (which includes NO release) maximizes near 
physiological pH regardless of the buffer due to trace metal ions existing in all 
buffer salts. The buffer purity and chelating agent greatly affects the 
decomposition rate, especially at near physiological pH.  A model involving 
metal ions and the associated equilibrium between different forms of the metal 
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ions agreed well with experimental observations.  The model provided a 
plausible explanation for the pH dependence on CySNO decomposition.  
 An improved nitrite/S-nitrosothiol detection method based on ammonium 
sulfamate pre-treatment and KI/I2-based chemiluminescence method was 
established, which gave less standard error and more data consistency. 
 Transnitrosation between BSANO and free CySH was found to be sensitive to 
various reductants and oxidants.  Oxygen and Cu2+ both can oxidize CySH, 
while ascorbic acid can react with Cu2+ so that less CySH will be oxidized.  
The NO transferred from BSANO increases significantly when the ascorbic 
acid concentration increases.  A mathematic model which included 
transnitrosation between BSANO and CySH, CySNO decomposition and 
CySH oxidation was developed to model the experimental data.  The results 
showed that the model described the transnitrosation reactions very well.  
Experimental results showed that ascorbic acid increases the CySNO 
decomposition rate constant and reduces the CySH oxidation rate constant, 
which is consistent with the reaction mechanisms.  Model sensitivity analysis 
showed that the transnitrosation rate constants kf and kr, and the CySNO 
decomposition rate constant kdc, have the most impact on the BSANO 
concentration time profile.  However, the ascorbic acid oxidation rate constant 
koa has less influence. 
 The previous protocol for making immobilized CySH on PET (PET-N(i)-
CySH) lead to an unstable polymer due to imine bond breakage between 
either CySH and glutaraldehyde or glutaraldehyde and the amine on PET.  
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Amide bond formation using DCCI or EDC coupling increased the stability of 
the modified polymer in acidic condition. However at neutral pH, some of the 
modified polymer still showed bond breakage and only one of the newly 
developed polymers (ethylenediamine treatment followed by EDC coupling) 
showed good bond stability in both acidic and neutral pH.  In addition to bond 
stability issues, cysteine on all the polymers can also be oxidized slowly just 
as the free cysteine oxidation which followed zero order kinetics in solution.  
Different immobilization methods appear to have a significant effect on the 
oxidation rate constant.   
 Ethylenediamine treatment can cause substantial amounts of cracks on PET 
surfaces and the higher concentration of ethylenediamine used, the bigger the 
cracks. Also, the PET thickness is reduced significantly after ethylenediamine 
treatment which potentially affects the mechanical properties or the stability 
of the modified polymer.  Immobilized CySH on PET-N(i)-CySH polymer is 
susceptible to light and air under dry conditions.  However light or air alone 
does not cause CySH oxidation.  This oxidation was found to be represented 
by a 3rd-order decay reaction with regard to the CySH surface concentration, 
but a detailed mechanism remains unsolved.  It was also discovered that 
CySH-modified PET can be stored in an amber vial at -20 ˚C for about 2 
months without noticeable oxidation. 
 The transnitrosation reaction between the CySH modified polymer (PET-N(i)-
CySH) and BSANO showed that cysteine on the polymer performs better 
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(transferring more NO from BSANO) than cysteine in the solution even 
without the help of ascorbic acid.  
 The transnitrosation reaction could be affected by mass transfer limitations as 
the kf value was two orders of magnitude smaller than the free solution 
transnitrosation value.  This may be a result of BSANO being a large 
molecule and cannot easily diffuse into the cracks. However, these cracks do 
not affect the surface CySNO decomposition since kdc remained almost the 
same compared to the free transnitrosation studies. 
 Modeling of CySH modified polymer contacting blood in a tubular flow 
system showed that the S-nitroso-human albumin (HSANO) concentration 
and CySH surface concentration have the most significant effect on the NO 
flux prediction.  Also the kinetic constant of kdc could also affect the NO flux 
rate.  However, the flow rate and tube diameter primarily only change the bulk 
HSANO concentration profile.  The model also predicts that using the CySH 
modified polymer made by previous researchers in this group (PET-N(i)-
CySH with about 4 nmol/cm2 CySH surface concentration) may not achieve 
complete platelet inhibition mainly because of the low HSANO concentration 
in the blood.   The HSANO level has been reported to range from 0.6 nM to 
200 nM, based on different analysis methods. The NO flux will be insufficient 
if the actual concentration is about one-half of the 200 nM value. However, 
this assumption needs to be verified by accurately measuring the HSANO 
concentration in blood, which is very challenging so far. 
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7.3 Future Work 
 In order to improve the performance of the CySH-modified polymer in 
physiological conditions for long terms, there are still many issues that need to be 
addressed. 
 A modified polymer is needed that has both structural integrity and stable bonds.  
In order to make a polymer with both good mechanical integrity and bond 
stability, two approaches can be attempted in the future: a) introduce amine 
groups on the PET without destroying the polymer and then do the EDC coupling 
or b) find a water soluble thiol protected CySH (which can later be deprotected) 
and attach it to carboxylated PET using the EDC method.   
 Transnitrosation kinetics between the modified polymer and CySNO 
decomposition at 37 ˚C need to be studied to predict the NO flux.  The current 
studies were only at 25 ˚C and the kinetics of transnitrosation and CySNO 
decomposition reaction rate constants are likely to be different due to a change in 
the temperature.   
 Glutathione effects on cysteine oxidation need to be studied since glutathione is a 
much stronger reducing agent compared to ascorbic acid.  Glutathione is present 
in the blood [Svardal et al. 1990; Flagg et al. 1993; Lim et al. 1995] and has been 
used to reduce various thiol compounds.  The transnitrosation under both ascorbic 
acid and glutathione also needs to be studied so that a more detailed and realistic 
kinetic model can be established. 
 An unsteady state model for the flow system needs to be developed to predict the 
temporal profile of the NO flux.  The model can further be improved by including 
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a laminar pulse flow pattern that is more consistent with blood flow as compared 
to the constant flow pattern considered in this work.  This change would give a 
more realistic prediction of the NO flux under physiological conditions.  
 Despite the possible low HSANO in vivo, which could bring a real challenge for a 
successful platelet-inhibiting CySH modified polymer,  the performance of the 
CySH-modified polymer can be improved by either modifying the polymer 
surface with multiple carboxyl groups such as polymethymethacrylate followed 
by CySH attachment or by immobilizing compounds with multiple thiol groups 
on the polymer surface.  Increasing CySH can significantly increase the NO flux, 
therefore compensating for the negative effect from the low HSANO 
concentration. 
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Scope and Method of Study: In order to improve the haemocompatibility of biomaterials 
so that platelet adhesion on the surface can be minimized, a cysteine (CySH) modified 
polymer was developed previously and preliminary blood contacting test has shown that 
the modified polymer can inhibit 60% platelet adhesion.  The mechanism of this modified 
polymer is that the immobilized cysteine on the polymer can seize nitric oxide (NO) from 
S-nitroso-albumin (AlbSNO) in blood through transnitrosation reaction, and then the 
unstable S-nitroso-cysteine (CySNO) decomposes and release NO, which is a well known 
platelet inhibitor.  However, the reason for incomplete platelet inhibition is unclear since 
measuring the NO flux from the modified polymer is difficult.  Therefore, a detailed 
kinetic model is required to predict this NO flux.  In this study, the kinetics of the 
associated reactions is investigated and stability of the modified polymer is evaluated and 
finally, NO flux is estimated by modeling in a tubular flow system.   
 
Findings and Conclusions: CySNO decomposition is sensitive to various environment 
conditions such as metal ion contamination level, pH and ascorbic acid concentration.  
Transnitrosation in free solution revealed that CySH is oxidized by metal ion or oxygen 
in solution during the reaction while ascorbic acid can prevent the oxidation caused metal 
ion, however, oxidation due to oxygen still exists.  On the other hand, previous technique 
for immobilizing CySH led to an unstable bond which is prone to hydrolyzation in 
neutral pH.  Increased temperature was found to accelerate this hydrolysis significantly.  
An improved modification method was developed and a stable bond was formed.  Out of 
the aqueous solution, immobilized CySH can also be oxidized when both light and air 
exists, while at -20˚C, CySH is very stable on the polymer surface for about 2 months.  
Immobilized transnitrosation showed that CySH on the polymer performs better than 
CySH in the free solution as it transferred more than three times of its own amount of 
BSANO before getting totally oxidized even without ascorbic acid.  The calculated 
kinetic rate constants showed that transnitrosation has mass transfer limiting behavior 
which is likely due to the cracks on the polymer formed during modification while the 
CySNO decomposition rate constant is not affected by the cracks.  The predicted NO flux 
by a model is sufficient for the platelet inhibition for previous in vitro blood test, however 
this flux is highly sensitive to AlbSNO concentration which can be much lower than the 
value used in the model setup. 
